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Against the backdrop of the global public health burden of psychiatric disorders and the 
consequent need for cost-effective care and prevention strategies, this research thesis set 
out to develop and test methods for conducting mental health economic analysis in an 
international context. The objectives of the thesis were: to develop appropriate 
methodologies for mental health care service utilisation and cost measurement; to 
generate comparative service utilisation, cost and outcome data; and to explore the 
relationship between cost, psychiatric symptoms, quality of life, needs and disability. 
The thesis is based on three international, collaborative studies: an EU-funded study of 
the needs and costs of schizophrenia care in five European health care systems 
(EPSILON); an international study of the quality of life and economic correlates of 
major depression in primary care (LIDO); and a mental health economics demonstration 
project in India and Pakistan (MENDIP). 
Methodological developments in the cross-cultural economic analysis of mental health 
care that have emerged from this work include: the development of service utilisation 
schedules, unit cost protocols and health system profiles for site-specific data collection; 
the application of emerging analytical techniques to mental health care evaluation; and 
the production of guidelines for mental health economic analysis. 
The use of these methodologies in the three source projects of the thesis has 
demonstrated the feasibility of undertaking multinational comparative studies, revealed 
the extent of cross-cultural variation in the use and cost of mental health services, and 
highlighted the complex set of inter-relationships that exist between costs, needs and 
outcomes. The thesis concludes with a discussion of future requirements for cross- 
cultural mental health economic analyses and the wider mental health policy 
implications of key findings. 
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An accumulating body of evidence has emerged, particularly over the last five years, 
which points to the immense burden that psychiatric disorders impose upon 
individuals, families and whole communities throughout the world (Ustiin and 
Sartorius, 1995; Desjarlais et al, 1995; Murray and Lopez, 1996). The increasing 
recognition of mental health as a significant international public health issue has led 
to additional demands for resources that are already stretched. There is therefore a 
requirement to demonstrate that investment into mental health is needed and 
worthwhile, which translates into generating evidence on affordable and cost- 
effective care and prevention strategies. Such an evidence base is an important step 
in convincing governments that additional mental health resources will generate 
significant health gain and other benefits. Unfortunately, however, there is currently a 
dearth of good quality cost and cost-effectiveness evidence in most regions of the 
world for mental health interventions with proven, likely or potential effectiveness 
(Gulbinat et al, 1996; Srinivasa Murthy, 1996; Shah and Jenkins, 1999; Chisholm, 
1999). This poses a predicament for international mental health policy-making, 
which is that despite the abundance of epidemiological and clinical evidence pointing 
to the need for investment, there is a paucity of economic evidence to guide or 
support these investment decisions. 
Together with the responsibility of governments and health care agencies to ensure 
that resources are targeted appropriately, a further source of growing interest in 
comparative studies of disease burden relates to the multiplicity of care arrangements 
for people with mental illness that have emerged in different countries. To date, most 
multi-national studies of mental disorder have focused on establishing the prevalence 
of the disease and assessing outcomes cross-culturally (WHO, 1986). Such 
international studies represent a fundamental step forward in cross-cultural 
psychiatric research, most notably in terms of developing methods and measures that 
are applicable across diverse cultural settings, which at their best can lead to 
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improved planning and resourcing of mental health services for the vast numbers of 
people suffering from psychiatric disorders who remain unrecognised or untreated. 
There is little comparative research, however, which examines the relationship 
between inputs, processes and outcomes (Thomicroft and Tansella, 1998), or more 
specifically, the resource implications of care for people with mental health problems 
living in different countries and settings. 
1.2 Research objectives and questions 
The end goal of the research can be stated as the generation of cost and cost- 
effectiveness methodologies and data that will enable improved decision-making in 
the allocation of resources to mental health care at an international level. Specific 
objectives and key research questions of the thesis are given below: 
Research objectives 
* To examine cross-cultural variations in the socio-political, financial and health 
system context within which mental health services are provided; 
To identify and develop culturally appropriate methodologies for the international 
measurement of mental health service utilisation and costs; 
To generate comparative service utilisation, cost and outcome data on the basis of 
international studies of major psychiatric disorders and key policy issues; 
To explore the relationship between the costs of psychiatric disorders and a range 
of individual and country-level characteristics, including socio-demography, 
symptom levels, quality of life, needs and disability; 
To identify and consider key methodological and policy issues for the 
development and future conduct of international mental health economic analysis. 
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Key research questions 
What is the extent of the economic burden that psychiatric disorders impose on 
communities and health care services in different parts of the world? 
How do health-seeking behaviours and patterns of service utilisation vary cross- 
culturally for groups of people with the same psychiatric diagnosis? 
How are improvements in clinical and social domains of outcome (e. g. symptom 
severity, quality of life, functioning) associated with changes in service utilisation 
and cost? 
How do associations between symptomatology, quality of life and service costs 
vary across cultures? 
1.3 Source projects 
This thesis is based on three separate international, collaborative studies that share a 
number of overlapping objectives, methods and approaches. Although these studies 
are concerned with more than one patient group, have been undertaken in a diverse 
range of care settings and have differing emphases, all are characterised by an interest 
in the cross-cultural, comparative assessment of mental health services. The 
epidemiological design of the three studies is essentially observational, that is these 
studies are essentially aimed at examining varying patterns of health service delivery, 
costs and outcomes between countries, as opposed to investigating the introduction 
of a specific new intervention or strategy. In addition, each study includes an 
economic component as an integral part of the core research activities. This has 
enabled lessons learnt from one study to be applied to the economic aspects of other 
studies. Taken together, these three projects provide an appreciable new source of 
data on the costs of providing care to people with mental health problems in different 
countries, as well as an increased understanding of the inter-relationship between 
costs and socio-demographic, clinical and socio-cultural variables. 
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Schizophrenia needs and costs in rive European countries (EPSILON) 
The EPSILON (European Psychiatric Services: Inputs Linked to Outcome Domains 
and Needs) study is a comparative, cross-sectional study of the characteristics, needs 
and life qualities of people with schizophrenia in five European countries, the 
services they receive, and the associated costs and satisfaction levels. The study was 
carried out in Amsterdam, Copenhagen, London, Santander and Verona, and the 
project was funded under the EU BIOMED Il programme. Specific objectives of the 
study were: 
* To produce standardised versions of five instruments in key areas of mental health 
service research in five European languages (Danish, Dutch, English, Italian and 
Spanish) each of which was converted from the original into the other four 
languages: the Camberwell Assessment of Need; the Client Service Receipt 
Inventory; the Involvement Evaluation Questionnaire; the Lancashire Quality of 
Life Profile; and the Verona Service Satisfaction Scale; 
e To compare, in five European centres, data about social and clinical variables in 
patients with schizophrenia, the mental health care they receive and its costs. 
Some of the findings and final results of the economic component of the EPSILON 
study have already been reported or have been submitted for publication (Chisholm 
et al, 2000a, 2000b; Knapp et al, 2000; see Chapter 3 for details). 
Longitudinal Investigation of Depression Outcomes (LIDO) 
The overarching aim of the Longitudinal Investigation of Depression Outcomes 
(LIDO study) is to explore the relationship between major depressive disorder in 
primary care patients and their quality of life and resource use, to be accomplished in 
a multi-centre, cross-national observational study with a prospective cohort of 
patients in primary care. The study was funded by Eli Lilly and Co., co-ordinated by 
Health Research Associates (Seattle, USA) and the participating study sites were: 
Barcelona,, Spain; Be'er Sheva, Israel; Melbourne, Australia; Porto Alegre, Brazil; 
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Seattle, USA; and St Petersburg, Russia. The specific objectives relating to the 
economic dimension of the LIDO study were: 
1. To develop a research method for the collection of health care service utilisation, 
associated costs data, and site-level socio-demographic and service profiles; 
2. To describe and compare key domains of service use, costs and outcomes for 
different study sites and sub-populations; 
3. To explore site-specific and cross-cultural relationships between service 
utilisation/costs and symptoms/QoL/functioning/treatment. 
The follow-up phase of this study was still in the field at the time of submission of 
this thesis. Consequently, Chapter 4 is restricted to consideration of methodological 
aspects of the economic component of the study, together with baseline and early 
follow-up results only (some of which are described in Chisholm et al, 2000c). 
Mental health economics demonstration project in India & Pakistan (MENDIP) 
Against the backdrop of a widening recognition of the global health burden of 
psychiatric disorders, the Mental Health Economics Demonstration Project in India 
and Pakistan set out to develop and test methods for conducting economic analysis of 
community mental health programmes in low-income countries. The research was 
funded by the UK's Department for International Development, and involved 
collaboration between the Centre for the Economics of Mental Health and the 
Institute for Health Sector Development (London), the Institute of Psychiatry, 
Rawalpindi (Pakistan) and the National Institute of Mental Health and 
Neurosciences, Bangalore (India). Specific objectives of the research were threefold: 
* To analyse the structure, delivery and financing of mental health care in India and 
Pakistan; 
* To develop culturally appropriate protocols, methods and guidelines for the 
economic analysis of community mental health care programmes; 
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To generate service use, costs and outcomes data, based on a demonstration 
evaluation of the integration of mental health care into primary care. 
The study was completed and a final report to the funding body written in 1999. 
Some of the key findings have subsequently been reported (Chisholm et al, 2000d; 
see Chapter 5 for details). 
1.4 Structure and content of thesis 
A chapter of the thesis is devoted to each of the three source projects, which follow a 
similar structure: the rationale for the study; aims, objectives and hypotheses; a 
detailed description of methods; presentation of results; and a discussion of key 
findings and implications for mental health services research and policy. The study- 
specific chapters are preceded by a review of the international research and policy 
context within which the source projects are located, including cross-cultural studies 
of psychiatric disorders and the contribution of health economics to mental health 
policy and services research. The thesis concludes with a discussion of key empirical 
findings, emerging issues in the cross-cultural measurement of service use and costs, 
and suggested directions for mental health economic analyses in the future. 
The specific emphasis of the three studies differs. The primary focus of the 
EPSILON study was the development of a range of mental health care evaluation 
measures capable of being used widely in a European context, subsequently 'tested' 
for their validity and applicability - within the confines of a cross-sectional survey - 
on a small cohort of schizophrenia patients. At the centre of the LIDO study, by 
contrast, was the prospective, cross-cultural exploration of the inter-relationships 
that exist between depressive symptoms, health seeking behaviours and user 
outcomes, with a view to better understanding the consequences of treatment (or non- 
treatment) in primary care settings. Finally, the MENDIP study was primarily 
concerned with demonstrating the feasibility of applying methods of economic 
analysis to mental health programmes in low-income countries, exploring as it did so 
the relationship between access to services, subsequent uptake of services and the 
impact of this uptake in terms of user outcomes. These respective differences in 
emphasis - instrument development in schizophrenia, cross-cultural associations in 
depression, and the application of mental health economics in low-income countries - 
are duly reflected in the reporting of the three source projects. Thus, for example, 
particular attention is given in Chapter 3 on the EPSILON study to the description of 
the development of a service receipt schedule capable of international use, whereas in 
Chapter 4 there is a detailed consideration of the methods required to make 
comparisons between countries with widely diverging health system and socio- 
demographic profiles. 
There is of course a substantial volume of work that the thesis draws and builds on, 
including: 
9 Clinical and epidemiological research in psychiatry, including international 
studies of particular disorders or initiatives (e. g. Sartorius and Harding, 1983; 
UstUn and Sartorius, 1995; Simon et al, 1999); 
9 Mental health economics and policy analysis in industrialised countries, 
particularly in the US and the UK (e. g. Knapp, 1995; Hargreaves et al, 1998); 
e International health economics research, including the development of general 
guidelines for the conduct of cost analysis and economic evaluation in developing 
countries (e. g. Creese and Parker, 1994; Mills and Lee, 1993). 
What is currently missing but required is a synthesis of these different strands of 
research into a coherent set of methods that will allow for the appropriate and 
culturally-sensitive assessment of the economic costs, organisational structures and 
health-related outcomes of mental health care programmes internationally. The 
contribution of the thesis to international mental health policy can therefore be stated 
in terms of the provision of these newly developed and tested methods for economic 
analysis in this international context and the initial generation of cost and outcome 
data to begin filling the existing gap in such information. 
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2. Policy and research context: the cross-cultural 
measurement and burden of psychiatric disorders 
This thesis is concerned with the development of cost: outcome methodologies and 
the generation of data capable of contributing towards more informed decision- 
making about the allocation of resources into mental health care at an international 
level. Its genesis arose, on the one hand, from awareness of an accumulated body of 
evidence from comparative and psychiatric epidemiology that has clearly pointed to 
the immense but under-recognised public health burden attributable to psychiatric 
disorders globally; and on the other, from an appreciation of the shortage of empirical 
evidence relating to the effectiveness and cost-effectiveness of mental health 
interventions in an international context. 
While the enormous gap that exists in many regions of the world between identified 
mental health needs and allocated resources to meet these needs is in no small part a 
consequence of the negative (public and political) perception or stigmatisation of 
psychiatric disorders, the paucity of local evidence for effective and affordable 
interventions is a further disincentive to appropriate investment. The generation of 
an international, research-based evidence base for mental health service development 
and intervention can therefore be seen as one important component of a broader 
policy agenda to reduce, in currently under-served populations, the existing gap 
between the need for and supply of mental health care. 
The focus of the thesis is on economic aspects of mental health care evaluation, but 
draws on the insights of other fields of research in medicine and the social sciences, 
including social psychiatry, psychiatric epidemiology, medical anthropology and 
health services research. Each of these research disciplines has added to a steadily 
accumulating knowledge base surrounding the aetiology, prevalence, interpretation 
and management of psychiatric disorders in different countries or cultures. Their 
relevance to the central research questions addressed in the thesis can be viewed in 
terms of their historical contribution to the cross-cultural measurement of psychiatric 
disorder, and in terms of key analytical issues or themes that they serve to highlight. 
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The inter-relationship between these separate fields of research was made apparent in 
a recent report on World Mental Health (Desjarlais et al, 1995; p. 43): 
'Given the enormous human andfinancial costs of serious mental illness, we have 
much to learn from investigating social, cultural and other environmental factors 
that influence the course and outcome of major mental illness' 
A chronological starting point for the review of these inter-related bodies of literature 
is the series of WHO-sponsored international studies which have documented the 
course, outcome and impact of psychiatric disorders in a variety of populations and 
countries throughout the world. This body of literature is briefly described below, 
together with a critique of its core assumptions by its principal detractors (exponents 
of the 'new cross-cultural psychiatry'). More recent developments in international 
mental health policy are then highlighted, including the actual and potential 
contribution of health economics to the cross-cultural measurement of psychiatric 
disorder and disease burden. 
2.1 Cross-cultural studies of psychiatric disorders 
Interest in carrying out multi-site cross-cultural research into mental illness can be 
traced back to the convening of a WHO expert committee in 1959 on the 
epidemiology of psychiatric disorders (WHO, 1979b). This committee reviewed 
existing knowledge, stressed the need for reliable and valid data on the incidence and 
prevalence of psychiatric disorders, and recommended that WHO should take the 
lead in developing appropriate methods for undertaking epidemiological research in a 
cross-cultural context. 
The possibility of transferring or adapting epidemiological research methods for 
psychiatric disorders from industrialised to low-income countries was first seriously 
tested in a study of psychiatric disorders among the Yoruba in Nigeria (Leighton et 
al, 1963), but the most notable consequence of the period of consultation following 
the WHO expert committee of 1959 was the development of an initial plan for the 
International Pilot Study of Schizophrenia (IPSS; WHO, 1973,1979b). This 
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landmark study, a multicultural investigation of 1200 patients in nine countries, 
provided for the first time a standardised method for the classification and 
measurement of mentally ill patients in an international setting. Principal areas of 
interest included the effect of culture on the form, content, course and outcome of 
schizophrenia, as well as the development of standardised, reliable and valid methods 
(WHO, 1973). A comparative, prospective study design was adopted, which 
involved the selection of (a range of) psychotic patients aged 15-44 years who were 
in contact with psychiatric services. The principal measure of symptornatology was 
the Present State Examination (PSE; Wing et al, 1974), adjudged by the investigators 
to have attained satisfactory acceptability, applicability and reliability across the nine 
sites. Comparison of PSE-generated clinical profiles indicated a high degree of 
concordance for patients with a diagnosis of schizophrenia (ICD-8 code 295) 
between the sites. 
The follow-up phase of the study focused on the course and outcome of the 
diagnostic groups within and between cultures (WHO, 1979b; Leff et al, 1992). A 
key finding of this phase of the work was that not only was the course and outcome 
of well-defined schizophrenia observed to be highly variable within centres, but there 
were also systematic (and statistically significant) differences in overall two-year 
outcome between centres, in particular between those in low-income countries (Agra, 
Cali, Ibadan) and the other six industrialised centres (Aarhus, London, Prague, 
Washington etc. ). The better outcome found in the low-income countries, attributed 
to social support within the family, lower expectations and low expressed emotion 
within the family, was maintained at five-year follow-up (Leff et al, 1992). Other 
sociocultural factors that have been argued to contribute to less severe course of 
illness include conceptions of cause and course, the opportunity to work or engage in 
meaningful labour and treatment settings, with institutionalisation in particular being 
less conducive to health improvement (Desjarlais et al, 1995; p. 43). The better 
outcome observed in the low-income countries was subsequently confirmed in the 
successor to the IPSS, the WHO Collaborative Study on the Determinants of 
Outcome of Serious Mental Disorder (Sartorius et al, 1986; Jablensky et al, 1992), 
which broadly mirrored the findings of the IPSS, but which was able to draw 
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conclusions on a more secure footing owing to the improved, incidence-based design 
of the study. 
Following a series of policy decisions concerning renewed commitment to primary 
health care by the WHO (I 979a) and recognition of the need to develop and evaluate 
alternative and low-cost methods of mental health care (WHO, 1975), an 
international collaborative study on Strategiesfor Extending Mental Health Care was 
carried out (Harding et al, 1980,1983; Sartorius and Harding, 1983). This study 
investigated the frequency and diagnosis of psychiatric disorders in primary health 
care settings in seven low-income countries. The investigators found that psychiatric 
disorders constitute a significant proportion of morbidity seen in primary health care 
(between 10.6% and 17.7% across the seven participating sites). The disorders 
detected were mainly neuroses, with psychosomatic symptoms being the most 
common presenting complaint. The high rate of somatic complaints was argued to 
be a key factor behind a further important finding of the study, which related to the 
relatively low level of detection of psychiatric disorder by (trained) primary care 
workers in the study areas (only one-third of research-diagnosed cases were 
identified). Few cases of psychoses were identified, in part due to lower incidence 
rates of serious mental illness but also because psychotic patients are not so inclined 
to seek care and treatment at the primary care level. In reaching this conclusion, the 
study explicitly raised the important economic and policy issue of the relative 
prioritisation to be accorded to providing services to the numerically few but 
symptomatically more severe people with psychoses as compared to the much greater 
number of people with more common and less severe psychiatric disorders (mainly 
depression and anxiety). 
The impact of depressed and anxious patients on the caseloads of primary health care 
professionals has been investigated by a series of further WHO international studies. 
A WHO Collaborative Study on the Assessment of Depressive Disorders, conducted 
in four cultural settings (Nagasaki, Montreal, Basle and Teheran), compared the 
characteristics of patients with depression presenting at primary care facilities 
(Jablensky et al, 1981; WHO, 1983). The study provided evidence, as the IPSS had 
for schizophrenia, that the characteristic syndrome of depression exists in different 
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cultural settings and includes symptoms which can be assessed clinically in a very 
similar manner across diverse settings. The results of the I 0-year follow-up study of 
course and outcome for the proportion of these patients for whom data could be 
collected (46%) showed that one-third had had at least one readmission, of whom 
about one-half had experienced a deterioration or no change in health status, while a 
further quarter had moderately good outcome without readmission (Thornicroft and 
Sartorius, 1993). The other major measure of outcome used referred to suicide: I I% 
of all patients completed suicide in the follow-up period, and 14% made unsuccessful 
attempts in the same period. 
A further cross-cultural investigation carried out under the auspices of the WHO was 
the Pathways to Psychiatric Care Study, a systematic examination of the Goldberg 
and Huxley model (1980) which described the referral pathways taken by 1554 
patients newly referred to mental health services in II countries (Gater et al,, 1991). 
The investigators found that the pathways in centres relatively well-provided with 
psychiatric staff (Granada, Manchester, Havana etc. ) were dominated by general 
practitioners and to a lesser extent hospital doctors, whereas the relatively less well- 
resourced centres (Bangalore, Rawalpindi and Ujung Pandang) showed a variety of 
pathways with native healers often playing an important role. In keeping with other 
similar studies, somatic problems were a common form of presentation in all centres. 
A key finding was that delays along the pathways to care were relatively short, 
irrespective of psychiatric resources, although in certain centres longer delays on 
pathways involving native healers were observed. 
The most recent report to document the dramatic impact of psychiatric disorder in 
primary health care settings is the WHO International Study of Psychological 
Problems in General Health Care, carried out in 15 primary care sites across both 
industrialised and low-income regions (PPGHC study; UstUn and Sartorius, 1995). 
Overall, primary care physicians identified 23.4% of attendees as being a 'case' with 
a psychological disorder (while a research instrument identified 33%). The most 
common psychiatric disorders in all centres were depressive disorders (10.4%) and 
anxiety disorders (7.9%). Patients with psychiatric disorder, particularly those with 
depression, perceived their health status to be poor and experienced physical and social 
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disability that exceeded that of people with common chronic physical diseases such as 
diabetes, arthritis and back pain (UstUn and Sartorius, 1995; Ormel et al, 1994). The 
primary care physicians reported that they provided treatment to 78% of cases whom 
they identified as having a psychological disorder (around half are given counselling, 
a quarter sedative medication and only a sixth receive anti-depressants). 
The principal finding of the PPGHC study was that significant amounts of psychiatric 
morbidity across all centres went untreated or undetected, which in turn raised 
critical issues relating to the appropriate training of primary health care workers in 
the recognition and management of psychiatric disorders, as well as the availability 
and supply of pharmacological and psychological forms of treatment for these 
disorders. The failure to recognise psychological disorders appeared to be particularly 
marked in those who presented with somatic symptoms or with a pre-existing physical 
illness, but the organisation of care provision also appeared to be important: centres 
with 'individualised care" (a personal physician responsible for co-ordinating the 
patient's care and who the patient sees by appointment) had higher rates of detection 
than centres using a 'collective care' model (patients attend a clinic without an 
appointment and see whichever doctor is there on that day). 
This series of international studies represented a fundamental step forward in cross- 
cultural psychiatric research, most notably in terms of developing methods and 
measures that are applicable across diverse cultural settings. This process of 
standardisation, resulting in a common language of diagnosis and outcome 
measurement, has allowed for the subsequent communication, exchange and 
comparison of epidemiological findings from different parts of the world. Put to 
their best use, such research findings can lead to improved planning and resourcing 
of mental health services for the vast numbers of people suffering from psychiatric 
disorders who remain unrecognised or untreated. At their worst, these studies have 
been viewed as 'psychiatric imperialism', involving inappropriate attempts to 
'impose Western concepts of psychopathology on non-Western peoples' (Leff, 1990; 
p. 305). The source of such criticism has been advocates of the so-called 'new cross- 
cultural psychiatry', brief consideration of which now follows. 
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2.2 Psychiatric disorders from a sociocultural perspective 
The traditional transcultural psychiatric approach had satisfied itself with focusing on 
the identification of variations and similarities in the frequency and patterns of 
symptoms across cultures, with a view to constructing improved and universally 
valid conceptual models of psychiatric disorder (Kleinman, 1977; Littlewood, 1990). 
In a comprehensive review of depressive disorders from a transcultural perspective, 
for example, Singer (1975, p. 297) concludes that 'the evidence does not support the 
view that culture influences the morbidity of depressive disorders ....... the concept of 
depressive disorder as it is held in the West emerges as universally valid'. The 
cputative rarity of depressive disorders' and 'pronounced somatisation and 
hypochondriasis in depressives' outside the Western cultures are put down to faulty 
study sampling, the reported rarity of suicides is regarded as an unreliable indicator in 
comparative studies, while 'the alleged increase in morbidity with increasing 
complexity of civilisation probably reflects an increase in availability of psychiatric 
facilities and a broadening of concepts of psychiatric disorder' (ibid). In a similar 
review of psychiatry in Africa, German (1987; p. 445) argues that 'the medical model 
- or perhaps more precisely the Western nosological model - seems capable of 
adequately accounting for the nature of the majority of these African mental ill-health 
problems'. 
Singer's review and other studies of the 'old cross-cultural psychiatry' have been 
castigated by Kleinman (1977, p. 3) as a 'breathless search through large amounts of 
data from different societies looking for universals'. Using material from field 
research in Taiwan and from other anthropological investigations, Kleinman argued 
that there are significant cross-cultural differences and that these differences are a 
function of the cultural shaping of normative and deviant behaviour: 'culture does 
considerably more than shape illness as an experience; it shapes the very way we 
conceive of illness' (ibid). Underlying this proposition is a vital distinction between 
disease and illness: disease refers to malfunctioning of biological or psychological 
processes, whereas illness is the personal and cultural reaction to disease. In this 
respect, illness is by definition a cultural construct. The depressive syndrome, for 
example, is argued to be 'a cultural category constructed by psychiatrists in the West 
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to yield a homogeneous group of patients' (1977, p. 3). The assumption that Western 
diagnostic categories are themselves culture-free entities has been labelled as a 
'category fallacy'; rather, such categorisation should be viewed as an 'explanatory 
model' specific to the Western context (Kleinman, 1980). 
The fundamental implication of this paradigm shift - in anthropological terms a move 
away from cultural universalism to cultural relativism - is that local meanings of 
mental illness, and individual or institutional responses to it, should be elicited and 
understood before attempting any comparisons across societies (Bracken, 1993; 
Chisholm and Bhugra, 1997). Accordingly, the International Pilot Study of 
Schizophrenia (WHO, 1973) - and other related studies - have come under fire for 
starting from 'a category fallacy which significantly limits its value as a study of 
cultural interactions on mental illness.... it can tell us almost nothing about the 
relationship of culture to either the group it includes or the larger one it excludes' 
(Kleinman, 1977, p. 4). In particular, the use of the Present State Examination (Wing 
et al, 1974) attracted criticism as a measure conceived and developed in the West, 
subsequently imposed - cultural assumptions and all - on other societies (Fernando, 
1988; Kleinman and Good, 1985). 
While the 'new cross-cultural psychiatry' has generated important insights into the 
feasibility or desirability of comparative, cross-cultural psychiatric research, Leff 
(1990) reasonably questions the practicality of undertaking the kind of exhaustive 
phenomenological descriptions envisaged by cultural relativists in all subsequent 
comparative research studies, and asks whether previous research failing to meet 
these criteria needs to be discounted (in Leff s terms, a case of 'throwing the baby out 
with the bath water'). One simple response to this relates to the position on a 
spectrum - extending from symptomatic psychoses, through schizophrenia and the 
neuroses, to the more 'culture-bound' conditions such as bulimia and drug overdose - 
that the clinical condition under cross-cultural investigation occupies, the implicit 
assumption being that culture exerts a stronger influence at the sociological than at 
the biomedical pole (Littlewood, 1990). With respect to schizophrenia, there are a 
sufficient number of completed ethnographic studies in Africa and elsewhere to 
suggest a reasonable degree of congruence with regard to the signs by which insanity 
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is recognised in different culture (even if explanatory models of the causation of 
insanity may differ widely). In the opinion of Murphy (1994), this congruence helps 
to cast a rather warmer light on the findings of the IPSS and related studies. 
Investigations of depression, by contrast, indicate a more culturally-constructed 
manifestation of underlying disease: for example, Kleinman (1982) indicates that the 
kind of depression which Chinese psychiatrists and their patients call neurasthenia is 
a culturally-constructed form of depression in which somatic symptoms are 
emphasised over psychological symptoms. 
2.3 The burden of psychiatric disorders 
Mental health and DAL Ys: The Global Burden of Disease study 
Building on the achievements of earlier collaborative work, and drawing on an 
increasingly wide range of disciplinary contributions, international mental health 
policy in the 1990s has seen a number of key developments. Perhaps the most 
important of these developments relates to the Global Burden of Disease (GBD) 
study compiled by the Harvard School of Public Health, the WHO and the World 
Bank, which for the first time attempted to assess not only the mortality effects but 
also the disabling consequences of disease (World Bank, 1993a; Murray and Lopez, 
1996). A key finding of this monumental piece of work - and to many outside the 
mental health field, a surprising one - was that by combining the mortality and 
disability effects of disease into a single metric, the Disability Adjusted Life Year 
(DALY), the massive burden of global disease attributable to non-conununicable 
disease, and neuropsychiatric disorders in particular, became readily apparent. 
Investing in Health (World Bank, 1993a) calculated that neuropsychiatric disorders 
accounted for 8.1 % of the global burden of disease in 1990. In the final report of the 
Global Burden of Disease study, the proportion of GBD caused by neuropsychiatric 
disorders was revised upwards to 10.5% (Murray and Lopez, 1996). The latest 
estimate for 1998, given in The World Health Report 1999, is 11.5% of GBD for all 
member states, 23.5% in high income countries and 10.5% in low and middle income 
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countries (WHO, 1999). Major depression is the leading cause of disability world- 
wide, owing to high rates of prevalence (particularly among women), non-detection 
(90% in many regions) and severity (a disability weight of 0.6 out of I in untreated 
form). Psychiatric disorders account for five of the ten leading causes of disability - 
unipolar depression, alcohol abuse, bipolar affective disorder, schizophrenia and 
obsessive compulsive disorder (Murray and Lopez, 1996). The burden imposed by 
these disorders is projected to increase to 15% of GBD by the year 2020, largely as a 
result of demographic trends such as the increased number of elderly individuals and 
consequent cases of dementia (Shah and Ames, 1994; Jenkins, 1997a). 
The significance of DALYs in highlighting the burden of disease attributable to 
different health conditions and causes of mortality (including psychiatric disorders) at 
global and regional population levels cannot be overstated, since it represents a 
fundamental move forward in bridging the gap between mortality and the effects of 
morbidity. Adopting techniques developed in the field of health economics, DALYs 
share many of the characteristics and limitations of Quality Adjusted Life Years 
(QALYs). The key distinction between the two measures is that QALYs are an 
output to be gained (quality of life being a positive outcome domain) while DALYs 
are an output to be averted through health care interventions. The outstanding feature 
of both forms of measurement is that they offer a set of parameters and dimensions 
with which to compare interventions for different conditions, as well as for different 
interventions for a specific condition under investigation. They also provide an 
explicit framework within which to assess the relative burden of disease or the 
relative effectiveness of alternative interventions, in terms of the methodological 
assumptions employed, the trade-offs that individuals are prepared to make between 
longevity and quality of life or disability and the weightings that are consequently 
accorded to different health states and client groups (Chisholm et al, 1997a). 
In attempting to capture disease burden or health improvements in a single numerical 
index, however, DALYs and QALYs fall prey to a number of well-founded 
criticisms concerning the placement of values on states of health and the scales along 
which these values are measured. In relation to DALYs, for example, disability 
severity weights were specified and derived by health care experts alone, which casts 
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doubt on the validity of both the conceptualisation of disability used and the 
valuation base adopted (Amesen and Nord, 1999). The findings of the GBD study 
are also weakened by the fact that results, particularly for developing regions, are 
based on inadequate or poor epidemiological data with respect to rates of prevalence, 
detection and treatment, which reduces the credibility of the findings to local policy- 
makers. A further limitation of the GBD study is that there is currently little 
indication on a practical level of how DALYs are to be systematically linked to cost- 
effectiveness evidence for improved health care decision-making and priority-setting. 
DALYs are not in themselves sufficient as a mechanism for resource allocation and 
priority-setting in health care (Anand and Hanson, 1997; Sayers and Fliedner, 1997); 
for these tasks, there is a need for an additional component, cost, which can be 
related subsequently to derive costs per DALY for different interventions. 
The economic burden ofpsychiatric disorders: cost of illness studies 
The burden or consequences of psychiatric disorders can also be usefully gauged 
from an economic perspective. Psychiatric disorders impose a range of costs on 
individuals, households, employers and on society as a whole (Box 2.1)-. 
Box 2.1 The burden of psychiatric disorders: a cost matrix 
A. Care costs A. Productivity costs A. Other costs 
1. Sufferers Treatment and service Work disability Anguish/suffering 
fees / payments Lost earnings Treatment side-effects 
Suicide 
2. Family and Informal Time off work Carer burden 
friends care-giving 
3. Employers Contributions to Reduced productivity 
treatment & care 
4. Society Provision of MH & Reduced productivity Loss of lives 
general medical care Untreated illness 
(taxation/insurance) (unmet need) 
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The overall economic burden associated with psychiatric disorders has been 
estimated in a series of 'cost of illness' studies which attempt to attach monetary 
values - as opposed to DALY estimates - to these various societal costs, typically 
expressed as an annual estimate aggregated across all involved agencies for a whole 
country. Such studies have direct parallels with epidemiological estimates of disease 
burden,, in the sense that the principal aim is to influence policy-making and resource 
allocation by demonstrating the relative magnitude or burden of economic costs 
associated with a particular disorder. Since no measures of outcome enter into these 
analyses, cost of illness studies cannot be considered as examples of economic 
evaluation per se, nor are they capable of demonstrating directly how resources 
should be allocated across different health care interventions. 
A recent comparative study of the Burdens of Disease carried out within the UK's 
National Health Service demonstrated the relative and absolute costs of care for a 
wide range of disorders, including the comparatively high annual expenditure 
associated with chronic disease conditions such as neurosis and psychosis (NHS 
Executive, 1996; Figure 2.1). 
Figure 2.1 NHS Burdens of Disease (NHS Executive, 1996) 
f million, 1992/93 







0 Inpatient 0 Outpatient 
0 Primary care 0 Pharmaceuticals 
0 Community health 0 Social services (adults) 
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Using these and other data, Patel and Knapp (1998) attempted to calculate the 
aggregate costs of all psychiatric disorders in the UK, arriving at an estimate of f32 
billion (1996/97 prices). This included not only the direct costs of health and social 
service provision and treatment for people with mental health problems, but also 
costs to the criminal justice system, costs to informal carers and lost work 
productivity as a result of suicide and impairment. The costs of lost productivity 
accounted for 45% of overall costs. 
The economic burden associated with schizophrenia and depression has been 
estimated in a series of similar 'cost of illness' studies carried out in a small number 
of countries (see Table 2.1 for a summary). Comparison between studies is 
complicated by the heterogeneity of methods used, for example whether an incidence 
or prevalence based approach is adopted, or whether the costs associated with 
premature mortality have been included. However, where a comprehensive estimate 
has been obtained, a common feature of these studies is that the lost productivity 
costs exceed the direct costs of care and treatment, sometimes by as much as six or 
seven times (Stoudemire, 1986; Kind and Sorensen, 1993). 
These high estimates of lost productivity costs are attributable to the use of a 'human 
capital' method of calculation, which assumes that all lost days of an adult's working 
life should be valued (typically at the wage rate of the person before their impairment 
or death). In prevailing conditions of unemployment, it has been argued that costs 
calculated on this basis represent an exaggeration or overestimation of the true 
opportunity costs associated with the condition under investigation. A more realistic 
basis for such computations is the 'friction-cost method', which only takes into 
account the productivity lost before a replacement worker is found (Koopmanschap 
et al, 1995; Goeree et al, 1999a). Applying this method to the costs of schizophrenia 
in Canada, Goeree et al (1999b) estimated that the cost of lost productivity resulting 
from mortality was $1.53 million, as opposed to $105 million if the human-capital 
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As with the Global Burden of Disease study, estimates of the economic burden of 
disease provide a useful research and policy context within which to investigate 
interventions or strategies that are capable of making an impact on this identified 
burden in terms of clinical and cost-effectiveness (Rupp et al, 1998). However, cost 
of illness studies in mental health have been very much concentrated on two 
psychiatric disorders in only a handful of countries (which arguably reflects the 
willingness of pharmaceutical companies to sponsor many of these studies as a 
marketing strategy for the launch of a new Product in these markets). As such, they 
have limited relevance to a more international perspective of the economic burden 
associated with a broader range of psychiatric disorders in the global population. 
Furthermore, there remains an outstanding concern that the reliance on a human 
capital approach leads to an over-estimation of the total cost burden. Currently, 
therefore, DALYs would appear to constitute the most internally consistent and 
universally valid metric for assessment of the burden of disease in an international 
context. This prompts the question of what are the key policy-orientated objectives 
and methodological principles that mental health economics must pursue in order to 
usefully inform international mental health policy dialogue and resource allocation? 
2.4 International mental health policy and economics 
Recent developments in international mental health policy 
Despite the weaknesses of some of the underlying data, the overall conclusion reached 
in the GBD study that psychiatric disorders, and depression in particular, constitute a 
major public health problem that on a global level largely goes unrecognised and 
untreated is widely accepted by mental health professionals and researchers. Outside 
the mental health arena, however, the newly recognised burden attributable to 
psychiatric disorders has received a less positive response. Indeed, despite the 
burden of psychiatric disorder that the 1993 World Bank report Investing in Health 
pointed to, it did not suggest that mental health should belong to the package of 
essential clinical services, indicating therefore that mental health services should 
somehow be viewed as discretionary. 
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Promulgation of the neglected state of mental health at an international level has 
come instead from World Mental Health (Desjarlais et al, 1995). co-ordinated by the 
Department of Social Medicine, Harvard Medical School. This report specifically 
concerned itself with amassing salient facts, figures and arguments pertaining to the 
burden of suffering imposed by mental and psychosocial health problems on low- 
income countries in Asia, Africa, Latin America and the Middle East. A particular 
feature of the report is its emphasis on the social and economic context in which 
mental and behavioural health problems occur, as made clear at the outset (Desjarlais 
et al, 1995; p. 3): 
'World mental health is first and foremost a question of economic and political 
wettare. Although the links between social forces and ill health are complex and 
varied, close inspection suggests that mental health concerns almost always relate 
to more general concerns that have to do with the economic wetfare of afamily or 
community, the environment in which a person lives, and the kinds of resources that 
he or she can draw on'. 
Pursuing this broad approach, chapters of the report are given up to consideration of 
issues specific to children and youth, women and the elderly, as well as the effects of 
dislocation on mental health. In so doing, clear relationships are made apparent 
between mental health and the effects of poverty and urbanisation, important links 
not only for an increased understanding of the impact of material or service-related 
poverty as a determinant of outcome (Harpham, 1994; Saraceno and Barbui, 1997), 
but also in engaging the interest and involvement of international agencies, such as 
the World Bank, USAID and the UK Government's Department for International 
Development, whose mission in the health sector is closely related to the alleviation 
of poverty. On the basis of the report's findings, the authors made a plea for mental 
health to be placed on the international agenda, backed up by recommendations and 
specific initiatives for meeting the challenges posed. The report was presented to the 
United Nations, which subsequently has set up a major initiative entitled 'Nations for 
Mental Health', the overall objectives of which are to raise awareness about the 
burden of psychiatric disorders, to support countries while they plan and implement 
strategies for reducing this burden, and to promote technical co-operation between 
countries (Jenkins, 1997b). 
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For a report that is focused on the mental health problems and priorities of low- 
income countries, however, the paucity of evidence reported in World Mental Health 
on the costs and relative cost-effectiveness of alternative policies or programmes - 
which is and must be a critical criterion for successful implementation and 
sustainability - represents a notable gap in coverage. Even in drawing up an agenda 
for research on mental health services, no mention is made of the need for new 
evidence relating to low-cost but effective care and prevention strategies. One 
probable reason why the report is able to do little more than pay lip-service to issues 
of cost-effectiveness is that there is currently a dearth of data relating to these 
concerns in low-income countries. Such a lack of data is also one important factor 
behind, for example, the World Bank's guarded position regarding supporting mental 
health care activities. At a two-day awareness-raising workshop for World Bank 
staff ('Mental Health and Development: what can the World Bank do? '; September 
1998)5 it was clearly stated that two key preconditions for World Bank assistance and 
support included explicit prioritisation of mental health by national governments 
seeking help and the existence of robust evidence relating to the cost-effectiveness of 
new interventions or strategies for mental health care. 
International mental health care policy is consequently faced with an apparent 
predicament, which is that despite the abundance of epidemiological and clinical 
evidence pointing to the need for investment, there is a scarcity of economic evidence 
to guide or support these investment decisions. The extent to which this is a valid 
characterisation of the state of international mental health policy and economics is 
reviewed below. 
The contribution of health economics to international mental health 
The increasing recognition of mental health as a significant international public 
health issue has led to additional demands for resources that are already stretched 
(Desjarlais et al, 1995; p. 67): 
'Economic constraints, particularly those resulting ftom mandated efforts to 
restructure economies, have placed extreme limits on governments' abilities to 
develop new services or extend successful programmes. In the context of scarcity, 
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mental health services are seldom given high priority by national governments or by 
international aid programmes. The importance of addressing the wide-ranging 
problems [associated with] mental and behavioural problems ... ... should 
be 
recognised as crucialfor both human and economic development. " 
There is therefore a requirement to demonstrate that investment is needed and 
worthwhile, which translates into generating evidence on affordable and cost- 
effective mental health care and prevention strategies (Chisholm, 1999). Such an 
evidence base is an important step in convincing governments that additional mental 
health resources, most notably in training, effective psychotropic drugs and basic 
infrastructures, will generate significant health gain and other benefits. The need for 
mental health economic evidence is made clear in the WHO's strategy on mental 
health policy and care (Gulbinat et al, 1996; p. 533): 
"Health policy decision makers are looking for cost-effective options in the 
organisation of mental health care at a time when international comparative studies 
of mental health services are extremely limited, indeed almost non-existent " 
Mental health economics as a topic and a discipline has much to offer in filling this 
gap. Most significantly, by valuing the costs and outcomes of alternative 
interventions or strategies, it is able to go beyond epidemiological estimates of the 
burden of psychiatric disorder (expressed in DALYs or other units of measurement) 
by demonstrating what can or should be done to respond to this known burden. This 
branch of health economics, economic evaluation, has developed at an exponential 
rate since the early-1970s, and there is no sign of this rate diminishing, as 
governments, health agencies and insurers alike bid to contain the costs of health care 
or subject the introduction of new technologies to a prior evaluation of their costs and 
benefits. Health economics as a discipline can also contribute to policy discussion 
through examination of the patterns of employment, the forces of demand and 
supply, the roles of markets in resource and treatment allocation, and the incentives 
and disincentives to better practice (Donaldson and Gerard, 1993; Chisholm and 
Stewart, 1998). Much of the mental health services research carried out in the US 
has in fact focused on mental health care financing, including reimbursement systems 
and insurance mechanisms (Frank and Manning, 1992). 
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The prevailing problem that is being addressed by economic analysis is one of 
resource scarcity. The ubiquity of resource scarcity, relative to needs, translates into 
a requirement to make choices about how these scarce resources should be most 
appropriately allocated. At the most aggregated level, a government could decide, 
say, to double its budgetary allocation to mental health care: while this undoubtedly 
would have many positive impacts, there would in all likelihood remain an 
outstanding pool of unmet mental health need in the population. Moreover, the 
decision to allocate a greater volume of resources to mental health care - in a 
constrained, publicly funded system, at least - impacts on the resources available for 
other health or welfare programmes that may equally deserve additional investment. 
At the level of mental health purchasers and providers, resource scarcity prompts the 
need to gather data or evidence with which to evaluate the clinical and cost 
effectiveness of new and current therapies. Purchasers, for example, require 
information on the relative worth of alternative interventions in order to improve or 
maximise the health gain of their local populations. 
The two fundamental objectives of economic analysis are to improve both the 
efficiency with which health care resources are employed and to target those 
resources on needs and demands (the equity objective). Efficiency is first and 
foremost concerned with establishing that health care programmes are worthwhile, in 
the sense that their benefits exceed their costs (allocative efficiency); at a technical 
level, efficiency is concerned with ensuring that best use is made of the scarce 
resources channelled into these worthwhile programmes. Efficiency therefore 
provides a framework with which to determine an optimal allocation of resources to 
various programmes of health care expenditure. Equity considerations revolve 
around the ideas that each person must be given their due and equals must be treated 
as equals. Discussions about justice or equity at a policy level have typically 
concentrated on the distribution or redistribution of (scarce) resources, which in the 
context of mental health care is typically determined by need and expressed in terms 
of access to or utilisation of services (Chisholm and Stewart, 1998). 
Despite the need for economic analysis, there remains a paucity of completed mental 
health economic evaluations from both developed and developing countries (Evers et 
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al. 1997; Shah and Jenkins, 1999). Although the study of mental health and 
economics can be traced back forty years (Fein, 1959), it is only in the last twenty 
years that evaluative studies have begun to emerge. In the US, Weisbrod et al (1980) 
applied (partial) cost-benefit analysis to Assertive Community Treatment, a model of 
care that has dominated policy discussions of alternatives to hospital care ever since 
(Latimer, 1999); the model was also applied and evaluated in a UK context (the 
Maudsley Hospital's Daily Living Programme), including a cost-effectiveness 
analysis (Knapp et al, 1998). Other evaluative studies that have had a significant 
bearing on UK policy includes the reprovision of long-term care from hospital and 
the development of community care (Hallam et al, 1994; House of Commons Social 
Services Committee,, 1990). 
The preponderance of completed economic evaluations in mental health care have 
been concerned with more specific treatment modalities for psychoses and affective 
disorders, in particular the cost-effectiveness of different psychotropic medications 
and, more recently, various psychotherapeutic approaches to the management of 
these psychiatric disorders. Since the 1950s, the treatment of schizophrenia and 
depression in industrialised countries has been dominated by pharmacotherapy, 
initially neuroleptics and tri-cyclic anti-depressants (TCAs), now increasingly so- 
called atypical anti-psychotics and newer anti-depressants such as selective serotonin 
re-uptake inhibitors (SSRIs). The weight of evidence points to the superior cost- 
effectiveness of SSRIs over TCAs and atypical over conventional anti-psychotics, 
however there is still no definitive evidence that demonstrates clear dominance (both 
in terms of costs and outcomes) for these newer drugs (Woods and Baker, 1997; 
Hotopf et al, 1996; Knapp et al, 1999). Encouraging evidence is emerging in relation 
to the cost-effectiveness of psycho-therapeutic approaches to the management of 
depression and schizophrenia, but again there is a need for more prospective studies 
with sufficient sample sizes and cost coverage to definitively address the issue of 
cost-effectiveness of these alternative interventions (Gabbard et al, 1997; Knapp, 
1999). 
Over the last few years, one or two studies have emerged from developing countries, 
including consideration of the cost-effectiveness of screening for mental illness in 
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primary care settings in Brazil and India (Sen et al., 1987; Isaac and Kapoor, 1980), 
family therapy for schizophrenia in rural China (Xiong et al., 1994), home versus 
hospital care in rural China (Wang et al., 1994) and post-discharge home visiting by 
nurses in South Africa (Gillis et al, 1989). In Guinea-Bissau, the evaluation of a 
comprehensive mental health service developed through the primary health care 
system achieved a favourable balance of costs and benefits (De Jong, 1996). Most of 
these studies, however, are modest in their design, size, coverage and generalisability 
(Shah and Jenkins, 1999). 
The paucity of mental health economic evaluative studies generally, and in low- 
income countries in particular, is a significant stumbling block to the investment of 
resources in mental health by governments and international agencies. The attention 
that the epidemiological reports reviewed above (in Sections 2.1 and 2.3) have 
brought to policy-makers, together with developments in the effective treatment of 
mental illnesses and the steady move towards more community-based models of care 
(Sartorius et al, 1993; WHO, 1979), offers an important opportunity not only to 
reinforce the need for appropriate programmes of care and prevention, but also to 
address the key issues of their affordability and sustainability. 
For economic contributions to international mental health care to be appropriately 
targeted on key policy issues and pursued in a consistent manner, there is an evident 
need for an overall framework or strategy within which inputs can be made. At a 
general level, economic considerations already comprise part of the WHO's strategy 
(Gulbinat et al, 1996), the goals of which are: i) to survey existing sources of data, 
information and knowledge; ii) to establish a multinational information resource 
based on a common framework; and iii) to conduct needed studies, including 
comparative studies of financing, costs, service utilisation and cost-effectiveness. 
Implementation of this broad agenda, however, requires more detailed consideration 
of the necessary principles and procedures that underpin such efforts. 
There is in fact broad agreement on the essential methodology that underpins the 
economic evaluation of health care programmes (Drummond et al, 1997; Gold et al, 
1996), and a number of texts specific to mental health care evaluation have also 
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recently emerged (Knapp, 1995; Hargreaves et al, 1998). An important analytical 
framework (originally developed with reference to social care) that underlies many 
completed studies in the UK is the 'Production of Welfare', which models the inter- 
relationships between resource and non-resource inputs and intermediate and final 
outcomes (Knapp, 1984); an exposition of its application to mental health care, 
together with practical illustrations of policy-orientated research in the UK context, 
can be found in Knapp (1995). 
Conceptual and definitional consensus is an important and necessary first step 
towards a standardised approach to the assessment of costs and outcomes, but is by 
no means sufficient to ensure that similar methods are used in practice. In fact, there 
is limited value in searching for a single, universal form of economic evaluation, 
since the precise form that an evaluation takes will depend on the nature of the 
problem under investigation, the study's perspective and the feasibility of measuring 
all identified costs and consequences. Rather, the requirement is for transparency in 
the approach that has been adopted, and adherence to a number of guiding principles 
(e. g. Drummond et al, 1997; Gold et al, 1996; Johnston et al, 1999). 
Over and above pursuit of these principles, there is a further set of issues that 
specifically arise from the conduct of multi-site or comparative international studies, 
including the heterogeneity of health care financing and delivery arrangements across 
countries, the identification of mutually acceptable service categories and definitions, 
translation and cross-cultural validation of service utilisation measures, and 
adjustment of the costs of services to take into account known distortional factors 
and differences in relative purchasing power in different economies. There is 
currently little guidance or empirical evidence relating to the incorporation of these 
additional methodological concerns into multinational economic analysis 
(Drummond et al, 1992), but without addressing and resolving these issues the 
measurement and comparison of mental health-related costs and outcomes can be 
expected to be flawed from the outset. 
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2.5 Emerging themes 
In this chapter, a series of inter-related research disciplines and studies that have an 
important bearing on the cross-cultural measurement and burden of psychiatric 
disorders have been reviewed, in order to provide the research and policy context 
within which the three source projects were undertaken. Out of this inter-disciplinary 
review, a number of key themes emerge which have particular relevance to the 
development and application of methods for economic analysis in cross-cultural 
mental health care evaluation. These include: 
* the significant variation, within and between countries, in the course and outcome 
of psychiatric disorders (WHO, 1979b; Leff et al, 1992; Simon et al, 1999), and in 
the pathways to, availability and organisation of care for people with psychiatric 
disorders (WHO, 1975; Gater et al, 1991); 
the conceptual distinction between universal versus relativist models of 
psychiatric disorder and individual or institutional responses to it (Kleim-nan, 
1987); or in other words, do local differences over-ride international comparisons? 
the sizeable burden that psychiatric disorders impose on local health care services 
(Harding et al, 1980,1983; Jablensky et al, 1981; Ustun and Sartorius, 1995) and 
on overall levels of global mortality and disability (Murray and Lopez, 1996); and 
the limited availability of appropriate methodologies and high quality international 
evidence relating to the costs and cost-effectiveness of different mental health care 
interventions, relative to the need for such data. 
Each of these themes resonate through the following three chapters and are picked up 
again in greater depth in the concluding chapter of the thesis. 
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3. Schizophrenia needs and costs in five European 
countries: the EPSILON study 
3.1 Rationale 
3.1.1 The public health burden of schizophrenia 
The public health impact of schizophrenia can be gauged according to a number of 
criteria, covering: (i) frequency; (ii) severity; (iii) consequences; (iv) availability and 
acceptability of interventions; and (v) public concern (Thomicroft and Tansella, 
1999). In terms offirequency, schizophrenia has a low incidence. In an extensive 
review of international studies (Warner and de Girolamo, 1995), including the WHO 
Collaborative Study on the Determinants of Outcome of Serious Mental Disorder 
(Jablensky et al, 1992), the incidence rates ranged from 0.07 to a maximum of 7.1 per 
1000 population per year. The wide range is accounted for more by methodological 
differences that any heterogeneity of envirom-nental or genetic factors (Hafner and 
der Heiden, 1999). Since schizophrenia is commonly a lifelong condition, its 
prevalence is higher than its incidence. The above review estimated the age- 
corrected prevalence rate of schizophrenia to be 5.8 per 1000 population (Warner and 
de Girolamo, 1995). The lifetime prevalence of schizophrenia is about I%. 
As far as severity and consequences are concerned, the burden of schizophrenia can 
be expressed in terms of suffering caused by a range of symptoms, lower quality of 
life, loss of independence, poorer social integration and higher mortality. Key 
4positive' symptoms of schizophrenia include hallucinatory voices and delusions of 
thought, control and influence, while 'negative' symptoms include incoherent speech, 
catatonic behaviour and social withdrawal (Wing, 2000). After a first episode, 
approximately 25% of individuals make a good recovery within five years, two-thirds 
will have multiple episodes with a variable degree of disability, and 10-15% will 
develop severe continuous disability from negative symptoms (ibid). Combining 
twenty studies from nine countries, Harris and Barraclough (1998) found an all cause 
of death risk 1.6 times that expected and a mortality risk for suicide nine times higher 
in schizophrenia. 
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Regarding the availability and acceptability of interventions, a range of drug and 
psychosocial interventions of proven efficacy have been developed over the last forty 
years. However, variable rates of efficacy, delayed onset of action and problems 
associated with medication compliance (and ensuing relapse) mean that treatment 
rates are often sub-optimal. One estimate from the US suggests that hospital costs of 
readmission are as high as care for first episode cases, of which 63% is due to lack of 
medication response and 37% due to non-compliance (Weiden and Olfson, 1995). 
Psychotherapeutic responses to psychiatric disorders, on the other hand, may improve 
compliance, and be associated with a reduction in total costs as a result of reductions 
in inpatient care and decreases in work impairment (Gabbard et al, 1997). 
Finally, in relation to public concern, a combination of ignorance, misunderstanding 
and fear serves to put schizophrenia in a particularly stigmatised category of public 
perception. Victorian asylums, the psychiatrists' couch and the madman's 
hallucinations remain as perennial caricatures which alarmist reports in the media 
only serve to reinforce. The World Psychiatric Association has recently launched an 
international programme to fight the stigma associated with this disorder. 
3.1.2 The economic burden of schizophrenia 
The chronic course and debilitating consequences of schizophrenia combine to create 
an illness which imposes a very considerable clinical, social and economic burden on 
societies throughout the world, resulting in it being a leading contributor to global 
and regional levels of disability and overall disease burden (Murray and Lopez, 
1996). From an economic perspective, this societal burden can be couched not only 
in terms of a far-reaching set of needs for formal health care provision that absorb 
high levels of public expenditure (NHS Executive, 1996; see Figure 2.1 in previous 
chapter), but also in other domains of support such as housing, employment, criminal 
justice services and informal care (Knapp, 1997). The estimated indirect annual cost 
of lost production in the UK, for example, is f 1.7bn, and it is the single largest 
disease category in terms of health service expenditure, accounting for 9% of in- 
patient health service expenditure (Knapp, 1997). 
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Other 'cost of illness' studies for schizophrenia have already been highlighted in the 
preceding chapter (section 2.3), most of which have adopted a prevalence-based 
approach for estimating the morbidity of the population in question and its need for 
care (e. g. Rice and Miller, 1995; Knapp, 1997; Goeree et al, 1999b). Incidence-based 
studies, which estimate the cost of managing an annual cohort of newly-diagnosed 
patients over the course of their illness, are relatively rare but have the distinction of 
being able to better reflect known intra-patient variations in resource use over the 
course of the disease (Andrews et al, 1985; Davies and Drummond, 1994; Guest and 
Cookson, 1999). All of these cost of illness studies demonstrate the absolute 
magnitude of costs associated with the disorder (0.5% to as high as 3.5% of gross 
national product), the high proportion of direct costs still tied up in hospital care 
(well over 50%) and the relative contribution of lost productivity and mortality to 
overall cost estimates (approximately half in many of the studies). The accumulated 
cost-effectiveness research regarding treatment responses to this identified burden of 
schizophrenia, although subject to a discernible level of uncertainty, indicates that 
community-based care such as assertive outreach represents a viable and cost- 
effective alternative to hospitalisation, that psychological approaches may offer cost- 
effectiveness advantages and that the newer atypical anti-psychotics produce better 
outcomes and lower costs compared to older drugs (Knapp et al, 1999). 
3.2 Study objectives and hypotheses 
As suggested at the outset of the thesis, the multiplicity of care arrangements for 
people with schizophrenia and other psychiatric disorders that have emerged in 
different countries, together with the responsibility of governments and health care 
agencies to ensure that resources are targeted appropriately, has led to a growing 
interest in comparative studies of disease burden, both within and between individual 
countries. To date, multi-national studies of schizophrenia have focused on 
establishing the prevalence of the disease and assessing outcomes cross-culturally 
rather than examining the relationship between inputs, processes and outcomes. 
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cl) 
, t:, r SILON study aims and hypotheses 
The EPSILON (European Psychiatric Services: Inputs Linked to Outcome Domains 
and Needs) study is a comparative, cross-sectional study of the characteristics, needs 
and life qualities of people with schizophrenia in five European countries, the 
services they receive, and the associated costs and satisfaction levels. Thornicroft and 
Tansella (1999) propose the 'matrix model' as a conceptual framework for mental 
health service evaluation. It has two dimensions: the geographical (levels: country, 
local and patient) and the temporal (phases: inputs, processes and outcomes). The 
EPSILON study concentrates on the local and patient level and on the phases of 
inputs and process of care. Specific objectives of the study as a whole were: 
1. To produce standardised versions of five instruments in key areas of mental health 
service research in five European languages (Danish, Dutch, English, Italian and 
Sp, pish) each of which was converted from the original into the other four 
languages: 
" Camberwell Assessment of Need (CAN; Phelan et al, 1995), 
" Client Service Receipt Inventory (CSRI; Beecham and Knapp, 1992) 
" Involvement Evaluation Questionnaire (IEQ; Schene, van Wijngaarden, 1992) 
" Lancashire Quality of Life Profile (LQoLP; Oliver et al., 1996) 
" Verona Service Satisfaction Scale (VSSS; Ruggeri and Dall'Agnola, 1993). 
2. To obtain and compare, in five European centres, data about social and clinical 
variables in patients with schizophrenia, the mental health care they receive and its 
costs. 
3. To test both instrument-specific and cross-instrument hypotheses (see Box 3.1 for 
hypotheses relating to needs, informal carer involvement, quality of life and 
service satisfaction; these hypotheses are not directly addressed further in this 
chapter, although the inter-relationship of these domains with service use and 
costs is considered here). 
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Box 3.1 EPSILON study hypotheses 
Needs 
9 The numbers of met needs and unmet needs do not differ across the five 
European sites. 
* Patients with more met and unmet needs have lower satisfaction with services 
and lower quality of life. 
Informal carer involvement 
o Caregiving consequences do not differ across sites. 
9 Caregiving consequences are mainly associated with patient characteristics like 
symptornatology, needs for care, service use and level of global functioning. 
e Caregiving consequences are not related with mental health service structure, area 
sociodernographic characteristics and study site. 
* Patient satisfaction with services and quality of life modulate the relationship 
between objective caregiving consequences and subjective distress in caregivers. 
Quality of life 
" Quality of life does not differ across sites. 
" Illness-related variables (level of functioning, symptoms) or disease duration are 
not related to quality of life. 
* There is no association between quality of life and service use and costs. 
e There is no association between quality of life and informal carer involvement 
in patients living with their familes. 
Service satisfaction 
e Satisfaction with services does not differ across the sites, irrespective of socio- 
demographic characteristics and service utilization. 
e In all sites, satisfaction with services is only weakly correlated with 
psychopathology and global functioning. 
9 In all sites satisfaction with services is strongly correlated with quality of life. 
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Aims and hypotheses relating to service utilisation and costs 
The aim of the economic component of the EPSILON study was to develop and 
apply appropriate methods and instrumentation for the cross-cultural measurement of 
service utilisation and costs for people with schizophrenia, which could be used 
subsequently to undertake comparative economic analyses across a number of 
European countries. A range of hypotheses relating to economic aspects of the 
EPSILON study - and the focus of this chapter of the thesis - were generated, a 
number of which concern a series of univariate,, inter-site comparisons for people 
with schizophrenia, the null hypothesis being that patterns, rates or levels in each of 
the following domains would be the same across the sites: 
" Patterns of employment (paid employment, voluntary, unemployed etc. ) 
" Patterns of service utilisation (inpatient care, primary care contacts etc. ) 
" Direct costs of care (primary and secondary health care, social care etc. ) 
A ftirther set of hypotheses were constructed that were focussed on the associations 
or inter-relationships between costs, socio-demographic characteristics, clinical 
symptoms and needs-related variables: 
e Greater needs, worse symptom severity and longer psychiatric history are 
positively associated with costs. 
* After standardising for symptom severity/need, higher service costs will be 
associated with better quality of life and greater service satisfaction. 
* Associations between symptoms, QoL and service costs are the same across sites. 
3.3 Method 
3.3.1 Selection of study sites, cases and instrumentation 
Study sites 
Six partners in five centres joined forces. The teams were located in Amsterdam, 
Copenhagen, London (Centre for the Economics of Mental Health and Section of 
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Community Psychiatry, Institute of Psychiatry), Santander and Verona. The criteria 
used to identify study centres were similar to those employed in other European 
research consortia (Dowrick et al, 1998): 
experience in health services research, mental health epidemiology, development 
and cross-cultural adaptation of research instruments, 
access to mental health services providing care for local catchment areas, 
a national mental health service providing community mental health services, 
9 geographical and cultural spread across the European Union 
Case identification 
A prevalence sample of people with schizophrenia in contact with mental health 
services in the three months preceding the start of the study was used in each site as 
the sampling frame, identified either from case registers (Copenhagen and Verona) or 
from the caseloads of specialist services. All sites had broadly sectorised mental 
health care delivery. Cases identified were diagnosed using the Item Group Checklist 
(IGQ of the Schedule for Clinical Assessment in Neuropsychiatry (SCAN; WHO, 
1992a). Only patients with an ICD-10 F20 research diagnosis were included in the 
study. The exclusion criteria were current residence in prison, secure residential 
services or hostels for long-term patients, co-existing learning disability (mental 
retardation), primary dementia or other severe organic disorder and extended in- 
patient treatment episodes longer than one year. These criteria were chosen to reduce 
bias between sites due to case-mix variation for those in long-term institutional care, 
and to concentrate on those in current 'active' care by specialist mental health teams. 
Instruments 
The set of instruments can be subdivided into three groups: 
1. Five instruments were converted for use in the five languages by: (a) accurate 
translation and back-translation into/from the other four languages, (b) checks of 
cross-cultural applicability using focus groups, and (c) assessment of instrument 
reliability (Schene et al, 2000; Knudsen et al, 2000). They were then used in the 
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second part of the study examining care for people with schizophrenia in the sites. 
They comprised the Camberwell Assessment of Need (CAN; Phelan et al, 1995), 
Client Service Receipt Inventory (CSRI; Beecham and Knapp, 1992) which 
became the Client Socio-demographic and Service Receipt Inventory - European 
Version (CSSRI-EU), Involvement Evaluation Questionnaire (IEQ; Schene and 
van Wijngaarden, 1992), the Lancashire Quality of Life Profile (Oliver et al, 1996) 
and Verona Service Satisfaction Scale (Ruggeri and Dall'Agnola, 1993). 
2. Local services were described using the European Service Mapping Schedule 
(ESMS; Johnson et al, 1998). The Brief Psychiatric Rating Scale (BPRS 24-item 
version; Ventura et al, 1993), and Global Assessment of Functioning (GAF; 
American Psychiatric Association, 1987) were also used. They were not translated 
into other languages but were used or produced in English. 
3. A third group includes instruments documenting the sampling process (Prevalence 
Cohort Data Sheet), area socio-demographic descriptors (Area Socio-demographic 
Data Sheet) and patients' psychiatric history (Psychiatric History Data Sheet). 
3.3.2 Development of a service receipt schedule 
Analytical perspective 
For the purposes of mental health economics research it is desirable to measure 
service use and costs comprehensively, since the broad personal and social impacts 
of schizophrenia typically result in a need for contact with a multiplicity of service 
agencies including health services, social services, housing and criminal justice 
services (Clark et al, 1994; Knapp et al, 1999; Weisbrod et al, 1980). This 
comprehensive perspective is particularly important for multi-national studies, since 
countries have established different boundaries between health and other services, 
and these boundaries have been known to shift over time as a result of changes in 
government policy or other forces. Also, the balance of responsibilities between the 
public sector (state) and other agencies might similarly vary from country to country. 
Data collection should therefore range beyond the immediately observable health 
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service inputs to include other service supports, contacts with other agencies (such as 
housing and criminal justice) and non-service implications of mental ill-health 
(particularly the costs of lost employment and productivity, and the economic burden 
falling on family caregivers). Moreover, data should be obtained on the frequency 
and intensity of any service contacts to allow for examination of service patterns and 
accurate estimation of associated costs. 
International research on service utilisation patterns, costs and other economic 
dimensions of mental health care is complicated by the need to reflect the contexts 
within which people live and receive their care. Arguably this is true of any research 
tool, but the problems of economic research which crosses international boundaries 
are especially acute when the objects of comparison are themselves heavily 
influenced by social, economic, political, historical and cultural structures and forces 
peculiar to those sites. To a greater degree than for the other instruments developed 
or tested in this study, therefore, we needed to ensure that the resource use 
instrumentation captured the core features of each of five health care and other 
systems covered by the study, whilst simultaneously being sufficiently standardised 
to permit meaningftil international comparison. A core feature of the methodology 
was thus to balance local relevance with international generalisability. 
Sources of resource utilisation and socio-economic data 
The most appropriate method of data capture for economic studies is contingent on a 
number of factors, including the primary purpose of the study, availability of funding 
and the data collection methods to be used for other evaluative information in the 
broader study. In the context of this study, the two broad options for data collection 
that presented themselves were to use existing information holdings by service- 
providing or funding agencies, or to rely on individual informants. One of the study 
sites (Verona) has a psychiatric case register that contains health service utilisation 
data, and other sites had some electronic data (for example, secondary health care 
information systems in London and Copenhagen). However, none of the local 
6routine information' systems was sufficiently compatible with the others to provide 
the basis for comparative research. Even if there had been compatibility, there would 
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be the question of data breadth: do extant systems keep data on all relevant services? 
Previous research has shown that schizophrenia sufferers use many diverse services 
(Knapp et al, 1999). Thus even if each site had computerised data, would these cover 
all relevant services? In the unlikely event that they did, there would then be the 
considerable challenge of merging data sets designed for different health care 
systems for different local management needs. Data capture via electronic 
information systems was therefore rejected at an early stage. 
The remaining strategies for collecting these data are to ask individuals, either 
through interview or self-complete questionnaire. Postal or self-complete methods 
(including diary cards) have been used in some previous studies (Gosden et al, 1997; 
Mauskopf et al, 1996) but were ruled out here partly because a low response rate was 
feared, but mainly for the pragmatic reason that other study objectives already 
required face-to-face interviews, and there is a long track record of collecting service 
utilisation and associated data alongside clinical data (Beecham, 1995). 
Three potential groups of respondents could be interviewed: case managers, family 
members or patients. If there is a case manager or key-worker to co-ordinate services 
for the patient, s/he might be a good respondent, although this would depend on the 
breadth of their responsibilities and knowledge (Widlak et al, 1992). Case 
management has been implemented in some guise in all the study sites, but the 
particular modes of operation and service structures that prevail in these different 
sites make standardised reporting of service uptake by case managers problematic. 
Where a patient lives with their family, another data source could be other family 
members (who may act as informal case managers). In some sites it transpired that a 
majority of the sample lived with at least one relative (72% in Santander, 50% in 
Verona), but elsewhere this was much less common (20% in Amsterdam and 
London, and only 4% in Copenhagen). Family members were interviewed for 
another part of the research study (to complete the IEQ; Van WiJngaarden et al, 
2000), but it was felt that this was not a sufficiently widely available data source for 
the purposes of the description of service use and cost calculations. 
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The patient is the only person who would have all or most of the information on 
which particular services have been accessed, how often and for what duration. A 
potential concern, however, is that the patient may not report service utilisation 
accurately, either because of their clinical condition, or because they exhibit the 
common human failing of poor recall. It was in fact decided to ask patients for these 
data, but especial care was taken with instrument design to improve the likely 
accuracy of the information provided (for example, by providing clearly defined and 
identifiable categories of service or state benefits). 
The comparative merits of retrospective and prospective data collection have been 
discussed elsewhere (Johnston et al, 1999). Prospective data collection essentially 
requires maintaining a diary of all service contacts, whilst retrospective collection 
involves occasional completion of an interview, reflecting back on services used in 
the previous few weeks or months. (Data collection should not be confused with 
design: prospective trials can of course use retrospective methods for collecting 
service use data. ) In this study, we adopted a three-month retrospective period, 
which is sufficiently long to pick up the wide range of services that individuals might 
take up but without stretching the respondent's powers of recall (there is evidence to 
suggest that interviewees significantly under-report frequent events when asked to 
report retrospectively over a six-month period; Jobe et al, 1990). 
Instrument development 
It is possible to distinguish a number of stages in the development of an instrument 
for collecting service use and related data. The first task was to identify criteria for 
selection or development of an instrument. Four requirements were identified: 
e It should span the domains of accommodation and living circumstances, 
employment and income, and service utilisation, so as to allow description of the 
economic and related circumstances of individual people and the service or care 
4 packages' that support them. 
* It should record the frequency and intensity of service use, with a view to 
enabling the accurate calculation of service costs. 
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* After translation and modest adaptation it should be suitable for use in other 
European countries. 
It should be understandable by respondents (people with schizophrenia) and 
manageable for use in interviews conducted by trained researchers. 
Rather than start from very first principles, it was decided to build on an existing 
instrument, the Client Service Receipt Inventory (CSRI). The CSRI has been widely 
employed and has a multitude of forms, having been used in over 100 studies since it 
was first developed in England in the mid 1980s. (Beecham and Knapp, 1992, 
introduce this instrument in the context of a wider discussion of cost research 
methods in mental health. ) A set of baseline questions was generated which covered 
the topics of interest (initially in English, subsequently translated into the other four 
languages). 
The baseline version of the Client Socio-demographic and Service Receipt Inventory 
- European version (CSSRI-EU) was constructed around five main sections (Box 3.2; 
for the full version of the instrument, see Appendix A). A manual was prepared in 
order to provide explanatory notes for particular questions or items in the schedule 
that required additional infonnation, definition or guidance (Appendix A). 
Box 3.2 Key domains and variables of the CSSRI-EU 
Section Key variables 
" Socio-demography Age, gender, marital status, ethnicity, mother tongue, years of 
schooling, educational level 
" Usual living situation Living situation (alone, with relatives etc. ), type of 
accommodation, household composition 
" Employment and income Employment status, occupational category, days of work lost, 
state benefits, source / level of income 
" Service receipt Hospital inpatient days, outpatient / day care attendances, 
community-based service contacts (mental health, social 
services & primary care), criminal justice service contacts 
" Medication profile Name/type of drug, dosage level and frequency 
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Socio-demographic information: A range of categorised socio-demographic 
variables, including date of birth, gender, marital status, ethnic group, mother tongue, 
years of schooling and level of educational attainment comprised the initial section of 
the instrument. Although some of these variables (such as age or gender) appear in 
other instruments, these data were comprehensively recorded here for completeness. 
Moreover, such data lead naturally onto consideration of other socio-economic 
circumstances. 
Usual living situation: Accommodation represents an important parameter for 
economic studies of psychiatric disorder, largely because of the high cost of specialist 
residential care. An individual's living situation (alone, within a family or living 
with other, non-related residents) is also a potentially significant predictor of cost 
(and outcomes). Accommodation was divided into domestic, hospital and 
community residential categories, each with clearly defined sub-categories (for 
example, tenure of domestic accommodation or staffing cover/intensity in residential 
care). Changes in accommodation over the retrospective period can be recorded. 
For all people resident in non-domestic accommodation, the completion of a one- 
page supplement was requested, containing information on the number of (available 
and occupied) places/beds in the facility, the total complement and cost of care staff, 
other revenue costs and the average weekly charge or fee per resident place/bed. This 
supplement, based on a schedule developed for costing mental health residential care 
in the UK (Chisholm et al, 1997c), was completed after the face-to-face interview, in 
consultation with a facility manager. 
Employment and income: This section aimed to elicit information on patients' 
employment and income circumstances. It is an important source of information for 
establishing the indirect costs and effects of schizophrenia, such as lost days of work, 
and also for estimating the living expenses of the patient. Employment status was 
divided into a number of appropriate categories (paid or self employment, 
unemployed, housewife/husband etc. ), whilst occupational categories were based on 
an international standard classification of occupations (manager/administrator, 
professional, skilled labourer etc. ). The approach taken with respect to the receipt of 
state benefits was to identifý a number of international categories of 
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benefits/entitlements, and to have a list of national variants that fell under these broad 
international categories. This met the dual requirement of making consistent 
comparisons between study sites whilst building up a set of data that has most 
meaning and use within each individual site. Personal (gross) income was also 
requested, using bands obtained from national statistics offices that reflected the 
quintiles of gross income in each country (thereby enabling comparison of 
proportions of patients falling into these internationally equivalent income bands). 
Service receipt: A range of psychiatric, social and general medical services were 
identified which together were considered a comprehensive profile of services 
available to the patient population in each of the five centres. The main categories 
were: psychiatric and general medical inpatient hospital admissions and total days; 
psychiatric and general medical hospital outpatient attendances; community-based 
day services (frequency and intensity of attendance); and contacts with primary care, 
social services and community mental health care professionals. Clear definitions 
were attached to individual service components or categories in order to enhance 
multi-site comparability, and space was left for inclusion of other services provided 
to patients that were not specifically identified in the inventory. For each service, the 
number of contacts in the previous three months was requested, and where 
applicable, the sector of provision (statutory/government, voluntary or private). A 
final sub-section asked for information relating to contact with criminal justice 
services (number of police contacts, nights in custody, psychiatric assessments or 
court appearances). 
Medication profile: A profile of the individual's use of all prescribed medications in 
the previous one month was requested, incorporating the name of the drug, the 
dosage level and frequency, and whether it was prescribed as a long-standing depot 
injection. 
Translations andfocus groups 
Once the baseline version of the instrument had been developed, the next steps were 
translation into the other four European languages (Danish, Dutch, Italian, Spanish), 
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either by professional translators or local researchers, followed by cross-cultural 
validation of the translated instrument. Since the CSSRI-EU is an inventory of 
socioeconomic indicators and service variables rather than a multi-item rating scale 
of a particular outcome domain, the focus in this study was on achieving face validity 
and semantic equivalence within and between individual participating sites, rather 
than formal exploration of the reliability of the measure between raters, sites or time 
points. This took place both through informal dialogue and discussion with principal 
investigators and other interested parties, and more fonnally through the conduct of 
focus groups. Focus group discussions consisted of between 6-10 individuals, 
spanning psychiatrists, other health professionals, social care workers, informal 
carers and service users, and were intended to address two aspects of the instrument: 
its content and its language (Knudsen et al, 2000). 
The CSSRI-EU focus groups generated a number of system-level comments that 
revolved around the perceived incompatibility of local or national health, social and 
welfare structures with the attempted European-wide structures or categories given in 
the initial version of the CSSRI-EU. These comments related to two sections of the 
instrument: usual living situation and employment and income. In particular, focus 
groups suggested reordering of categories of employment, benefit entitlements and 
accommodation that better reflected their own national taxonomies. These 
suggestions were incorporated as far as possible without losing the core requirement 
of inter-site comparability. For example, four international categories of state 
benefits were developed (unemployment/income support; sickness/disability; 
housing; pension), within which sites could specify local variants of these broader 
categories. Residential care was a further area that required reordering, owing to the 
heterogeneity of service arrangements in different sites. In this case, the final 
categories were couched in neutral, broad terms to overcome this differentiation 
(overnight facility, 24-hour staffed; overnight facility, staffed (not 24-hours); 
overnight facility, unstaffed). 
A second set of comments revolved around country-specific suggestions for 
enhancing the understanding, definition or measurement of individual items or 
components included in the service receipt section of the inventory. A particular area 
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of discussion concerned the appropriate classification and definition of day care and 
community-based mental health services. For example, the Dutch system of RIAGGs 
(community-based mental health centres) needed to be correctly classified under the 
appropriate item in the inventory. The instrument was then revised, both in its 
original English form (in the light of focus group recommendations as to content) and 
in each of four translations (in the light of recommendations about terminology or 
language). 
3.3.3 Service costing methodology 
For each of the service components covered by the CSSRI-EU, unit costs were 
calculated in all five sites. Where possible, and following conventional practice in 
health economics research, short-term average costs were used as a proxy for long- 
run marginal costs of services (Beecham, 1995). The key categories of cost 
incorporated into unit cost estimates were: salaries of staff employed in the direct 
care and management of patients; facility operating costs where the service was 
provided (cleaning, catering, consurnables etc. ); overhead costs relating to the service 
(personnel, finance etc. ); and capital costs of the facility (buildings and equipment). 
Unit cost templates were developed to assist in the calculation of these site-specific 
costs. In one site (Amsterdam), and for certain services in other sites, only insurance 
reimbursement or other price data were available as the basis for calculating unit 
costs. Profit motives and varying reimbursement practices mean that the use of per 
diems or charges may not represent a good proxy of opportunity cost. However, the 
social insurance system in The Netherlands, in addition to detailed economic costing 
of specific service components, allowed us to be confident that opportunity costs 
were being closely approximated. Site-specific unit costs are given in Table 3.1. 
For the purposes of international comparisons of cost, a mechanism for converting 
national costs or prices into a common currency is required. The most obvious 
option is to employ official currency exchange rates. However, when a cost or price 
is converted to another using exchange rates, the resulting figure will reflect not only 
differences in the quantities of services purchased, but also differences in price level 
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Exchange rates are also subject to rapid changes, owing to the volatility of certain 
currencies. Another option is to construct a set of conversion factors based on a 
market-basket approach (Schulman et al, 1998). This approach has the benefit of 
being more closely tuned to the particular inflationary and other forces that 
characterise a particular market or sector (thus, the 'basket' could incorporate service 
elements specific to mental health care delivery). In the context of this study, it was 
decided that there were an insufficient number of services common to all five 
participating study sites that could be used as the basis of working out reliable 
- -1. adjustment factors (arguably there are also too few sites and cases). 
A final option, and the one used in this study, is the use of 'purchasing power 
parities' or PPPs, which reflect the relative cost of goods in particular sites. 
Routinely calculated by the OECD in collaboration with the Statistical Office of the 
European Communities, PPPs are the rates of currency conversion which eliminate 
the differences in price level between countries (OECD, 1996). Thus, when the 
conversion is made using PPPs, it reflects only the differences in the volume of 
goods and services purchased. The conversion factors or PPPs for each site are 
tabulated below (Table 3.2). Cost of care reported here are expressed in UK f 
sterling PPPs. (To convert reported cost results into an alternative currency, divide 
values by 0.32 (Dutch Guilders); 0.08 (Danish Kroner); 0.005 (Spanish Pesetas); 
0.0004 (Italian Lire); for example, to express all costs in Dutch guilder PPPs, divide 
national costs by 4.08 (COP), 0.32 (LON), 60.8 (SAN) and 776 (VER)). 
Table 3.2 Purchasing power parities used in EPSILON study (OECD, 1996) 
AMS COP LON SAN VER 
AMS 1.00 4.08 0.32 60.8 776 
COP 0.24 1.00 0.08 14.9 190 
LON 3.17 12.9 1.00 193 2458 
SAN 0.016 0.067 0.005 1.00 12.77 
VER 0.0013 0.0053 0.0004 0.0783 1.00 
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3.3.4 Statistical analysis 
Categorisation of resource utilisation and service cost data 
For the purposes of comparative analyses, service utilisation items in the CSSRI-EU 
were aggregated into a number of categories, so that data could be usefully 
summarised (but without unduly obscuring potential variations): hospital inpatient 
days (psychiatric and general medical care wards); hospital outpatient visits 
(psychiatric, general medical and emergency departments); day care attendances 
(including day hospital, community mental health centre, day centre, drop-in centre 
and sheltered workshop); community-based contacts (including primary care doctor, 
practice nurse, social worker, community-based psychiatrist, psychologist, 
community psychiatric nurse and home care worker); and residential care days 
(overnight hostel accommodation with permanent, regular or ad hoc staff cover 
arrangements). The five components represent functional (rather than organisational) 
components of the services participating in the study. 
Univariate analyses 
The chi-square test statistic was used for testing inter-site categorical and 
proportional differences. For socio-demographic variables, adjusted standardised 
residuals of +/- 3 (categorical data) are reported to illustrate the more extreme 
relative contribution(s) of cells to the test statistic. Owing to the skewed distribution 
of mean service utilisation and associated cost variables, confidence limits and F 
statistic probability values for inter-site comparisons were obtained by a non- 
parametric bootstrap (Efron and Tibshirani, 1993). Bootstrapping employs large 
numbers of repetitive computations (in this study, 500) to estimate the shape of a 
statistic's sampling distribution, thereby avoiding the strong distributional 
assumptions of parametric estimation. In order to address hypothesised site-level 
socio-demographic and clinical differences, analysis of raw service use and costs 
scores was followed by estimation and testing of adjusted means or proportions 
(factors adjusted for in the OLS regression were study centre, gender, marital status 
and employment; covariates adjusted for were age, education, GAF and BPRS score). 
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Multivariate analyses 
The multivariate analytical strategy had three stages. First, a preliminary analysis was 
performed of the relationship between cost and key socio-demographic and clinical 
characteristics in each of the participating sites. This used multivariate ordinary least 
squares (OLS) methods on (untransformed) cost data, and was aimed at identifying 
those explanatory factors which were likely to be worth considering in subsequent 
analyses. In the second stage, a more detailed analysis was performed by site, in order 
to identify models which would be both more parsimonious and also more 
appropriate in terms of statistical assumptions. Forward stepwise regression was used 
to identify reduced models. The third stage involved fitting a global model to the 
combined data set, in order to identify any strong relationships which would hold 
across sites. In order to illustrate the differences obtained under various assumptions, 
results from different types of model are given, and conclusions are based on those 
findings which are relatively robust. 
In each of these models, the dependent variable of interest was the mean annual 
service cost (or its natural logarithm), expressed in UK f PPPs. The independent 
variables introduced into the analyses were as follows (those asterisked are indicator 
or 0-1 variables): age, education level attained, gender*, marital status*, ethnic 
group*, language*, living situation*, accommodation type*, employment status*, 
total number of psychiatric admissions, years of contact with psychiatric services, 
GAF score, BPRS mean score, number of met and unmet needs, average global well- 
being and average quality of life score (from LQoLP), global and average satisfaction 
scores (from VSSS). Ethnic group and language were not included in the Santander 
or Verona analyses as there were no non-indigenous people in these samples. 
In stage one, using OLS regression on the raw data, sampling distributions of 
coefficients were estimated using bootstrapping (Efron and Tibishirani, 1993). 
Where the percentile-based 95% confidence intervals excluded zero when estimated 
in this way, they were judged to be non-significant at p=0.05. Significance was also 
assessed using parametric methods for comparison. The robustness of the OLS 
models was investigated using Kolmogorov-Smirnov tests for the normality of the 
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residuals, and visual examination of plots of the residuals against the independent 
variables. Comparison between the two log-based models was made on the basis of 
root mean squared and mean absolute errors, and published recommenclations. 
The non-normal residual errors for certain site-specific OLS regressions on raw data 
led to the need for a set of models in stage two that satisfied distributional 
assumptions (as well as homoscedasticity and independence). Transformation of cost 
onto a logarithmic scale is one method for addressing the related problems of 
skewness, outliers and heteroscedasticity (Diehr et al, 1999). In addition to OLS 
regressions, therefore, site-specific log-transformed models were derived for stage 2. 
As an alternative, GLMs (generalised linear models) with a gamma distribution and a 
log-link function, which incorporates the logarithmic scale through a link function 
but fits expected values to data on the raw scale, assuming that the errors have a 
gamma (long-tailed) distribution (Diehr et al, 1999). 
In stage 3, hypotheses I and 2 were tested on a global level (pooled across sites) 
using the same strategy as in the site-specific modelling was employed: OLS 
estimation on untransformed and log-transformed cost data, followed by the log- 
gamma GLM. Dummy variables for sites were entered into these model, and tests of 
interaction between site and the other covariates were performed, using the final 
preferred model (OLS log-normal), in order to assess the evidence for inter-site 
differences in the direction and magnitude of effects. Since there was evidence for 
heteroscedasticity in the log-normal residuals at site level, a non-parametric 
correction factor ('Duan smearing') was applied to the exponentiated site coefficients 
in the global log-normal model (Manning, 1998). This allowed direct comparison 
with the coefficients of the GLM model. 
Sample size considerations were focused on the reliability component of the 
EPSILON study, resulting in tests of differences for disaggregated service costs (for 
example, day care) that are subject to power constraints. Non-significant differences 
for these disaggregated service elements and costs therefore need to be interpreted in 
the light of these likely power constraints. 
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3.4 Results 
3.4.1 Description of sites and service systems 
Amsterdam: Data were collected in Amsterdam South East which is a 30-year old 
borough and a mainly residential area for a middle class population. It has a total 
population of I 10,000 of which about 50% are from one of the 60 minority ethnic 
groups. The mental health services in Amsterdam South-East are in the process of 
change and integration. The former psychiatric hospital Santpoort (20 miles from city 
centre) only recently started to deliver services integrated with local area services. 
Outpatient services are now available from the Regional Institute for Ambulatory 
Mental Health Care, the outpatient department of the Academic Medical Centre and 
the outpatient department of Santpoort. These three services are being integrated into 
a multi-site Social Psychiatric Service Center. Other services available for patients 
with schizophrenia are non-hospital residential services, home care, two shelters for 
homeless people with psychiatirc disorders, a day care centre and vocational 
rehabilitation services. 
Copenhag! ýn: The city of Copenhagen has a total population of 483,700 and is 
divided into 14 districts (boroughs). The two districts of Vesterbro and Kongens 
Enghave, where the study was performed, are neighbouring districts with a total 
population of about 48,000. Comprehensive mental health services in Vesterbro and 
Kongens Enghave are provided by Hvidovre Hospital. A liaison psychiatric service is 
provided to the general hospital. In addition, Hvidovre hospital has three community 
mental health centres. Vesterbro, Community Mental Health Centre mainly provides 
services for people with chronic illnesses living in Vesterbro and Kongens Enghave. 
A multidisciplinary team provides outpatient care, structured daytime activities 
(social training, arts, cooking, sports, psychoeducation), and home visits to patients. 
There is close collaboration between the community mental health centres and other 
health services (GPs, social care and residential services, voluntary organisation etc. ). 
London (Croydon): Croydon is predominantly a suburban borough in south London 
with a total population of 330,000. The population ranges from a somewhat deprived 
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area in the north of the borough to a more affluent, middle class and semi-rural 
southern area. In this study, patients were recruited from a catchment area of about 
67,000 people. Specialist mental health services in Croydon are purchased by 
Croydon Health Authority and provided by the Bethlem & Maudsley NHS Trust. For 
the provision of community mental health services the borough is divided into three 
localities, each serving a population of about 100,000. There are four community 
mental health centres for the whole borough of Croydon. These function as 
community multidisciplinary team bases, settings for out-patient and depot 
medication clinics, and as day-centres providing occupational therapy and 
psychotherapeutic groups. Social Services and the private and voluntary sectors also 
provide day-care places, work opportunities and 'pop-in' services. 
Santander: The study was conducted in Santander, the capital of Cantabria, an 
Autonomic Community with a population of about 560,000 inhabitants in northern 
Spain. The city of Santander is a University town, predominantly middle class, with a 
total population of about 194,000 inhabitants. Psychiatric services in Santander are 
provided by the Spanish National Institute of Health, Autonomic Health 
Administrations, and non-profit religious organisations. The main services are an 
acute psychiatric in-patient unit provided by the University Department of Psychiatry 
at a large teaching hospital, a 24-hour acute emergency unit at the same hospital, two 
multidisciplinary adult mental health teams, and, for long term psychiatric care, some 
patients are referred to two long-stay psychiatric hospitals (from which only patients 
with stays shorter than one year were recruited). The majority of patients with 
schizophrenia receive care from public mental health services. 
Verona: Data were collected in the South-Verona community mental health service. 
South-Verona is a predominantly urban area with a mainly middle class population of 
about 70,000. The South-Verona community mental health service from which 
patients were recruited has developed gradually over the last 20 years, and it is the 
main psychiatric service providing care to South-Verona residents. It supplies a wide 
range of well-integrated hospital and community services, including in-patient and 
day care, rehabilitation, out-patient care and home visits, as well as a 24-hour 
emergency service and residential facilities for long-term patients. With the 
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exception of hospital nurses, all staff (psychiatrists, psychologists, social workers, 
community nurses) work both inside and outside hospital. The vast majority of 
patients with a diagnosis of schizophrenia are on the caseloads of public mental 
health services. 
Table 3.3 gives details of the populations and socio-demographic descriptors of the 
study sites; unemployment rates varied from 7% in London to 16% in Amsterdam. 
There were also substantial differences in service organisation, including the 
availability of residential services in the study sites. In particular, the provision of 
both non-acute hospital and non-acute non-hospital (residential) places in 
Copenhagen far exceeds numbers in the other sites, with substantial variation in the 
number of non-acute hospital beds across the remaining sites and almost a complete 
absence of non-acute non-hospital residential places in Cantabria. These differences 
in service availability are discussed further with respect to individual-level uptake of 
services in the concludng section of this chapter. 
Table 3.3 Socio-demographic characteristics and residential services 
(per 100,000 adult population) in five European study sites 




Area population (18-64) 73,454 36,581 41,636 323,851 50,455 
Female* (%) 50 48 52 50 49 
Married' (%) 37 25 29 61 64 
Unemployed 16 14 7 12 7 
inhabitants living in single- 15 6 2 10 9 
parent families' (%) 
Residential places per 100k 
Secure hospital places (a) - 7 6 1 - 
Acute hospital places (b) 59 125 28 13 29 
Acute non-hospital places (c) - - I - 2 
Non-acute hospital places (d) 58 73 9 75 23 
Non-acute non-hospital 79 176 74 4 52 
(residential) places (e) 
Total residential places 196 381 118 93 106 
denominator: population aged 18-64 years; + population aged 18-99 years; ++ population aged 0-99 
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3.4.2 Key socio-demographic characteristics of the sampled populations 
A total of 404 subjects across the five participating sites were recruited into the study 
(Table 3.4). There was a higher proportion of men than women in all sites (typically 
a ratio of 60: 40), except in Verona where the proportions were similar. 
Approximately two-thirds of study members were single (range 58-72%), and no 
more than a quarter were married (range 10-24%). The mean age of subjects was 42 
years (SD 11), of which an average of 10.4 years (SD 2.7) had been spent in general 
education. Sites differed significantly with respect to the ethnic composition of the 
sampled populations, with a large percentage in Amsterdam (46%) and London 
(35%) perceiving their ethnic identity to be other than white European, compared to 
less than 10% in Copenhagen and 0% in Santander and Verona. There is also a clear 
distinction between the sites with regard to the living situation of the subjects, 
ranging from Santander and Verona, where over 90% of subjects live in domestic 
accommodation (mainly with their relatives), to the other sites where the proportion 
residing in domestic accommodation was between 70-80%, mainly living alone (42- 
65%). 
The proportion of subjects who were students or in open employment was low (5% 
in London, 15-23% elsewhere), whilst a further 1-8% were in sheltered employment. 
The majority of subjects were long-term unemployed or pensioned, and in receipt of 
some form of state benefits (except in Verona, where only 35% were receiving 
financial support from the state). This finding is borne out by the relatively higher 
number of subjects in this site for whom their main source of income is from wages 
(23%), family (29%) or other (23%). Many patients in Santander are also primarily 
supported financially by their relatives (40%). In the other three sites, 85-98% of 
subjects viewed state benefits as their primary source of income. 
In terms of clinical characteristics, there was a statistically significant inter-site 
difference in symptom severity as measured by the Brief Psychiatric Rating Scale 
(range 1.47 to 1.67; ANOVA test: p=0.047), but no appreciable difference in the 
Global Assessment of Functioning (range 56.48 to 58.97; p=0.273). 
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Table 3.4 Comparison of key socio-demographic and clinical characteristics 
AMS COP LON SAN VER ALL SITES 
Variable (N=61) (N=52) (N=84) (N=100) (N=107) (N=404) 
% % % % % % p value 
Gender Male 67.2 59.6 58.3 59.0 48.6 57.4 
Female 32.8 40.4 41.7 41.0 51.4 42.6 0.197 
Marital status Single 72.1 59.6 64.3 71.0 57.9 64.9 
Married 9.8 11.5 15.5 16.0 24.3 16.6 
Other 18.0 28.8 20.2 13.0 17.8 18.6 0.102 
Ethnicity White 54.1 92.3 65.5 100.0 100.0 84.9 
Other 45.9 7.7 34.5 0.0 0.0 15.1 <0.001 
Language National 78.7 88.5 92.9 98.0 100.0 93.3 
Other 21.3 11.5 7.1 2.0 0.0 6.7 <0.00 I 
Living situation Alone 49.2 65.4 41.7 7.0 15.0 30.2 
With partner 8.2 11.5 16.7 17.0 25.2 17.1 
With relatives 19.7 3.8 20.2 72.0 49.5 38.6 
With others 23.0 19.2 21.4 4.0 10.3 14.1 <0.001 
Accommodation Domestic 70.5 80.8 79.8 100.0 91.6 86.6 
Community 27.9 15.4 13.1 0.0 7.5 10.9 
Other 1.6 3.8 7.2 0.0 0.9 2.4 <0.00 I 
Occupation 
Employed / student 18.0 15.4 4.8 20.0 23.4 16.8 
Sheltered work 8.2 3.8 1.2 2.0 4.7 3.7 
Unemployed/pension 57.4 80.8 91.7 65.0 57.9 69.6 
Housewife/husband 16.4 0.0 2.4 13.0 14.0 9.9 <0.00 I 
State benefits Yes 93.4 100.0 91.7 74.0 35.5 73.8 
No 66 0.0 8.3 26.0 64.5 26.2 <0.001 
Income source Salary/wage 11.5 2.1 2.4 13.3 23.1 11.9 
Benefits 85.2 97.9 89.3 469 25.0 62.2 
Family 3.3 0.0 7.1 39.8 28.8 19.5 
Other 0.0 0.0 1.2 0.0 23.1 6.3 <0.001 
Mean Mean Mean Mean Mean Mean P value 
(SD) (SD) (SD) (SD) (SD) (SD) (A NO VA) 
Age of respondent (years) 39.9 39.4 43.8 39.9 43.0 41.8 0.024 
(9.9) (9.6) (12.3) (9.3) (12.4) (11.1) 
General education (years) 11.8 9.9 11.3 10.7 8.7 10.4 <0.001 
(2.2) (2.3) (1.5) (2.3) (3.2) (2.7) 
GAF score 56.48 53.57 58.71 58.97 56.64 57.26 0.273 
(11.9) (14.3) (11.1) (18.8) (16.6) (15.3) 
BPRS score 1.648 1.666 1.513 1.596 1.467 1.562 0.047 
(0.47) (0.49) (0.43) (0.52) (0.46) (0.48) 
Note: Figures in bold - adjusted standardised residuals > 3.0; figures in italics >-3.0 
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3.4.3 Univariate analyses of service utilisation and costs 
Rates of contact with services 
The proportions of patients in each site who had been in contact with a range of 
health and social care services in the previous three months are reported in Table 3.5. 
For each service category, there are sizeable and statistically significant differences in 
contact rates between the five sites, even after adjustment for the sociodemographic 
and clinical variables reported in Table 3.4 (Chi Square statistic: p<0.05). Adjusted 
values were very similar to raw observed values, and consequently are not reported 
here. The proportion of subjects who had had an inpatient admission across all five 
sites was 11.6% (95% C1 = 9-15%), but this varied from 1.6% in Amsterdam (only 
one patient out of sixty-one sampled) to 23.1% in Copenhagen. The proportion of 
patients who had had at least one hospital outpatient attendance in the sites other than 
Verona varied between 11% and 28%. In the Verona site, the proportion was 84%, 
reflecting the fact that within the continuity of care model pursued in this locality, all 
contacts with a psychiatrist, whether in a hospital or community setting, are recorded 
as outpatient visits. This high proportion pushes the overall pooled proportion up to 
36.9% (95% CI = 32-42%) 
The mean contact rate for day care support was 52% for the four sites other than 
Santander (where no day care services are available), but this disguises the very high 
rate of contact with such services in the Copenhagen site (92%). Community-based 
contacts, which included primary health care and social care as well as community 
mental health workers, varied between 44% (Copenhagen) and 99% (Santander), 
with an overall pooled proportion of 78% (95% Cl = 73-82%). Finally, the 
proportion of patients who had been in residential care for at least some of the 
preceding three months was on average 14.5% (95 Cl% = 11-19%). This excludes 
Santander, where residential care arrangements are not present. There were 
considerable differences between sites, for example 28% of Amsterdam patients had 
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Quantities ofservices used 
Table 3.6 reports (raw and adjusted) mean receipt of services for the total sampled 
population (not just those patients who actually used services). It is apparent from 
Table 3.5 that rates of contact with certain categories of service are modest, leading 
to seemingly low (and uncertain) estimates of service receipt. However, it is the 
mean service utilisation for a total population (rather than the sub-population of 
users) that has most relevance to mental health policy and planning. 
The unadjusted mean number of occupied hospital inpatient days in the previous 
three month period was 3.63 (95% Cl = 2.4-5.0), ranging from 1.48 days in 
Amsterdam and Santander to 8.54 days in Copenhagen (bootstrapped F test statistic: 
p=0.056). Adjustment for key sociodemographic and clinical variables produced an 
appreciably lower value for Copenhagen (6.46 days); the inter-site test for difference 
is similar (p=0.046). Hospital outpatient visits were highest in Verona (a mean of 4.9 
visits in the previous three months, for the reasons given above), and in the other 
sites ranged between an average of 0.5 and 2.2 attendances. Adjustment of raw 
scores had no appreciable impact on these findings, which demonstrate a highly 
significant inter-site difference due to the higher Verona values (p<0.001). 
The overall mean number of day care attendances in the four sites where these 
services exist was 12.9 (95% CI 10.1-15.7). After standardisation, mean day care 
attendance levels are lower in Copenhagen (15.9 as opposed to 18.4 attendances), 
and higher in the other three sites where day care services exist. Both raw and 
adjusted tests of inter-site differences are statistically significant at p=0.05. For the 
sample as a whole, there was a mean of 8.0 community-based contacts (95% Cl 6.5- 
9.5), unadjusted values ranging between 4.7 in Santander and 9.8 in Amsterdam 
(bootstrapped F test: p=0.090). Following standardisation, the inter-site test of 
difference returns a significant result at the p<0.05 level, with marked changes in 
Amsterdam and Copenhagen. There are also statistically significant differences in 
the mean number of days spent in residential care (p<0.05), ranging from 6.7 days for 




Levels of service uptake were converted into UK f, PPPs to give an estimate of the 
yearly cost implications of existing patterns of provision (Table 3.7). For certain 
service categories, the cost results closely reflect service use comparisons. For 
example, following adjustment of the mean annual cost of inpatient care (pooled 
mean = f281% 95% CI f 1819-3865), the inter-site difference apparent before 
standardisation is no longer statistically significant at the p<0.05 level (p=0.090), 
largely as a result of correcting for the relatively less severe caseload in Copenhagen 
(adjusted mean = f5772, a reduction of f1881). There are also significant 
differences between sites in the (raw and adjusted) mean cost of hospital outpatient 
care (overall mean = f285,95% Cl f210-384; range f 5.40 - f-624; p<0.05). 
For other service categories, the process of costing leads to different findings. An 
example of this relates to residential care (pooled mean = f497 p. a., 95% Cl f337- 
657), differences in the cost of which are not statistically significant at the 5% level 
before adjustment (p=0.200). By comparison, non-monetised quantification of 
residential care days showed a statistically important difference (Table 3.6). Day 
care support represents a significant proportion of overall cost in the four sites where 
such services are available (mean =f 1408,95% Cl f, 1014-1802; range f 891-1750; 
12-46% of total unad usted costs). Again differences in cost, although quite large, 
are not statistically significant before ad ustment (p=0.246). After standardisation, 
however, bootstrapped F statistics for day care and residential care show significant 
differences. Comparison of community-based care contacts, by contrast, reveals 
significant cost differences (adjusted means vary between f90 in Santander and 
f-1086 in London; p<0.01). An obvious factor in the interpretation of these tests of 
differences relates to power (see section 3.5) 
The total annual cost per patient for the combined sample is an estimated f5038 
(95% CI f3888-6237). Unadjusted means are f3778 (Amsterdam), f9934 
(Copenhagen), f6071 (London), f1558 (Santander) and f5819 (Verona). Cost 
comparisons between sites, using adjusted means as the appropriate measure, reveals 
statistically significant differences (p=0.005), ranging between f 1444-7460. 
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3.4.4 Multivariate analyses of service costs 
Model performance 
The initial OLS regressions, by site, introduced all of the independent variables noted 
earlier, covering socio-demographic characteristics, service history, needs and 
clinical circumstances (Table 3.8). The overall goodness-of-fit (shown by the R' and 
adjusted RI statistics) is quite reasonable for a cross-sectional analysis, and a number 
of regressors proved significant. Non-parametric bootstrap and parametric analyses 
showed slightly different patterns of significance. The equations estimated for 
Amsterdam, Copenhagen and London satisfied the requirement of normally 
distributed residuals, but those for Santander and Verona did not. 
Because of this potential specification problem in our first stage analyses, and to 
build parsimonious models, site-specific equations were re-estimated, firstly by 
analysing logarithm of cost using OLS, and secondly by fitting the log-gamma 
generalised linear model (Table 3.9). Only variables reaching or close to significance 
at the 5% level were included. The overall goodness-of-fit for these reduced site- 
specific equations is again reasonable, with RI values ranging from 0.118 (Verona) to 
0.367 (Amsterdam) for the OLS log-normal model. Since there was no evidence of 
heteroskedasticity in these site-specific analyses, it is possible to use the 
exponentiated coefficients (Exp (p)) to interpret the links between personal 
characteristics and costs in terms of multiplicative factors (see below). 
In the pooled, cross-site analyses Table 3.10) the OLS model on the untransformed 
costs was not satisfactory: the Kolmogorov-Smirnov test statistic was 4.85 (P<0.001), 
indicating that residuals are not normally distributed, which could lead to biased 
estimates. Log-transforming the dependent variable overcame this problem 
(Kolmogorov-Smirnov statistic = 0.888, p=0.409). A log-gamma GLM was also 
fitted. Diagnostic tests were quite satisfactory for the log-normal model, except that 
kurtosis in the residuals for certain models was high (>3); there was also slight 
evidence of heteroscedasticity by site. 
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Table 3.8 OLS linear regression analyses of costs for people with 
schizophrenia in five European countries, by site 
Dependent variable = Total annual service cost (incl. residential care), expressed in EUK PPP, 1998 
Site 











Age -150 503 
- 
66 -169 -12 (years) 
Education -9.5 596 -390 -144 -574 (years) 
Gender -2248 -21948 2993 828 1972 (0 = female; I= male) 
Marital status -1420 182 -2026 1604 -4043 (0 = single; I= married/other) 
Ethnicity -3431 -2204 584 
(0 = white European; I= other) 
Language 1383 24509 -6446 - - (0 = national; I= other) 
Living situation 1692 15940 9595 1130 -7649 (I = with others; 0= alone; ) 
Employment 4642 3635 2579 -1207 -263 
(0 = employed; I= other) 
Psychiatric admissions 123 -445 115 880 201 
GAF score 89 -514 -118 -3.9 97 
BPRS mean score 7339 -4702 -1775 39 -2244 
CAN met needs score -237 616 2488 -467 917 
CAN unmet needs score -1004 -1395 -604 914 2037 
LQoLP mean score -1167 4974 -5178 807 603 
VSSS mean score -2199 -14826 -4077 -2385 -745 
R2 0.390 0.422 0.467 0.296 0.250 
Adjusted R2 0.167 0.101 0.342 0.179 0.125 
F statistic (df) 1.75 1.32 3.74 2.53 2.00 
(15,41) (15,27) (15,64) (13,86) (13,79) 
P value for F statistic 0.079 0.259 <0.00 1 0.005 0.032 
P value for K-Smimov test 0.115 0.775 0.563 0.001 <0.001 
(residuals) 
Coefficients in italics are significant at p<0.05 (95% Cls estimated parametrically); 
Coefficients in bold are significant at p<0.05 (bootstrapped 95% Cls estimated, 1000 repetitions). 
Coefficients in bold italics are significant at p<0.05 under both estimation approaches. 
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Table 3.9 Reduced log-normal and GLM models for people with 
schizophrenia in five European countries, by site 
Dependent variables: Log of total annual service cost (OLS); Total annual service cost (GLM) 
Site-specific independent variables 
OLS log-normal model 
Exp 
GLM (log-gamma) model 
Exp 
Amsterdam 
Ethnicity (I = not white European) -1.075 0.341 -0.695 0.499 
Employment status (I = not employed) 1.823 6.194 1.377 3.965 
Living situation (I = live with others) 1.063 2.896 0.691 1.997 
BPRS mean score 0.778 2.178 0.951 2.588 
Copenhagen 
Living situation (I = live with others) 1.256 3.510 1.121 3.067 
GAF mean score -0.067 0.936 -0.065 0.936 
London 
Language (I = not national) -1.384 0.250 -2.173 0.114 
Previous psychiatric admissions (total) -0.035 1.035 0.075 1.078 
CAN met needs mean score 0.442 1.556 0.372 1.451 
Santander 
Age -0.034 0.966 - - 
Previous psychiatric admissions (total) 0.236 1.266 0.32f' 1.378 
GAF mean score - - -0.417 0.659 
CAN unmet needs mean score 0.229 1.322 - - 
Verona 
Gender (I =rnale) 0.236 1.260 0.658 1.932 
Previous psychiatric admissions (total) 0.045 1.046 0.056 1.058 
GAF mean score -0.029 0.971 -0.018 0.982 
CAN met needs mean score -0.049 1.050 0.106 1.111 
Diagnostics 
----------------------------- Fit 1 
(R 2, Adj R2 
OLS log-normal model 
r ------------------------- I -------------------------------------------------- K-Smirnov Kurtosis Mean sq. 




Amsterdam (df 4,56) 0.367 0.321 1 0.75 2.23 1.98 1.68 
Copenhagen (df2,46) 0.257 
I 
0.225 1.00 4.66 3.67 2.91 
London (df3,78) 0.348 0.323 0.556 2.75 1.86 1.72 
Santander (df3,95) 0.189 0.163 0.059 4.87 1 2.29 3.44 
Verona (df4,95) 0.118 0.081 0.384 4.07 4.56 2.16 
Note: Coefficients in bold are statisitically significant at p<0.05 (parametric estimation) 
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Table 3.10 Reduced OLS linearl log-normal and GLM models for people 
with schizophrenia in five European countries, pooled analyses 
Dependent variable = Total annual service cost (incl. residential care), expressed in LUK PPP, 1998 
Pooled site equations (n=385) 
OLS model OLS log-normal model GLM (log-gamma) model 
Variable 
(: E, PPP) (f. log, PPP) (f., PPP) 
P P Exp Exp (P) 
Constant term 11873 8.407 12.827 
Site 2 (Copenhagen) 4647 -0.022 0.978 0.734 2.083 
Site 3 (London) 1279 0.108 1.114 -0.171 0.842 
Site 4 (Santander -1611 -1.871 0.154 -1.240 0.289 
Site 5 (Verona) 1945 -0.096 0.909 0.535 1.708 
Gender 1122 0.383 1.466 0.341 1.407 
(0 = female; I= male) 
Psychiatric admissions (total) 284 0.053 1.055 0.052 1.053 
GAF score -66 0.022 0.978 -0.020 0.980 
CAN met needs score 595 0.119 1.126 0.090 1.094 
VSSS mean score -2234 -0.251 0.778 -1.151 0.316 
R2, Adjusted R2 0.125,0.104 0.295,0.278 
K-Smimov test (p value) 4.85 <0.001) 0.888 (0.409) 
(standardised residuals) 
Mean squared error (f log) 10,276 11,3331 
Mean absolute error (f log) -69 644 
Notes: 
Coefficients in italics are significant at p<0.05 (95% Cls estimated parametrically); for OLS 
models only, coefficients in bold are significant at p<0.05 (95% Cls estimated by a non- 
parametric bootstrap, 1000 repetitions) and coefficients in bold italics are significant at p<0.05 
under both estimation approaches. 
Tests of interaction between site and OLS log-normal model variables revealed no inter-site 
differences except CAN met need (F value = 3.60, p=0.007). 
73 
For the GLM model, deviance was lower but kurtosis is high. High kurtosis suggests 
that the log-normal OLS model is preferable to the GLM (Manning and Mullahy, 
2000) and therefore, of the three models, this is preferred. The root mean squared 
error and the mean absolute error also slightly favour the log-normal model 
compared to the log-gamma GLM (if one outlying case is omitted). The log-normal 
OLS model was thus generally satisfactory, except for evidence of heteroscedasticity 
by site (P=0.001, Cook-Weisberg test). This feature partly explains the apparent 
discrepancy between the two models' site coefficients, since after applying Duan's 
smearing estimator to the OLS log-normal model, the exponentiated coefficients 
were much closer to the GLM model (Copenhagen = 1.892; London = 1.050; 
Santander = 0.250 and Verona = 1.343 - all relative to Amsterdam). 
Interpretation of coefficients 
The OLS log-normal model is the main focus for the interpretation of results, 
although the GLM results are also discussed as evidence of robustness. Inter-patient 
cost variations are marked, especially when looking across health care systems. It 
could reasonably be expected that some part of that variation would reflect inter- 
patient differences in clinical symptoms, needs and care history. Three composite 
hypotheses prompted the analyses of inter-patient cost variations in this study: 
Hypothesis 1: Met and unmet needs, symptom severity and longer psychiatric history 
are positively associated with costs. 
The evidence in support of this hypothesis is mixed. More often than not, the site- 
specific analyses show no significant associations between costs, on the one hand, 
and needs, symptoms and psychiatric history on the other. When the relationships 
were significant, they universally supported the hypothesis: higher needs, greater 
symptom severity and longer psychiatric history (as measured by number of previous 
in-patient admissions) were all associated with higher costs, other things being equal. 
The care systems are therefore responding in part to inter- individual differences in 
clinical circumstances. Using the OLS log-normal exponentiated coefficients in 
Table 3.9, which provide the multiplication factor attached to a unit change in the 
independent variable - for example, in Amsterdam costs for patients who are not 
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white European are about a third (0.341) of the costs of those who are - costs are 
higher or no different (but never lower) for people who are younger; who live with 
others; who are not employed; who have had more previous psychiatric admissions; 
and who have higher BPRS scores, lower GAF scores, higher CAN met needs scores 
or higher CAN unmet needs scores. Ethnic group and language are each relevant in 
one site (Amsterdam and London, respectively), but both dummy variables needed to 
be defined on a site-specific basis. 
Hypothesis 2. - After standardising for symptom severity and need, higher rates of 
service use are associated with better QoL / service satisfaction 
Quality of life scales provide patients with the opportunity to describe their own 
views of their lives and (more obliquely) of the care they receive. Satisfaction with 
services measures directly address patients' feelings regarding their treatment and 
care. We found no statistically significant associations between costs and quality of 
life, or between cost and service satisfaction in any of the robust site-specific 
multivariate analyses (Table 3.9). 
Hypothesis 3. - Associations between symtomatology, quality of life and service costs 
are the same across the sites. 
Not only do average costs of care vary significantly between sites, from f 1,558 per 
annum. in Santander to f9,934 in Copenhagen (Table 3.7), but also there are quite 
marked differences between the five European sites in the patterns of association 
(Tables 3.9-3.10). Using the log-normal model fitted t the pooled site data, and 
controlling for site, costs are significantly associated with: gender (male patients are 
47% more costly than female); previous psychiatric hospital admissions (5% higher 
per additional admission); GAF total score (ten points higher is associated with a cost 
decrease of 15%); CAN met needs score (13% more costly per additional met need) 
and service satisfaction (VSSS) score (a 20% decrease in cost per unit of improved 
satisfaction). Only one site dummy proved significant: costs are appreciably lower in 
Santander (25% of the cost of the reference site, Amsterdam). Tests of interaction 
between site and OLS log-normal model variables revealed no inter-site differences 
except CAN met need (F value = 3.60, p=0.007); Amsterdam and London showed 
strong positive effects whereas the other sites did not. 
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3.5 Discussion 
The inclusion of a health economics component into the EU-funded EPSILON study 
has enabled not only the development of a standardised instrument for the collection 
of service utilisation data in Europe, but also the analysis of patterns of service 
utilisation and associated costs for 404 people with schizophrenia receiving care and 
support from the services of five different health care systems. 
Methodological considerations 
A particular attribute of the study has been the common methodology employed for 
the collection, standardisation and analysis of data, which has strengthened the 
study's capacity to make international comparisons on a consistent basis. Whilst of 
increasing interest to policy-makers, international comparisons pose a number of 
methodological and analytical challenges, each of which needs to be satisfactorily 
addressed if meaningful use is to be made of such comparative data. Key issues 
identified and resolved over the course of carrying out the economic component of 
this study include: 
* the identification and specification of items and categories of service that have 
local meaning or validity whilst also being internationally comparable; 
the application of a consistent framework and method for costing services, both 
for individual professionals and facilities or organisations; 
the employment of a method other than exchange rates (such as PPPs) for the 
transformation of national currencies into a common currency; and 
the use of adjusted or standardised values for the multinational comparison of 
service uptake and costs to account for underlying site-level differences in 
sociodemography and psychiatric morbidity. 
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The adoption of these methodological principles and procedures can certainly help to 
enhance the quality and reproducibility of results from multinational studies, but 
there remain significant sources of uncertainty and variability. For example, despite 
our best efforts to employ a consistent costing methodology, as well as 
standardisation of relative price differentials of the participating countries through the 
application of PPPs, resulting unit costs for certain services remained variable. In 
particular, use of average tariffs in the Dutch site result in consistently lower values 
than those estimated for sites with shared characteristics using an opportunity cost 
approach (London and Copenhagen). The high unit costs for London reflect the 
known (and included) increased prices of staff and capital associated with health 
service provision in that locality relative to the rest of the UK (Chisholm, 1997b). 
Although these discrepancies do not unduly effect single country analysis, they do 
hinder the interpretation of comparative, multinational data. 
There are also issues relating to the validity and reliability of the service receipt 
schedule. Since the CSSRI-EU is an inventory of variables required for economic 
analysis rather than a multi-item rating scale, the focus in this study was on achieving 
face validity within and between individual participating sites, rather than formal 
exploration of the reliability of the measure between raters, sites or time points. The 
absence of such reliability measures represents a gap in our understanding of how 
accurate the CSSRI-EU is in recording rates of service utilisation. While significant 
but relatively uncommon events such as hospitalisation are readily recalled, there is 
concern that reporting of the frequency and intensity of contact with community- 
based service professionals by patients is subject to recall error (Jobe et al, 1990; 
Clark et al, 1994,1996; Johnston et al, 1999). 
This potential error can be examined by comparison of the values given by patients in 
the CSSRI-EU with an alternative data source, either another informant (an informal 
carer or key worker) or an administrative database. The limitations of these 
alternative sources of data in an international context have already been noted, 
specifically the incomplete knowledge of other informants and the absence of 
standardised, high-quality information systems across countries. Where they exist, 
however, well-maintained psychiatric case registers do offer one important data 
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source against which to assess the performance of certain elements of service receipt 
schedules such as the CSSRI-EU. Such an analysis did not comprise an objective of 
this study, but recent work in one of the sites (Verona) has recently considered these 
issues and showed that the agreement on overall psychiatric costs was high: the 
Concordance Correlation Coefficient was 0.93 for all patients and 0.97 for patients 
with a diagnosis of schizophrenia (Mirandola et al, 1999). At a more disaggregated 
level, agreement was high for hospital and residential care, but considerably lower 
for primary care and community-based care. 
Further methodological limitations of the study included the use of a cross-sectional 
design, which removes our capacity to link costs to user outcomes (i. e. changes in 
health and welfare), and the short period over which inpatient service use data were 
collected also proved problematic; in common with other service categories, a 
retrospective period of three months was used so as to minimise recall bias 
(subsequently converted into annual rates and costs), but since a proportion of 
sampled inpatients had been discharged and not used inpatient services again at the 
point of being interviewed some months later, their annual use of inpatient days is 
underestimated (this explains the very low inpatient care rates - reported for 
Amsterdam). 
As with so many mental health economic analyses, the final key limitation of this 
component of the study relates to issues of sample size and power (Sturm et al, 1999; 
Chisholm, 2000a). The numbers of patients recruited in the participating sites were 
dictated by power requirements for the reliability component of the study (a 
minimum of 50 cases Per site) and the time and resource constraints of two of the 
centres. Even for total aggregated costs, standard deviations are typically double 
that of the mean, so this inevitably casts doubt on the power of the study to detect 
statistically significant differences in more disaggregated components of resource 
utilisation and costs. In fact, many of the inter-site differences tested for did reach 
statistical significance at the 5% level, which indicates that there were sufficient 
numbers of cases to disprove the null hypothesis. Nevertheless, future multinational 
mental health economic studies need to be mindful of the importance of sample size 
if results are to be appropriately powered. 
78 
International variations in costs of care 
In relation to the hypotheses stated and the results obtained, the clear conclusion is 
that there are widespread and considerable differences between the participating sites 
both in the proportions of patients in contact with services and in the absolute level 
of service utilisation. By attaching costs to service utilisation patterns, resources 
employed across a number of sectors are converted into the common metric of 
money, which usefully highlights the considerable financial implications of providing 
care for people with schizophrenia. Our estimates of total average costs of care, 
ranging between f 1,558 in Santander to f-9,934 in Copenhagen, are broadly in line 
with previous local estimates of annual mean cost for this client group (Bonizzato et 
al, 2000; Evers and Ament, 1995; Haro et al, 1998; McCrone et al, 1998a). It is 
worth emphasising, however, that behind the estimated total annual cost per patient 
for the whole sample of 404 sub ects (f 5,03 8), there is not only a six-fold variation 
between sites but also a much larger variation within sites. 
Such variations have been explored at the individual level through multivariate cost 
analyses, which provide an empirical baseline from which to examine differences 
within and across sites in the patterns of relationship in costs and their associations 
with individual needs, psychopathology, socio-demographic features, service history 
and service satisfaction. Site-specific analyses demonstrated a number of (intuitively 
logical) associations between costs and higher needs, greater symptom severity and 
longer psychiatric history (hypothesis 1), but not for quality of life or service 
satisfaction (hypothesis 2); these associations were broadly mirrored in pooled 
analyses (hypothesis 3), with the addition of the hypothesised association with 
service satisfaction. 
There are also key site-level characteristics that have an important bearing on cost 
variations. The inclusion of site-dummy variables into pooled multivariate analyses 
provides initial evidence for this (for example, the Santander site had a significant 
cost-reducing impact), but the opportunity to incorporate other site-related factors 
into the individual -level cost data is constrained by a lack of degrees of freedom. In 
particular, there is a link between rates of service uptake and local levels of service 
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availability, support for which is given by a post hoc comparison between log- 
transformed service costs and total inpatient hospital and residential care places 
(Figure 3.1). For example, the fourfold difference in residential places between 
Copenhagen (381 per 100,000 population over 18 years) and Santander (93 places) 
closely mirrors the difference in service costs for these sites. 














Amsterdam Copenhagen London Santander Verona 
Total service cost (f , PPP) 
3779 9934 6071 1558 5819 
-4-No. of places 196 381 118 93 106 
The linked processes of individual service uptake and local service availability are in 
turn effected by political and economic decisions at a regional or national level, 
including overall levels of resources allocated to mental health services and 
prevailing models of social choice (Chisholm and Stewart, 1998; Thomicroft and 
Tansella, 1998). For example, it has been noted that by comparison with other 
regions of Spain, mental health service development in Cantabria has been modest 
(Haro et al, 1998). Such exogenous, 'supply-side' influences elude simple or 
consistent measurement, yet have a potentially sizeable impact on the otherwise 
'demand-led' comparative assessment of individual mental health service need, 
uptake and cost. The analytical challenge that lies ahead, therefore, is to 
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satisfactorily address the complex set of inter-relationships that exist between 
individual needs and health-seeking behaviours, local service responses or structures, 
and national indicators of political position, economic wealth and cultural identity. 
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0 4. Longitudinal investigation of depression outcomes: 
the LIDO study I 
4.1 Rationale 
4.1.1 The public health burden of major depression 
Depression is one of the most common psychiatric disorders and constitutes a 
significant public health burden as a result of its high prevalence, long duration, 
likelihood of recurrence, under-diagnosis and inadequate treatment (Bland, 1997). 
An accumulating body of evidence has emerged, particularly over the last five years, 
which clearly demonstrates the immense burden that depression imposes upon 
individuals, families and whole communities throughout the world (UstOn and 
Sartorius, 1995; Murray and Lopez, 1996). 
This 'burden' of depression has been measured from a clinical or epidemiological 
perspective in terms of disability effects, levels of morbidity and mortality rates. 
There is substantial evidence to indicate that persons with depression suffer from a 
number of functional limitations, including poorer physical, psychosocial and role 
functioning and an increased number of disability days (Sturm and Wells, 1995; Von 
Korff et al, 1992; Broadhead et al, 1990). It has also been estimated that 15% of all 
patients with a major depressive disorder die by suicide (Brent et al, 1988). 
A notable attempt to capture both the mortality effects and the disabling 
consequences of disease was undertaken by the Global Burden o Disease study 
(Murray and Lopez, 1996), a key finding of which was that by combining the 
mortality and disability effects of disease into a single metric (the Disability 
Adjusted Life Year or DALY), the immense burden of global disease attributable to 
neuropsychiatric disorders became readily apparent. Major depression is estimated 
to the fourth largest contributor to the global burden of disease (3.7% of all causes), 
1 The LIDO study was an ongoing prospective research investigation at the time of submission of this 
thesis. This was envisaged from the outset. It is included in the thesis because it was considered that 
there were sufficient methodological developments and interim prospective findings to be of interest 
and relevance in their own right. Accordingly, this chapter focuses on the development and 
application of the economic methods used in the LIDO study, together with a (largely descriptive) 
analysis of baseline and 3-month follow-up data. 
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and by 2020 is projected to become the single largest in developing regions, owing to 
high prevalence rates (particularly among women), non-detection (90% in some 
regions) and severity (a disability weight of 0.6 out of 1 in untreated form). 
A critical issue in the management of depression is non-deteetion. In a recent six- 
country survey in Europe, nearly 60% of those with major depression received no 
treatment (Lepine et al, 1997). The majority of these people did not even seek 
treatment for their symptoms, and only a quarter received an antidepressant. High 
rates of non-detection were also reported in the WHO study of psychological 
problems in general health care (Ustiin and Sartorius, 1995), while the GBD study 
estimated that 8.4% (out of 83 million) episodes of depression in the developing world 
receive treatment compared to 35% in developed regions. Increasing the rate of 
treatment to that currently achieved in more developed regions would therefore reduce 
the burden of illness due to depression in the developing world by 13%, saving 5.7 
million DALYs per year. Failure to detect eases is largely attributable to 
misdiagnosis due to concurrence of other symptoms or somatic disorders, the 
physical expression of depressive symptoms (somatisation), or factors relating to the 
consultation process (such as clinical expertise or patient trust). This indicates that 
there has been a massive underestimation of the economic impact of depression. 
Even when a patient has been correctly diagnosed, adequacy of treatment is not 
assured. Recommended dosages of antidepressants and treatment guidelines for 
depression are widely available but may not be heeded owing to the side-effect 
profiles of these medications or insufficient monitoring by practitioners of 
appropriate therapeutic levels and/or duration. Sub-therapeutic prescribing of anti- 
depressants appears to be highly prevalent, particularly for the older tricyclic 
antidepressants (Donaghue and Tylee, 1996). This not only has educational 
implications for primary care doctors, but is also likely to be associated with poorer 
outcomes, leading in turn to greater use of health and social care services. Patients 
may also interrupt their treatment, which unless the depression is naturally resolving, 
is likely to increase relapse and lead to higher medical resource consumption in the 
long term. One study concluded that a treatment failure was associated with an 
increase of over US $1,000 over a one-year period in medical costs (McCombs and 
Nichols, 1993). 
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4.1.2 The economic burden of depression 
The burden or consequences of depression can also be usefully gauged from an 
economic perspective (Chisholm, 2000b). Depression imposes a range of costs on 
individuals, households, employers and on society as a whole (see Chapter 2, Box 
2.1), the overall economic burden of which has been estimated in a series of 'cost of 
illness' studies which attempt to attach monetary values to these various societal 
costs (Table 2.1. ). Where a comprehensive cost estimate has been attempted, total 
estimated costs amount to 0.4 billion in the UK, and between $30-40 billion in the 
US in 1990 price levels (Kind and Sorensen, 1993; Greenberg et al, 1993; Rice and 
Miller, 1995). A common feature of these studies is that costs due to mortality and 
lost productivity constitute a very significant proportion of the total cost, due in part 
to the method used for calculating lost productivity, which assumes that all lost days 
of an adult's working life should be valued. In prevailing conditions of 
unemployment, this 'human capital' method represents an overestimation of true 
opportunity costs. In a less comprehensive but comparative cost of illness study in 
the UK, the NHS Executive (1996; Figure 2.1) demonstrated the relative magnitude 
of depression costs. Costs to the NHS for neurotic disorders amoqnted to f-887 
million in 1992/93, exceeded only by psychotic disorders (f, 1,159m) and 
considerably greater than, for example, diabetes (f 3 00m) or hypertension (f-43 9m). 
The costs of not treating depression in the US were considered by Rupp (1995), who 
performed a 'what-iff scenario to analyse the changes in costs of depression that 
would result from an increase of adequate treatment to 70% of all depression cases, 
and concluded that the direct costs of care and treatment in the US would increase by 
$4.2bn, but mortality and morbidity costs would each decrease by over $4.2bn, 
giving an overall 'saving' of $4.1 bn to society. 
Measurement of total depression-related costs is important because of the possibility 
that, in the long-run, mental health care may reduce general medical expenditures. 
Using data from the Medical Outcomes Study, Sturm and Wells (1995) demonstrated 
that although treatment for depression in the mental health specialist sector is more 
expensive than treatment in the general medical sector, it also leads to greater 
improvements in functional outcomes and represents the more cost-effective 
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strategy. Similarly, Zhang et al (1999) show that while the expected costs of 
treatment for the average patient receiving depression treatment in the mental health 
sector were $1,224 higher than that in the general medical sector, lost earnings were 
$2,101 lower (a net saving of $887 per patient per year). A review of this 'cost- 
offset' effect concluded that although a number of cross-sectional and quasi- 
experimental studies support an association between depression and medical 
utilisation, there are no experimental studies which clearly establish that such a cost- 
offset can be realised (Simon and Katzelnick, 1997). 
A prevailing issue for multi-national investigations is the extent to which it is 
possible or sensible to pool site-specific clinical and economic data in order to make 
comparisons between centres or countries. While there is evidence to suggest that 
core concepts of depression and quality of life can transcend national boundaries 
(Ormel et al, 1994; WHOQOL Group, 1998), there is far less consensus on the 
transferability of resource utilisation or cost data, since these constructs are so 
heavily influenced by the historical, cultural and political circumstances of service 
development and provision. Previous international studies of depression have yet to 
fully address these issues (Dowrick et al, 1998). A key concern of this study, 
therefore, was to examine the feasibility of combining data from sites in different 
cultural settings for the purposes of pooled comparisons of service use and costs. 
4.2 Study objectives and bypotheses 
The overarching aim of the Longitudinal Investigation of Depression Outcomes 
(LIDO study) is to explore the relationship between major depressive disorder in 
primary care patients and their quality of life and resource use, to be accomplished in 
a multi-centre, cross-national observational study with a prospective cohort of 
patients in primary care. A series of more specific objectives were formulated, 
including comparison of depressive symptoms, resource use and QoL over time 
among treated versus untreated patients, and identification of predictors of change in 
these domains (Patrick et al, 2000). The specific objectives of the economic 
dimension of the LIDO study were: 
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1. To develop a research method for the collection of health care service utilisation, 
associated costs data, and site-level socio -demographic and service profiles; 
2. To describe and compare key domains of service use, costs and outcomes for 
different study sites and sub-populations; 
3. To explore site-specific and cross-cultural relationships between service 
utilisation/costs and symptoms/QoL/functioning/treatment 
A central set of hypotheses were generated over a number of initial meetings of 
collaborators, and were informed by the construction of a conceptual model (Figure 
4.1) which attempted to address a number of key research questions relating to 
potential cross-sectional and longitudinal associations, including how treatment 
received at baseline predicts costs in later follow-up periods, how medical and/or 
psychiatric co-morbidity predicts subsequent costs, and whether improvement in 
depression is associated with significant reductions in health care costs. 










- healthcare costs 







quality of life 
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4.3 Method 
4.3.1 Selection of study sites, cases and instrumentation 
Study sites 
A number of research institutions, each with a successful track record of international 
collaborative research into quality of life, were approached and asked to participate 
in the study. Six out of the seven sites approached initially agreed to participate and 
concur with the international study protocol: 
o Be'er Sheva, Israel 
Barcelona, Spain 
Porto Alegre, Brazil 
e Melbourne, Australia 
o St Petersburg, Russia 
o Seattle, USA 
Case identification 
(Dr Amir, Ben-Gurion University of the Negev) 
(Dr Lucas, Fundacio Parc, Tauli) 
(Dr Fleck, Univ. of State of Rio Grande do Sul) 
(Dr Herrrnan, St Vincent's Hospital & CPS) 
(Dr Lornachenkov, Bekhterev Research Institute) 
(Dr Patrick, University of Washington) 
Patients attending the primary care facilities of the participating centres were 
approached by the primary care physician, clinic or research staff and invited to 
complete a screening assessment package, subsequently scored for initial eligibility, 
defined as a score of 16 or greater on the CES-D (Centre for Epidemiologic Studies - 
Depression; Lyness et al, 1977). For those patients meeting initial eligibility criteria, 
a baseline assessment was conducted, which included administration of a depression 
diagnostic instrument (Composite International Diagnostic Interview, version 2.1 or 
CIDI; Weiller et al, 1994) and other measures of socio-demographic status and 
service contact. Patients who were diagnosed as clinically depressed by the CIDI, 
who met other inclusion criteria for the study (age 18-75 years), and who were 
willing to enroll in the study were asked to register their informed consent to 
participate in follow-up measures of depression, quality of life and resource 
utilisation. Patients with a known major psychiatric or organic disorder were 
excluded, as were those currently or in the previous three months in receipt of 
treatment for depression. 
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Instruments 
A range of outcome measures in key study domains were employed at a series of 
follow-up assessment points over the course of the study (Table 4.1). The majority of 
the instruments selected for use in the study already had published versions available 
in the six LIDO centres. For those that were not available, standardised translation 
methods were employed in order to complete the battery of measures (Medical 
Outcomes Trust, 1997). For the economic component of the study - questions 
relating to service systems and their costs, site- and individual-level 
sociodemography and uptake of services by the sampled populations - three sets of 
instrumentation were specifically developed for the purposes of the study. 












Symptornatology CIDI (Weiller et al, 1994) 
CES-D (Lyness et al, 1977) 
SCL-90 anxiety subscales 
(Derogatis et al, 1976) 
Quality of life Quality of Life Depression Scale 
(QLDS; Hunt and McKenna, 1992) 
AýHOQOL Bref 
(WHOQOL Group, 1998) 
Functioning MOS SF-12 
(Ware and Sherboume, 1992) 
Comorbidity AUDIT (Qs 1-3; Seppa et al, 1995) 
Comorbid conditons (Wells et al, 199 1) 
Economic measures 
Sociodemography Demographic questions 
Resource utilisation Resource utilisation questionnaire 
Service systems Local sociodemography/service profile 
Service costs Unit cost templates * 
Notes: i) 9 and 12 month follow-up analyses (shaded columns) not reported in this thesis 
ii) asterisked instruments specifically constructed/adapted for the LIDO study 
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4.3.2 Development of a site-level socio-demographic and service profile 
The take up and subsequent effectiveness of services is determined to an (unknown) 
extent by the access, availability and quality of primary and secondary health 
services. Without comparable and standardised descriptions of the structure of 
service systems, analysis of the role of organisational characteristics in evaluating 
costs and outcomes is compromised. In this international study, it was therefore vital 
to have an understanding of the features that characterise each site's local service 
system. Moreover, differential levels of service utilisation, costs, functioning and 
outcomes within and between sites are predicted to be associated with socio- 
demographic variables such as age, gender, employment status and income. In 
addition to the collection of socio-demographic characteristics of study subjects, 
therefore, there is a need to derive a socio-demographic profile of the local 
population. 
Several attempts have been made to develop a standard technology for mental health 
(and general medical) service description. However, none of the developed 
instruments have gained wide international acceptance, largely due to their failure to 
adequately capture the cross-cultural heterogeneity of service systems (Johnson et al, 
1998). It has therefore been necessary to draw on a number of instruments and 
studies in order to obtain the required coverage of this study in depression. The 
principal instruments/studies upon which the Local Socio-demographic and Service 
Profile (see Appendix B) was based are: 
Domain Instrument Istudy Authors 
Socio-demography Socio-demographic Beecham J, Johnson S and the EPCAT Group, 
Schedule (SDS) 2000 
Mental health services Service Mapping Johnson S, Kuhlmann R and the EPCAT Group, 
Schedule (SMS) 2000 
Primary care services WHO PPGHC study Usttin TB and Sartorius N (eds) Mental Illness 
I in General Health Care, 1995 
Site investigators were requested to co-ordinate the completion of this profile, in 
collaboration with local service planners and researchers. The profile was completed 
for their local catchment area (data relating to the whole country were also requested 
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for some of the questions). In selecting the appropriate local catchment area to be 
profiled, the following principles were applied: 
a local catchment area is a geographical region within which a comprehensive set 
of mental health services is available. 
the local catchment area should be representative of the area from which study 
subjects are drawn. 
* there should be readily available information relating to the local catchment area, 
usually in the form of regularly reported/updated statistics. 
* socio-dernographic and health service profiles should relate to the same 
population (i. e. select a catchment population for which both socio-demographic 
and service statistics are available). 
4.3.3 Development of a service receipt schedule 
A range of primary care, psychiatric, social and general medical services were 
identified which together were considered a comprehensive profile of potential 
service receipt for the patient population in the six international centres (A-Ppendix 
C). The range of identified services was based upon the local clinical experiences of 
the site investigators and previous studies of service utilisation in the mental health 
field (Chisholm et al, 2000a; Chapter 3, Section 3.3.2). The three main categories of 
service contact were: 
9 Primary care and outpatient services: These are services which involve contact 
between primary / mental health care professionals and patients for some purpose 
related to the management of mental or physical illness (other than the delivery 
of inpatient or day services), and may occur in a hospital outpatient department, 
primary care centre, private clinic/practice or at the patient's own home. Average 
contact time includes consultation time only (not travelling or waiting time). 
Day services: These are services which are provided to several patients at a time 
and usually provide a combination of treatment for problems related to mental 
illness, structured activity, social contact and/or support. Facilities have regular 
opening hours. 
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Inpatient hospital services: Am inpatient stay in a hospital ward; both psychiatric 
and general medical admissions were incorporated. 
In addition, all drugs that had been prescribed to the patient (not just those related to 
depression) were recorded, and finally a section that asked for patients' own 
perceptions about potential barriers to accessing care or treatment (treatment too 
expensive, care centre inconvenient to reach, discouragement from family members, 
etc. ). An iterative process of cross-cultural validation was pursued in order to ensure 
standardised definitions and semantic equivalence of services across sites, resulting 
in a finalised baseline version of the schedule which could subsequently be translated 
into the local langauge of each participating centre. 
4.3.4 Principles and processes of service costing 
The principles employed in the LIDO study for the costing of services were closely 
based on existing guidelines (Beecham, 1995; Drummond et al, 1997; Hargreaves et 
al, 1998), and are summarised in Box 4.1. The process of costing can be broken 
down into three connected tasks: measurement of the quantity of resource use (via 
the collection of service receipt or utilisation data by individual clients or patients 
over a consistently defined period); the assignment of unit cost or prices, that is the 
costing or pricing of each of the service used; and the combination of these two sets 
of information in order to calculate the individual patient's cost (Beecham, 1995). 
In the context of international studies, a fourth task can be added, namely the 
transformation of site-specific service costs into a common currency, which enables 
the direct comparison of costs using the same metric (such as international dollars). 
In the context of the LIDO study, the first task was carried out via the administration 
of a service receipt schedule developed specifically for use in this project (see 
Section 4.3.3). For the second step, that is the costing or pricing of each of the 
service used, there were four main categories of cost that needed to be quantified: 
salaries / wages of staff employed in the direct care and management of patients; 
facility operating costs where the service is provided (cleaning, catering etc. ); any 
overhead costs relating to the service (personnel, finance etc. ); and the capital costs 
of the facility where the service is provided (land, buildings etc. ). A unit cost 
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protocol, similar to that employed in the EPSILON study, was developed in order to 
facilitate the computation of these categories of cost, both at the level of individual 
professionals and facilities (Appendix D). 
Box 4.1 The LIDO study: principles of unit cost data collection 
The broad perspective to be employed in the costing of services is an economic one, such that 
in principle service costs are derived by reference to their marginal long-term opportunity 
costs (Knapp, 1995). For example, the opportunity cost of an inpatient hospital bed is in 
principle to be based on established calculations of how those resources could be used in their 
best alternative use, such as a day care place or an entirely different service within or outside 
mental health care. In practice, derivation of costs in this way is difficult. It is therefore 
conventional to use short-term average costs as a proxy for long-run marginal costs (Beecham, 
1995; Beecham and Knapp, 1992). There is widespread consensus in health economics as to 
the validity of these proxies, provided that necessary adjustments such as the inclusion of 
capital in a unit of service provision are made (see Chisholm et al, 1997c for a practical 
application to mental health residential care; see Netten and Dennett, 1998 for a range of UK 
unit costs of health and social care). 
2. Economic or opportunity costs are distinct from market prices, charges, or per diems. Profit 
motives, varying accounting and reimbursement practices mean that per diems and hospital 
charges are unlikely to represent a good proxy of opportunity cost. For example, a private, for- 
profit company may charge a fee above what it actually costs to provide care. Where fees or 
charges are used, therefore, this should be acknowledged, justified and, ideally, adjusted to 
reflect the real economic cost. 
3. Estimation of costs should either be based on local catchment area data, or where this is not 
possible, on national data so long as the local catchment area is typical or representative of the 
national picture. As a general rule, the unit cost of contacts with primary care workers or 
outpatient consultants are not likely to vary significantly (making national estimates an 
acceptable choice), whereas the unit cost of day care provision and particularly inpatient 
services may vary considerably between different areas of the country. Facility-specific 
estimates should be obtained if possible. A ftu-ther general principle is that routinely collected 
data are preferable to data collected on a one-time basis. 
4. A final principle of cost evaluation is that the resource implications of all elements of a service 
should be considered. Again, there are difficulties in realising this principle on pragmatic 
grounds; for instance, the ftill cost of a day care place may include inputs from unpaid 
volunteer staff or financial contributions from clients over and above those of the managing 
agency. Closely related to this issue is the analytical perspective of the study. Possible points 
of view include a governmental department or ministry (health or other), the statutory sector as 
a whole, a provider or insurance agency, an employer, the patient and/or his family, and 
society generally. The societal perspective is the broadest but also the most complicated 
perspective to adopt. 
The third task - combination of service use and unit cost data - is a straightforward 
computational exercise that is best undertaken using a computer spreadsheet or 
database package. For example, the cost of primary care would be derived by 
multiplying the number of contacts by the average duration of contact, then by the 
unit cost per minute of face-to-face contact Individual service component costs can 
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subsequently be aggregated to derive total costs per individual or costs broken down 
by sector, primary versus secondary care, generic versus specialist care, and so forth. 
For the final stage, transformation of service costs into a common currency, a 
number of alternative mechanisms can be considered, including official currency 
exchange rates, GDP 'purchasing power parities' or a more specific set of purchasing 
power parities for the particular sector of interest, based on a selected basket of 
sector-specific commodities (see Section 3.3.3 for a more detailed discussion). 
Following review and experimentation with these alternative methods, PPPs were 
employed for the LIDO study, since they are readily available, avoid the limitations 
of exchange rates and provide a more robust set of conversion factors than the 
market-basket approach Table 4.2). 
Table 4.2 GDP purchasing power parities, 1997 
Australia Brazil Israel Russia Spain USA 
Australia 0.57 2.29 2.86 88.9 0.71 
Brazil 1.75 4.0 5.0 156 1.25 
Israel 0.44 0.25 1.25 38.9 0.31 
Russia 0.35 0.20 0.80 31.1 0.25 
Spain 0.011 0.006 0.026 0.032 0.008 
USA 1.4 0.8 3.2 4.0 124.4 
(Lource: World Bank, 1999; Table 5.6) 
Data analysis and sample size considerations 
Since the focus of the study was on unrecognised new episodes or diagnosed cases of 
major depression presenting to primary care providers, an important early 
consideration was on the expected number of patients who would need to be 
screened in order to derive a meaningful sample of positive cases for the duration of 
the study. Allowing for a potential attrition rate of 30% of enrolled cases and a 
caseload-constrained end sample of 150 cases per site, it was estimated that the 
screening package would need to be administered to approximately 4,300 individuals 
at each site. Minimum detectable differences with 80% power were derived, both 
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per site and for pooled data, for outpatient utilisation, CES-D and health status (Table 
4. 
-3). 
With respect to comparing the estimated 75 people per site who were treated 
versus those not treated at baseline, large differences in service costs (a factor of 2.5) 
would have to be present, whereas it seemed more likely that differences in QoL and 
initial CES-D would be detectable, especially if all the clients can be combined. In 
terms of change over time, patients' service costs would have to decrease by two- 
thirds in order to show a statistically significant difference (per site), or by 23% if 
site-data was pooled, whereas quite small changes could be detected in CES-D or 
health status. Finally, it was estimated that a differential of 2.74 points (or 1.03 if 
data is pooled) on CES-D score for treated versus untreated could be detected with 
80% power. The difference in QoL score - 11.9 points per site, 4.5 if pooled - was 
thought to be probably too large to be attained, and there was insufficient data upon 
which to base an estimate for differences in service costs. 
Table 4.3 Minimum detectable differences with 80% power 
Comparison N, N2 Service cost CES-D Health status 
(QoL) 
Treated vs non-treated 75 75 2.52 1.4 12.22 
x7 x7 1.48 0.5 4.61 
Change from baseline 150 150 1.66 1.37 5.9 
x7 x7 1.23 0.52 2.2 
Change in treated vs 75 75 N/A 2.74 11.9 
change in untreated x7 x7 N/A 1.03 4.5 
4.4 Results 
4.4.1 Description of sites and service systems 
Barcelona, Spain 
Location and socio-demography: Barcelona is the main city of the autonomous 
region of Catalonia in North East Spain, with a population of 1.7 million. The size of 
the population has remained very stable for twenty-five years, but with an increasing 
proportion of elderly people. The proportion of the population in full-time 
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employment (41%) is correspondingly quite low. Unemployment stands at 
approximately 10%. Health system: Barcelona is one of eight decentralised health 
regions in Catalonia, which operates a mixed health care model; health care is 
financed from federal and state-level dedicated tax contributions, and is provided for 
all citizens both through public and contracted private sector providers. Overall 
health spending in Spain amounts to 8% of Gross Domestic Product (GDP). Primary 
care services: Three urban primary care centres in Barcelona took part in the study, 
each covering a population of approximately 25,000 inhabitants and seeing 7,800 
patient per month. Primary care centre staff include nurses, social workers and 
administrative personnel, as well as physicians, who see an average of 520 patients 
per month. Physicians and nurses also make home visits one day per week. An 
estimated 25% of visits are due to acute illness and injuries, 60% are due to chronic 
diseases and 10- 15% because of psychological problems. 
Be'er Sheva, Israel 
Location and socio-demography: Be'er Sheva is located in the southern region of 
Israel in the Negev desert. Its population of 440,000 inhabitants is predominantly 
made up of younger adults (aged less than 45 years of age) and children, reflecting 
the lower socio-economic status and larger family units of this region of Israel. The 
main local sources of employment - manufacturing, business and education - broadly 
correspond to the national economy. The unemployment rate currently stands at 
9.5%. Health system: Israel has a semi-public system, dominated by the country's 
four sick funds which are regulated by the Ministry of Health (which also has 
responsibility for mental health services). Insurance in a sick fund is compulsory for 
all citizens, financed through federal income taxation which is subsequently allocated 
to the sick funds. Health spending rose from 4.1 % of GDP in 1995 to 8.2% in 1997. 
Primary care services: A number of centres of different sizes participated in the 
study. In the centre from which the majority of patients were recruited (Dimona), 
approximately 5600 patients are seen per month (a doctor: patient ratio of 1: 800), 
the majority of whom present with chronic illnesses (60%); psychological illnesses 
account for 10% of presented problems. 
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Melbourne, Australia 
Location and socio-demogrqphy: The LIDO study catchment area was defined as the 
Melbourne metropolitan area in the state of Victoria, in which over three million 
people reside. Melbourne is characterised by its cultural diversity with a quarter of its 
inhabitants born overseas in a non-English speaking country. The local economy is 
service-orientated, with an unemployment rate of 9.1%. Health system: The main 
feature of the health care sector is Australia's Medicare scheme, financed through 
general taxation and a 1.5% levy upon personal income, which provides universal 
insurance against the costs of pharmaceuticals, public hospitals, private GPs and 
upon referral, private specialists (expenditure totals 7.8% of GDP). Mental health 
services are community-based, evidenced by the relatively low number of psychiatric 
beds (27 per 100,000 population over 18 years). Primary care services: The 
principal PHC centre involved in the study was the North Yarra Community Centre, 
which sees 6500 patients per month. The centre has 5.4 full-time equivalent (FTE) 
physicians (who see an average of 800 patients per month), 3.6 FTE nurses and 29 
other staff. Psychological problems account for 20% of attendances. 
Porto Alegre, Brazil 
Location and socio-demography: The LIDO catchment area is Conceiýdo, a district 
in the north of Porto Alegre, capital of the State of Rio Grande do Sul, Brazil. It has 
a population of 100,000 inhabitants, the majority of whom are younger adults and 
children (68%). 35% of the population earn less than US$200 per month, and 10% of 
working age adults are unemployed. Health--system: Over the last two decades, 
access to health care in Brazil has evolved into a universal right of citizenship. Public 
health services together with private health care services form the "Sistema Unico de 
SalUde" (SUS). Private non-profit and for-profit organisations provide the majority 
of medical assistance, particularly inpatient care. Brazil spends about 6.5% of its 
GDP on health, one half of which is private expenditure. Primary care services: The 
primary care unit (Serviqo de Saude Comunitaria Nossa Senhora da Conceiqdq) is 
composed of 13 units, including a 30-bed inpatient facility, and serves a population 
of 120,000 people (29,000 enrolled families). The unit has a total of 44 FTE doctors 
and II nurses, who between them see an estimated 17,400 patients per month (the 
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doctor: patient ratio is 1: 395), predominantly in the form of outpatient attendances; 
12% of attendances are attributable to psychological problems. 
Seattle, United States 
Location and socio-demogrLaphy: The LIDO site was located in south King County, a 
south-west portion of the Seattle metropolitan area with a population of 1.7 million 
residents. Seattle has a relatively high per capita income and a low rate of 
unemployment (4%). Health system: Health services are financed by a mixture of 
private insurance (covering approximately 75% of the population) and tax-supported 
insurance programs for low-income residents, older persons and persons with 
disabilities qualifying for the federally sponsored Medicare benefits. 5-10% of the 
population has no source of health insurance coverage and must pay out of pocket. 
Insurance coverage for mental health is often limited. Health expenditures amount to 
13.7% of GDP. Primary care services: Patients were recruited from practices in the 
south-west Seattle metropolitan area, including residents of the cities of Burien and 
SeaTac. Practices were widely varying in composition, but were broadly 
representative of the market-based US health care system. Practice caseloads ranged 
from 500-1200 patients per month, with a typical doctor: patient ratio of 1: 350. 
Most attendances were attributable to chronic illnesses (70%), with acute and 
psychological problems accounting for half each of the other attendances (15 %). 
St Petersburg, Russia 
Location and socio-demography: Situated in the North-West of Russia, St Petersburg 
is a city with a population of 4.7 million. 70% of the population are adults (aged 
between 16-65). The population has a high mortality rate (631 per 100,000 
population under 65 years). Unemployment levels have grown significantly in recent 
years, although the official rate produced by the city's statistical bureau for residents 
registered for government work is only 2%. Health system: Health services are 
financed by a combination of state insurance and allocations from the city budget. 
Mental health services are financed solely from the city budget. Utilization of 
inpatient and outpatient services has been stable during the last decade, and is still 
orientated towards a hospital-based service (195 psychiatric beds per 100,000 
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population over 18 years). Primm care services: The study clinics from which study 
patients were drawn are generally representative of the Russian health care system. 
Each clinic serves a population of approximately 40,000 residents and sees an 
average of 25,000 patients per month. The ratio of patients to doctors is high (1,113 
patients per month per doctor). Only 4% of reasons for attendance are attributed to 
psychological problems. 
Socio-demographic, health system and primary care service indicators are 
summarised in Table 4.4, which illustrates the differential age and mortality 
structures, the diversity of health care financing and provision mechanisms and also 
the varying levels of health service availability or supply that are in place across the 
six participating sites. In terms of socio-demographic characteristics, there are 
marked differences in the age profile of the populations (ranging from a high 
proportion of children and young adults in Be'er Sheva and Porto Alegre to a 
relatively high percentage of older adults in Barcelona), the employment rate (40% in 
Barcelona, 70% in Seattle and 90% in St Petersburg, although the latter figure is the 
official government rate only) and mortality rate (from 66 deaths per 100,000 
population under 65 years of age in Melbourne to nearly ten times this rate in St 
Petersburg). 
There is also appreciable diversity across sites with respect to how health services are 
financed and provided, including the extent of publicly provided care, a threefold 
difference in the proportion of national income (gross domestic product) allocated to 
health care and a seven-fold difference in the number of psychiatric hospital beds. 
Finally, the profiles completed for participating primary health care centres reveals 
the varying caseloads, doctor to patient ratios and payment methods across the six 
LIDO sites. Such diversity is not in itself surprising, but has a potentially decisive 
role to play in the interpretation of resource utilisation and cost findings at the level 
of sampled populations. 
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Table 4.4 Site-level socio-demographic and service provision indicators 
Barcelona Be'er Melbourne Porto Seattle St 
Sheva Alegre Petersburg 
Indicator (Spain) (Israel) (Australia) (Brazil) (USA) (Russia) 
Sociodemography (local) 
Gender % female 53 49 48 55 50 55 
Age % children 18 44 27 34 27 16 
% young adults 30 36 35 34 31 37 
% older adults 32 15 30 27 32 33 
% retired 21 7 11 6 10 14 
Employ % employed 41 44.5 57 48 70 90 
% unemployed 19 9.5 10 10 4 2 
% other 49 46 39 42 26 8 
Mortality rate (per 100k 196 157 66 443 191 631 
population < 65 years) 
Health care system 
Total expenditure (% GDP) 1 8.0 8.2 7.8 6.5 13.7 5.4 
Public sector (% total spend) 1 71 75 72 49 44 77 
Main finance source (sector) Public Public Public Private Private Public 
Main provider (sector) Private Private Public Private Private Public 
Overall typology (sector) Semi- Semi- Public Semi- Private Public 
public public public 
Medical beds per 100k popn 604 545 400 558 499 782 
Psychiatric beds per 100k 70 193 27 75 42 195 
Primary care services (local) 
Caseload (patients / month) 7800 5600 6500 17400 500-1200 28000 
Staff FTE doctors 15 7 5.4 44 1-6 22 
FTE nurses 14 5 3.6 11 2-4 > 200 
Ratio (doctor: patient) 520 800 1200 395 350 1270 
Reason % acute illness 25 30 20 74 15 40 
% chronic illness 60 60 60 20 70 56 
% psychological 10-15 10 20 6 15 4 
Typical visit (minutes) 5 10 10-15 20 15 15 
Access % easy (< 0.5 hr) 100 100 65 85 90 80 
Payment consultation State State Copay State Copay State 
medication Copay Copay Patient Copay Copay Patient 
' 1997 estimates (World Health Report; WHO, 2000) 
99 
4.4.2 Description of the sampled populations 
A final sample of 1,180 primary care attenders with a CIDI diagnosis of major 
depression were enrolled into the study, out of a total of 2,363 primary care attenders 
who had screened positive (a score of 16 or over) on the CES-D screening measure. 
Further information on the recruitment of subjects into the LIDO study are reported 
elsewhere (Patrick et al, 2000; Herrman et al, 2000). Out of this sample of 1,180 
patients, 140 were lost to follow-up at the three month assessment point. Comparison 
of baseline assessments between those who dropped out of the study and those who 
reached 3-month follow-up revealed a number of differences in socio-demographic 
characteristics (males, unemployed persons and those living alone were 
disproportionately represented in the drop-out sample) and clinical scores (CES-D 
and QLDS scores were slightly higher in the drop-out group), but not with respect to 
previous treatment or use of services. Since this latter category is the principal focus 
of interest, analyses of changes over the first 3 months of follow-up are focused on 
the 1,040 subjects for whom assessments were available at both time points, and are 
adjusted for these baseline socio-demographic and clinical differences. 
Sociodemography 
Comparison of the socio-demographic characteristics of the sampled populations 
who met eligibility criteria for the study in each site are given in Table 4.5 
(categorical variables with adjusted standardised residuals greater than +/- 3 are 
highlighted to illustrate the more extreme relative contribution of cells to the chi- 
square test statistic). The mean age of all subjects was 40.2 years (SD 14.5), of 
which 11.5 years (SD 3.5) had been spent in education. There were statistically 
significant differences in these characteristics, with an inter-site range of 38.2 - 46.4 
years (age) and 9.1 - 13.3 years (education). The highest mean age and years of 
education was reported in St Petersburg. The striking similarities with respect to the 
gender of the sampled populations - in each of the six sites, women constituted two- 
thirds to three-quarters of the sample (71.1 % overall) - is largely an artefact of the 
sampling strategy; in order to undertake sub-group analyses, a minimum of 50 males 
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The proportion of subjects who were married ranged from 25.1% in Melbourne to 
69.7% in Be'er Sheva, with a grand mean of 47.5%. The low rate in the Melbourne 
sample is reflected by high numbers of people no longer married (36.1%) or never 
married (3 8.7%), as well as by the relatively high proportion living alone (2 5.1 %) or 
with non-family members (30.9%). A quite high proportion of cases in St Petersburg 
were also no longer married (36.5%). There was a clear similarity in the living 
situation of subjects from Barcelona, Be'er Sheva and Porto Alegre, characterised by 
a very high percentage of subjects living with family (83.0 - 87.9%). 
Finally, there were appreciable inter-site variations in employment status; the 
proportion of subjects who were employed (or students) ranged between 53.0 - 
70.1 %, while the unemployment rate among the six sampled populations ranged 
between 6.2% in Barcelona to 23.6% in Melbourne. The unemployment rate in the 
sampled populations of all sites (except Barcelona, which shows the opposite trend) 
is notably higher than that for the general population (Table 4.4). Days absent from 
work for subjects in open or sheltered employment (or students) are reported in Table 
4.6. At baseline, mean days absent from work (out of 65 working days in the 
previous 3 months) exceeded 10 in Barcelona (11.4 days, or 17%), Be'er Sheva 
(11.8,18%) and St Petersburg (16.3,25%). At 3-month follow-up, the number of 
individuals reporting work absences fell in all sites, and in four of the sites the 
average level of absence also fell (although in Be'er Sheva and Melbourne, average 
days went up). For the sample as a whole, 40 less people reported absence, and 
average days of absence decreased by 4.3% (2.8 days). 
Table 4.6 Unrecognised major depression: days absent from work 
N 
Baseline 
Mean SD %b N 
3 month follow-up 
Mean SD %b N 
Change 
Mean %b 
Barcelona 111 11.4 23.9 17.5 100 6.5 18.9 10.0 11 -4.9 -7.5 
Be'er Sheva 76 11.8 17.0 18.1 70 14.2 22.2 21.8 6 2.4 3.7 
Melbourne 81 8.2 16.8 12.6 69 8.5 20.4 13.1 -12 0.3 0.5 
Porto Alegre 77 5.9 16.5 9.0 67 5.0 17.3 7.7 -10 -0.9 -2.7 
Seattle 106 6.4 12.5 9.8 105 4.0 5.8 6.2 -1 -2.4 -3.6 
St Petersburg 89 16.3 22.6 25.1 89 6.9 15.7 10.6 0 -9.4 - 14.5 
Total 540 10.0 19.1 15.4 500 7.2 17.2 11.1 -40 -2.8 -4.3 
F statistic_ 3.91 (p = 0.002) 3.46 (p = 0.004) 
' inclusion criteria: open or sheltered employment and students b out of the last 90 days /3 months 
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4.4.3 Descriptive analysis of service use, costs and outcomes 
Service utilisation 
Service utilisation rates by the sampled populations in the six sites are reported in 
Table 4.7. Numbers of contacts with a range of professionals have been aggregated 
into three categories (one-on-one contacts with health and social care professionals; 
day care / support group attendances; and inpatient days), and are not adjusted for 
potential baseline differences (such as illness severity or comorbidities). The mean 
numbers of visits to individual health and social care professionals in the three 
months prior to baseline ranged from 5.7 (SD 6.4) in Barcelona to 11.4 (SD 13.6) in 
Seattle, with an overall mean of 8.4 visits (SD 9.5). The average number of 
attendances at a day care centre or support group in the previous three months was 
less than one in all sites except Seattle (1.9 attendances, SD 9.7). Likewise, the only 
site where the number of inpatient days out of the previous 90 days exceeded one 
was St Petersburg (2.4 days, SD 7.7). These baseline results for primary care 
attenders with an (unrecognised) diagnosis of major depression indicate a reliance on 
general medical services at the primary care level and a correspondingly low level of 
specialist or secondary care inputs. In all sites there were appreciable reductions in 
contact rates with PHC and outpatient care providers over the first 3 months of 
follow-up, but little change in day care attendances or inpatient days. When all sites 
are pooled, such changes are statistically significant, indicating the need for large 
sample sizes to detect these differences. 
Service costs 
Table 4.8 provides a breakdown of the costs of service utilisation at baseline and 3- 
month assessments, both by type of contact (PHC and outpatient, day and inpatient 
care) and by sector (mental health and general medical care). Mental health care 
speciality costs included contacts with a psychiatrist, a psychologist, a mental health 
worker, attendances at day care centres or support programmes for people with 
mental health problems, and admissions to a psychiatric hospital. A key finding 
from the application of unit costs to service use data was that, even after attempted 
adjustment for the relative price of health care services in the six sites through the 
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application of purchasing power parities, very marked differences in cost remain, 
reflecting differential levels of service volume or uptake. Most starkly, there was a 
30-fold difference in the total average service cost between study subjects in Seattle 
($809 over 3 months) and St Petersburg ($26 over the same period). (Since contact 
rates were not so noticeable different, this perhaps suggests an under-adjustment in 
the parity measure. ) A second clear observation is the very considerable deviation 
around reported mean values, indicating the marked variation in service uptake 
between subjects in individual sites; standard deviations are typically at least double 
the mean value. A third finding from these analyses is evidence of a cost-offset 
effect; although the overall cost of care did not alter over the first three months of 
follow-up, the proportion of cost associated with speciality mental health care did 
change (Figure 4.3). Across all six sites, general medical care service costs 
decreased significantly, by an average of $57 (95% CI -110, -3), while mental health 
care costs increased by an average of $47 (95% CI -15,110). For individual sites, 
however, paired sample t-tests of cost differences over time were not significant, 
partly due to modest effect sizes, further compounded by the marked uncertainty 
around point estimates of cost. 
Clinical outcomes 
Key measures of outcome available for analysis at the interim, 3-month assessment 
point were the CES-D, the QLDS and the SF-12 (the CIDI, principal measure of 
depression, and also measures of co-morbidity, were not available as they were only 
being administered at the principal 9-month follow-up point). For the CES-D, QLDS 
and mental health summary score of the SF-12, there were statistically significant 
improvements in all sites between baseline and 3-month follow-up. There were also 
statistically significant differences in the SF-12 physical health summary score for 
three of the sites (Barcelona, Seattle and St Petersburg). Although there were 
significant inter-site variations in the mean scores for these measures, these results 
provide a clear and consistent picture of positive change in symptom severity, quality 
of life and functioning cross-culturally. CES-D scores decreased by an average of 6 
points (from 29.3 to 23.3., 95% Cl -6.7, -5.3), QLDS scores decreased by 1.3 points 
(95% Cl -1.5, -1.0; lower scores indicate better QoL) and SF-12 mental health 
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Barriers to access 
Differential patterns of service utilisation may not only be related to severity of 
distress or comorbidities, but also to supply-side factors such as distance from the 
agency, affordability of treatment, or awareness about the change intervention can 
bring about. Information was therefore sought on the health-seeking behaviour and 
perceptions of care of the sampled populations, in order to explore issues around 
access to services. Sociocultural factors affecting use of services at baseline 
assessment are shown in Figure 4.2. 












Barcelona Be'er Sheva Melbourne Porto Alegre Seattle St Petersburg 
0 Inconvenience 0 Risk to job M Expense M Embarrassment 
M Family discouragement El Side-effects E3 Other reason(s) 
The key factors identified by subjects were the cost of care (over 20% in all sites, 
rising to 76% in St Petersburg), feelings of personal embarrassment/shame (20% or 
more in Be'er Sheva, Melbourne, Seattle and St Petersburg), and concern about the 
side-effects of medication (inter-site range: 18-44%). Lower-level concerns were the 
risk to one's job, the convenience of getting to treatment centres and discouragement 
from family members to seek care. Other reasons, one or more of which were 
identified by over 20% of subjects in Melbourne, Seattle and St Petersburg, were 
mainly focused around the perception that care, if sought, would not be effective or 
of good quality. 
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4.5 Discussion 
An integral aim of the LIDO study, an international prospective investigation of the 
economic and quality of life correlates relating to recognised depression in primary 
care, was to compare the uptake of available treatment and care in each of the six 
participating sites and to observe the impact of this treatment over time on 
subsequent resource utilisation, work disability and health-related quality of life. In 
addressing this aim, study investigators have been mindful of the need to appreciate 
the complex set of inter-relationships that exist between these (and other) parameters, 
including the potential influence of site-level service and socio-cultural 
characteristics (Figure 4.1). Data have therefore been collected across a wide 
spectrum of measurement domains (Table 4.1) to enable the comprehensive 
exploration of these inter-relationships in each site and also assessment of the 
feasibility of pooling data sets for comparative analyses. 
Cross-cultural differences in the provision of and access to care 
One important element of the data collection process was the construction of a brief 
profile of key socio-demographic features, health care financing mechanisms and 
primary care services for each participating site, which it was hoped would provide 
useful contextual information for the analysis and interpretation of resource 
consumption by sampled patient populations. A basic, if unsurprising, finding 
apparent from comparison of these profiles is the wide diversity observed between 
sites with respect to key health service indicators, not only in terms of overall 
expenditure and service inputs (for example, a threefold difference in the proportion 
of GDP devoted to health care and a sevenfold difference in the numbers of 
psychiatric beds available), but also in terms of the underlying model of health care 
finance and provision (two public, three semi-public and one private systems). A 
number of these differences appear to be borne out by analysis of baseline 
assessments for the sampled populations. For example, service utilisation patterns in 
the relatively well-resourced, managed care system prevailing in Seattle are rather 
different to those found in the lower-resourced, hospital-based system of St 
Petersburg, arguably reflecting differences in the principal locus of care. 
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Links can also be made between site-level indicators and assessment of subjects' 
socio-derno graphic characteristics and perceived barriers to access and treatment 
(Figure 4.2). One clear illustration, in common with other epidemiological evidence 
(Bland, 1997), is that despite being equally distributed in the overall population of 
the six catchment areas, rates of depression are higher among female primary care 
attenders, outnumbering men in the sampled populations by a factor of at least two 
even after specific booster sampling for males. A further striking example is the 
high proportion of subjects in the St Petersburg catchment area (76%) for whom cost 
is a perceived barrier to treatment, which is in line with the payment mechanism for 
medications in primary care and the current economic situation in Russia, as well as 
the high proportion of retired and unemployed study subjects in this site. Further and 
more sophisticated analyses of these and other potential associations (via 
multivariate regression and random effects models) will be an integral component of 
the final follow-up analyses of the LIDO study once all data have been collated 
(including CIDI depression status and the extent of co-morbidity at 9 months). 
The cost-offset effect associated with recognised major depression 
Participating primary care providers were informed of the diagnostic status of all 
study subjects in their local area (even if the physician him/herself had not made 
such a diagnosis of depression). The broad effect of this across the participating sites 
over the first three months of the follow-up period was an increase in the amount of 
specialist mental health care provided to sample populations (by definition, such care 
was negligible for the period preceding baseline since depression treatment was an 
exclusion criterion of study eligibility). What is also generally apparent is that this 
specialist care was provided in place of, rather than in addition to, general medical 
care service use. Such a cost-offset effect is shown in Figure 4.3, which illustrates 
the extent of change in mental health and general medical care costs in the six sites. 
The most pronounced cost-offset is apparent in Seattle, where mental health 
speciality costs rose by $260 and general medical costs fell by $173 over a three 
month period. Elsewhere, too, there were clear-cut shifts in the pattern of utilisation 
(Barcelona, Melbourne and Port Alegre). In Be'er Sheva both cost categories 
increased very slightly and in St Petersburg both fell from what was already a very 
low baseline. 
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Barcelona Be'er Sheva Melbourne Porto Alegre Seattle St Petersburg 
Ongoing andfuture analyses of costs, quality of life and depression 
The observed baseline diversity across participating centres with respect to health 
seeking behaviours, in addition to organisational characteristics of health care, raises 
both a question and a challenge to health service researchers. The question is the 
extent to which it is sensible or feasible to pool data from participating sites, either 
with a view to enhancing the power with which study hypotheses can be addressed or 
in a bid to carry out standardised comparative analyses. Put another way, is it wise to 
compare resource utilisation patterns and associated costs in depressed subjects in 
Seattle to their counterparts in St Petersburg? The answer to this question is also the 
challenge to health service researchers just posed, namely integrated, simultaneous 
assessment of individual-level and site-level characteristics. 
Preliminary longitudinal analyses of the LIDO data set reported here, relying only on 
the 3-month follow-up assessments, has shown that changes in service utilisation are 
accompanied by positive and significant improvements in depression score (as 
measured by the CES-D screening measure), quality of life (QLDS) and functioning 
(SF-12), as well as work disability (see Table 4.6). Disentangling the inter- 
relationship of these changes in a systematic way, however, adopting multi-variate 
techniques to simultaneously adjust for the potential effects of access to and 
provision of treatment, remains an outstanding task for study investigators. 
The analytical approach to be pursued in the LIDO study will be to progressively 
move from site-specific, individual-level analyses of the inter-relationship over time 
between depression symptoms, quality of life and costs, towards consideration of 
pooled analyses through the execution of a series of fixed- and random-effect models 
(Diehr et al, 1999; see also Chapter 3, section 3.3.4). To date, initial attempts to 
explore these multi-variate relationships from an economic perspective (using the 
incomplete and short-term data available at time of submission) have not produced 
parsimonious or powerful models; no clear set of variables are associated with 
changes in total service costs (owing to the cost-offset effect) or in the mental health 
or general medical sub-components of total cost. It is anticipated that inclusion of 
subsequent follow-up data will enable improved modelling of the complex inter- 
relationships that exist between depressive symptoms, health seeking behaviours and 
user outcomes. For these analyses, varying combinations of sites and site-level 
variables will be introduced into these models, with the expectation that pooled data 
for certain combinations of countries - that is, those with overlapping socio- 
economic and health system characteristics - will perform better than other 
combinations. 
In so doing, we will be seeking to generate new insights into the extent to which site- 
level characteristics, such as relative levels of service provision, access and 
expenditure, have an effect on individual costs and outcomes. Such insights stand to 
tell us much about the opportunities in different regions of the world for reducing the 
current international burden of depression. 
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5. Mental health economics demonstration project in 
India and Pakistan: the MENDIP study 
5.1 Rationale 
As reviewed in Chapter 2, international epidemiological research has demonstrated 
the very considerable public health burden that psychiatric disorders impose on 
individuals, communities and health services throughout the world. Primary care 
physicians participating in an international study of psychological problems in 
general health care, for example, identified an average of 24% of attendees as being a 
'case' with a psychological disorder (Usttin and Sartorius, 1995), while the Global 
Burden of Disease study (GBD) estimated that 10.5% of GBD in low- and middle- 
income countries is attributable to neuropsychiatric disorders (Murray and Lopez, 
1996; WHO, 1999). National studies carried out in India and Pakistan have similarly 
shown both the very high prevalence of psychiatric disorder in rural communities, 
particularly anxiety and depression among women (Mumford et al, 1996,1997; 
Srinivasa Murthy, 1996), and the consequences of this disorder in terms of disability 
(Patel et al, 1998). 
The GBD study also estimated that only 8.4% (out of 83 million) episodes of 
depression in the developing world receive treatment while in developed countries the 
proportion in receipt of treatment is 35%. Since the study also estimated that standard 
treatment for depression will reduce disability by a factor of two (the disability weight 
drops from 0.6 to 0.3), it is possible to project that the application of currently available 
technology to the 76 million depressed individuals in the developing world who do not 
receive treatment could potentially reduce the total burden of illness due to depression 
by about 46%, saving 19.5 million DALYs per year. Alternatively, increasing the rate 
of treatment to that currently achieved in the developed world would reduce the burden 
of illness due to depression in the developing world by 13%, saving 5.7 million DALYs 
per year. 
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One model of mental health care and prevention that has long been advocated as an 
appropriate way forward in many low-income countries is one that is integrated into 
the local community context, particularly the existing primary health care system 
(WHO, 1975,1979; Sartorius and Harding, 1983; Schulsinger and Jablensky, 1991). 
The strengths of this approach include the wide coverage that it can expect to attain, 
the holistic concept of health that it would engender, and the low costs of its 
implementation. Assessment of the cost-effectiveness of integrating mental health 
services into primary health care (PHQ would show what such a strategy costs 
(including its impact on other primary health care services), what it produces (in 
terms of increased treatment and referral rates as well as individual 
functioning/quality of life etc. ) and whether these outcomes are worth their cost. The 
expectation would be that the introduction of a mental health care component will be 
associated with improved PHC process indicators (rates of detection, referral etc. ) 
and patient outcomes, achieved at relatively low additional cost. Such data, almost 
non-existent now, would be helpful to the many governments either committed to 
providing effective and affordable services to their mentally ill populations. 
In countries such as India and Pakistan where the preponderance of health care is 
privately provided and purchased, however, an important concern relates to the 
extent to which people with health problems actually utilise government primary 
health care services (Government of Pakistan, 1993,1998; Kishore Kumar et al, 
1998). Although services in the public sector in both countries are theoretically 
provided free or at a nominal charge, a shortage of drugs and a poorly maintained 
public infrastructure means that individuals mainly purchase medicines and local 
health care from private providers. Accordingly, a significant proportion of overall 
health care costs is borne privately (75% in India, 66% in Pakistan; Khattak, 1998). 
This chapter describes a demonstration cost-outcome study relating to the integration 
of mental health services into primary health care in India and Pakistan. In so doing, 
it also illustrates the feasibility of undertaking economic analysis in low-income 
countries, and highlights important methodological and policy issues that will require 
consideration in the further development of mental health services in this context. 
The specific objectives of the demonstration project were: 
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e to review key issues relating to the access, provision and financing of mental 
health care as they relate to low-income countries; 
to develop and test protocols for the economic evaluation of community mental 
health programmes, based on a demonstration project in India and Pakistan; 
to generate a framework and accompanying guidelines for the conduct of mental 
health care economic evaluations in low-income countries. 
5.2 Methods 
5.2.1 Study design and selection of cases 
The demonstration project was initiated by the candidate (CEMH, Institute of 
Psychiatry) and carried out as part of the evaluative research programmes of the 
Institute of Psychiatry, Rawalpindi (State of Punjab, Pakistan) and the National 
Institute of Mental Health and Neurosciences, Bangalore (State of Karnataka, India). 
Selection was based on existing networks, a proven ability to carry out required 
research activities and the active pursuit of a community mental health care strategy. 
Study design 
The chosen design of the study was to recruit and follow-up patients meeting ICD- 10 
diagnostic criteria for affective and neurotic disorders (WHO, 1992) from two rural 
catchment areas, one reflecting the standard primary health care system, and one in 
which mental health care had been incorporated into primary health care practice. 
The standard primary care centres were Jigani (Bangalore) and Lehtrar (Rawalpindi), 
and the centres in which mental health training and support had been given were 
Sakalwara (Bangalore) and Taxila (Rawalpindi). Following previous studies and 
methods (Mumford et al, 1997), a community survey design was adopted, involving 
the mapping of whole local communities and randomly selecting members of 
individual households. This approach enabled the health-seeking behaviour of the 
whole local population to be observed (rather than primary care attenders only), 
thereby affording the opportunity to assess the extent of unmet mental health need. 
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Recruitment of study participants 
A two-stage process was used to recruit subjects: i) initial screening for mental 
disorder by trained research field workers via the Self Report Questionnaire (SRQ; 
Harding et al, 1980); ii) for all those scoring above the SRQ threshold for caseness 
(in India, a score of 5 or more indicates a probability of psychiatric morbidity, in 
Pakistan 6 or more), a diagnostic assessment was made by a psychiatrist (the 
Psychiatric Assessment Schedule or PAS; Mumford et al, 1997; in India, the 
Schedule for Clinical Assessment in Neuropsychiatry or SCAN; WHO, 1992). 
Different instruments were used because the Rawalpindi collaborators were not 
trained in SCAN, but both provide ICD-10 diagnoses. Only new episodes of 
affective and neurotic disorder were included (ICD-10 categories F32-F48), defined 
as the presence of a set of symptoms for which no mental health treatment had been 
sought in the last month. Other inclusion criteria included the age of patients (18-60 
years of age) and local residence. 
Those study subjects meeting diagnostic criteria were informed of their health status 
by the psychiatrist and were provided with information about possible treatment 
options, how and where to seek local treatment for their condition, and advice about 
psychosocial. problems such as alcohol or drug dependency in their spouse. 
5.2.2 Measurement and analysis of costs and outcomes 
Patient measures 
A range of clinical/social measures were administered via face-to-face interviews at 
entry into the study and again three months later, in order to observe any changes in 
outcomes. Data were obtained on symptomatology (Hamilton Depression Rating 
Scale; Hamilton, 1960), disability (Brief Disability Questionnaire; von Korff et al, 
1996) and quality of life (WHOQOL Bref-, WHOQOL Group, 1998). Further patient- 
level data were collected via the completion of a sociodemographic form (age, 
gender, education, employment, income) and a service utilisation form, based on the 
Client Sociodemographic and Service Receipt Inventory (CSSRI-EU; Chisholm et al, 
1999: see Section 3.3.2; see also Appendix E). 
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A range of psychiatric and general medical services were identified which together 
were considered a comprehensive profile of services available to the populations in 
each locality. The main categories were: contacts with government primary health 
care workers (doctor, nurse, health visitor, other PHC worker); local general 
practitioners and indigenous healers (including pirs or faith healers); and (psychiatric 
or general medical) hospital inpatient stays and outpatient attendances. Clear 
definitions were attached to individual service components or categories in order to 
gain multi-site comparability, and space was left for inclusion of other services 
provided to patients that were not specifically identified in the inventory. For each 
service, number of contacts were requested, either in the previous one month 
(baseline) or over the previous three months (follow-up) and where applicable, the 
sector of provision (statutory/government, voluntary or private). In addition, 
information was obtained on individual's use of medication, support and help 
received from family and friends, as well as individuals' personal perceptions of 
providers and issues affecting access to services and attitudes towards mental health. 
The schedule was then refined in a similar way to the CSSRI-EU, based on 
discussion with principal investigators- and fieldworkers in each site. 
Cost measures 
The perspective of the economic analysis was a societal one, such that the costs of 
not only the health sector were considered, but also the time costs and out-of-pocket 
expenses of users and their (informal) carers. This is a wider perspective than that 
used in the EPSILON and LIDO studies, since there was particular interest in trying 
to quantify the impact of common mental disorders on households and individuals, 
rather than on use of health services only. Unit costs were derived for a range of 
primary health care contacts (key workers, such as a doctor, nurse or pharmacist; 
other workers, such as lady health visitors; and psychiatrist), on the basis of facility- 
specific data on staffing levels and salaries, plus other revenue and capital costs 
relating to the premises at which the professionals worked. Total annual costs of 
professionals were divided by working days per year and hours worked per day, 
resulting values subsequently weighted by the ratio of time spent in/not in contact 
with patients. A series of other unit costs were also estimated for outpatient and 
inpatient hospital contacts, based on available hospital finance data. 
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Privately purchased health care and medications were costed as the fees that patients 
or their families actually paid to local providers (recorded in the service receipt 
schedule, and assumed to broadly reflect long-run marginal opportunity costs). 
Where patients or families contributed to the cost of publicly provided hospital care, 
this was separately quantified and subtracted from the total cost that would have 
applied if fully financed by government. Finally, estimates were calculated for the 
opportunity costs associated with informal care-giving (hours per week multiplied by 
an hourly wage rate for a house-maid - Indian Rupees 6; Pakistani Rupees 12), and 
also for time spent travelling to or waiting for care providers and lost opportunities 
for work (derived from the patient's estimated wage, based on gender-adjusted 
average earnings for labourers or skilled workers). 
Analysis 
The purpose, design and scale of this demonstration project precluded the conduct of 
a full-scale cost-consequences analysis (which would require a controlled, 
experimental study design, a larger sample size and a longer follow-up period). 
Moreover, the observational design of the study, together with differences in the 
structure of local health services,, means that relative changes in costs and outcomes 
between catchment areas are not necessarily causally related, making causal 
inferences about cost-effectiveness based on such comparisons hazardous. (As in the 
EPSILON and LIDO studies, adjustment for differences in subject and site 
characteristics would allow for the observation of potential associations between 
localities, but that was not the principal analysis of interest in this prospective 
cost: outcome study. ) Accordingly, the focus of analysis in this study was not on 
comparisons between catchment areas or sites, but on changes over time in the 
principle cost and outcome domains for each of the localities (using a two-sided 
paired-sample t-test statistic for changes in mean costs or clinical scores, and a two- 
tailed McNemar test for detecting statistically significant differences in changes in 
dichotomised variables). For assessing the impact of perceived barriers to access on 
the use of government health services specifically, (univariate) odds ratios were 




5.3.1 Description of sites and service systems 
The organisation, delivery andfinancing of health care in India and Pakistan 
In order to assess the feasibility of introducing a successful model of community 
mental health care, there is a need to understand the service systems, structures and 
processes that characterise mental health care and delivery in India and Pakistan. To 
at least the extent found in industrialised countries, fundamental problems and 
obstacles facing the provision of mental health services in low-income countries 
include: 
" insufficient resourcing (especially training, drugs and basic infrastructures) 
" inequitable (or non-existent) access to mental health services 
" variable efficiency in the provision of services 
" inadequate quality of services 
" lack of co-ordination between agencies (health, social services, education etc. ) 
Political, administrative, geographical and socio-economic structures will also have 
an impact on the uptake of mental health care services in rural areas. As indicated by 
Table 5.1. India and Pakistan are fairly similar in terms of socio-demographic and 
economic indicators. The two countries share a similar structure of health financing, 
with services in the public sector theoretically provided free or at a nominal charge in 
both countries. (In Pakistan, for example, patients entering the hospital system are 
asked to pay one rupee per outpatient visit and five rupees per inpatient day). Overall 
levels of expenditure on health care in India and Pakistan amount to 6% and 3.8% 
respectively. In both countries less than 1% of this is spent on mental health services. 
Because of a lack of available drugs and a poorly maintained infrastructure, 
individuals often purchase medicines or treatment from a private provider, since the 
private or non-govenunental sectors are viewed by many as providing a more 
efficient and effective service (Government of Pakistan, 1998). Accordingly, a 
significant proportion of overall health care costs is bome privately (75% in India, 
66% in Pakistan; WHO, 1999). 
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Table 5.1 National sociodemographic and health sector characteristics 
National indicators India Pakistan 
Socio-dernographic indicators 
Population (millions) 960 million 144 million 
Populatiorn growth rate 2.0% 3.0% 
Life expectancy Male 62 years 64 years 
Female 62 years 64 years 
Literacy rate 52% 38% 
GNP/capita ($) $340 $460 
Health indicators 
Death rate/ 1000 10.5 9.8 
Infant mortality/ 1000 75 75 
Access to antenatal health services (%) 62 28 
Access to safe water (%) ? 50 
Fertility rate (%) 3.1 5.0 
Health expenditure 
Private expenditure as % total expenditure 75% 66% 
Health expenditure as % GDP (public sector) 2% 0.70% 
Health expenditure as % of GDP (all sources) 6% 3.8% 
Source: World Health Report; WHO, 1999 
In both countries, service delivery is a combination of both public and private care. In 
Pakistan, public health care delivery is undertaken by government hospitals, Rural 
Health Centres (RHQ and Basic Health Units (BHU), generally under the 
administrative control of the District Health Office. A programme of Lady Health 
Workers (LHWs), selected by the communities, trained for three months and 
subsequently supervised by the professional staff of BHUs and RHCs, act as a bridge 
between the community and the health units, generally serving a population of about 
1000 individuals. The non-governmental sector provides health care to an estimated 
70% of the population and includes general practitioners, small/medium-sized 
hospitals, maternal and child health centres and dispensaries (with outpatient primary 
care facilities), as well as indigenous practitioners such as homeopaths, tabibs and 
vaids. Pirs or faith healers are important agents in the local community and often act 
as local advisors to households on religious, economic and family matters, as well as 
health referral agents (Gater et al, 199 1). 
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In India, public health care services consist of an average of one community health 
centre per 450,000 population, one PHC centre per 40,000 and one health sub-centre 
per 6,700 (World Bank, 1993b). Rural health care is supported by one local hospital 
located in each district headquarters. Primary health centres are usually staffed by a 
nurse, a pharmacist and a multi-purpose health worker. As in Pakistan, general 
practitioners form a major part of the total number of more than 284,000 doctors in 
the country. There are also independent medical practitioners, unqualified doctors, 
pharmacists, faith healers and traditional healers. 
In terms of manpower for mental health care, there are only about 100 psychiatrists 
nationally in Pakistan who are concentrated in the teaching hospitals in Lahore, 
Rawalpindi and Karachi. There are very few trained clinical psychologists or 
psychiatric social workers and there is a chronic shortage of psychiatric nurses. In 
1995, there were only about 3000 psychiatrists in the whole of India (a six-fold 
increase since 1972! ) but there has not been a commensurate increase in the number 
of trained clinical psychologists, psychiatric social workers, psychiatric nurses or 
rehabilitation personnel (Srinivasa Murthy, 1996). In the countries of South East 
Asia (i. e. India, Pakistan, Bangladesh, Sri Lanka, Nepal and Myanmar), there was 
only I psychiatric bed for every 30,000 people, in contrast to 2-13 beds for every 
1 000 people in Europe (Sartorius, 1990). 
Local health service catchment areas 
The sociodemographic characteristics of the four catchment areas are given in Table 
5.2. Inter-site comparisons of age distributions and employment are made hard by 
the use of different stratifications in the two countries, but as expected the great 
majority fall into the categories of young adults or children, whilst the main category 
of employment for the adult population as a whole is 'other economically inactive' 
(includes household production). There is comparability of age distributions and 
employment categories within sites (i. e. between the two catchment areas of each 
country). There are clear differences in the percentage of adults not married, with 
higher rates in the Pakistan catchment areas (particularly Taxila), and also the 
population mortality rate (India's is nearly double that of Pakistan). 
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Table 5.2 Local catchment area characteristics 
I Sociodemographic indicator 
Age distribution 
India Pakistan 
" Children (0-14) (0-18) 
" Young adults (15-25) (19-39) 
Older adults (25-59) (40-65) 




" Other economically inactive 
Social indicators' 
0% adults, not married 
0% adults, living alone 
0% adults, single parent with children 
Mortality indicators 
" Death rate/ 100,000 






40.2 41.3 25.2 30.8 24.0 29.5 
20.4 19.9 16.2 14.8 18.6 12.4 
31.6 31.9 7.0 4.5 7.7 6.3 
6.8 7.7 0.9 0.6 1.1 0.45 
36.1 38.1 65.2 6.9 61.4 6.7 
0.4 0.1 22.1 10.3 24.3 10.0 
62.5 61.8 12.7 82.8 14.3 83.3 
10.7 9.9 29.5 40.0 
0.7 0.4 0.4 0.5 
6.4 5.8 1.5 2.1 
930 930 489 503 
385 403 
I adults defined as people over school leaving age 
Profile ofparticipating PHC centres 
Jigank Jigani PHC is 32km from Bangalore and the residents in this area are mostly 
involved in agriculture. There is a nearby industrial area which employs 3,000 
individuals, 25% of whom reside in the Jigani catchment area. The PHC centre is 
served by 6 sub-centres, which together serve a population of 32,398, covering 95 
villages over an area of 20 kM2 .A single medical officer at the clinic 
is supported by 
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I nurse, 2 health workers and five other staff. There are an average of 961 
consultations per month and daily attendance is 50-140. 
Sakalwara: Sakalawara is located about 15 krn from Bangalore, and caters for a rural 
population of 5,160, which is considerably smaller than Jigani. There is one sub- 
centre serving this centre, which is staffed by I physician, 3 nurses, and five other 
staff. One doctor and three nurses have received additional training in mental health 
care, which included 3 days initial training plus 3 days follow up. The rural health 
centre also provides weekly clinics in the villages. Approximately 702 patients visit 
the centre per month. 
Taxila: This site has recently been upgraded from a Rural Health Centre (RHQ and 
is now a 60 bedded RHC/hospital. It is served by 6 Basic Health Units (B14Us). 
Those who are involved in direct patient care include 6 medical officers, one female 
medical officer, a dentist, 2 nurses plus a radiographer, dental technician and nurse 
(or dispenser). Approximately 300 patients are seen a day, approximately four of 
which are cases of addiction and 30-50 patients have a mental disorder of some sort. 
Mental health training within Taxila has been underway for 18 months via a two-day 
workshop and two six-day courses. The number of staff who have received 
additional training over the last two years have been one doctor and three nurses. 
Lehtrar: Lehtrar is a rural health centre set in the hills to the East of Islamabad, and 
has two supporting Basic Health Units. The average number of new cases per day is 
36.4. Most attendees live over 30 minutes from the centre. Staff who are concerned 
with direct care of patients within this centre include 3 medical officers, one female 
medical officer, 5 dispensers, 7 dressers, I dentist, I dentist technicians and one 
radiographer. 
The characteristics of the participating primary health care centres are summarised in 
Table 5.3. Three of the four centres are based in rural settings, and the other centre 
(Taxila, Rawalpindi) is suburban. The population of the Taxila centre's catchment 
area is nearly 50,000, compared to 25,000-32,000 for Lehtrar and Jigani respectively, 
and only 5,000 in the Sakalawara locality. Staffing levels at Taxila Rural Health 
Centre (RHQ are correspondingly higher, with 15 physicians and 29 other key PHC 
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workers, who between them see an average of 4,500 patients per month. Lehtrar 
RHC has 4 physicians and 13 other key PHC workers, who see 3,000 patients per 
month. The Bangalore PHC centres are smaller scale, with only one physician and 
three other key PHC workers. The caseload of both Bangalore PHC centres is below 
1,000 patients per month. 
In all four centres, acute illnesses/injuries represent the most common reason for 
patients' visits, with a particularly high proportion reported in Jigani. Definite 
chronic disease represented 15-27% of cases, but ill-defined chronic illness was more 
varied, with higher proportions evident in the Rawalpindi site (about 30%, compared 
to 5-10% in Bangalore). Presentation with psychological problems represented the 
smallest category (10% or less), except in Sakawalara where these problems 
constituted 30% of caseload. The age-sex distribution of the four centres was 
strikingly similar, with children representing the largest proportion of cases (20%), 
and retired /elderly people accounting for less than 5% of cases. The proportion of 
funds spent on salaries appears to be higher in the Pakistan PHC centres, whereas a 
proportionally larger amount is spent on maintenance in the Indian centres. The 
proportion of funding spent on drugs is fairly standard throughout. Transport to all 
centres is thought by the majority to be at least slightly difficult, apart from in Taxila, 
where the majority deemed transport to the centre to be easy. 
In terms of size, population served and mean number of patients served per month, 
therefore, there are evident differences between the centres, which has implications 
for making comparisons between the catchment areas. Accordingly, analysis of costs 
and outcomes has focused on changes over time within the different localities, as 
opposed to comparisons between catchment areas or sites. 
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Table 5.3 Profile of participating PHC centres 





" Setting Rural Rural Rural Suburban 
" Size 
30kM2 5 kM2 l0km2 5 kM2 
" Inhabitants 32,370 5,160 24,760 47,700 
Staffing (full-time equivalents) 
" Physicians 1 1 4 15 
" Nurses (incl. LHV) 1 3 1 9 
" Health workers 2 0 12 20 
" Other staff 5 5 22 54 
" Physician time with patients 80% 90% 80% 80% 
Funding (Rupees p. a. ) 13.2 Lakh 20 Lakh 36 Lakh 29 Lakh 
Salaries 53% 45% 72% 78% 
Drugs 7% 10% 8% 8% 
Maintenance 16% 20% 4% 4% 
Other 20% 25% 16% 10% 
Caseload 
" Mean no. of patients / month 961 702 3000 4500 
" Average length of visit 8 mins 10 mins 10 mins 10 mins 
" Reason for visits (%) 
a) Acute illnesses/injuries 65% 45% 37% 37% 
b) Definite chronic disease 15% 20% 27% 25% 
C) Ill-defined chronic illness 10% 5% 28% 31 % 
d) Psychological problems 10% 30% 8% 7% 
" Age / sex distribution (%) MF MF MF MF 
a) Children 25 15 25 20 18 18 18 22 
b) Younger adults 15 10 10 15 12 14 11 16 
C) Older adults 15 15 10 12 16 13 16 14 
d) Retired/elderly 23 34 53 22 
Transport to PHC centre (%) 
o Easy 36% 40% 10% 60% 
With some difficulty 30% 35% 50% 20% 
Difficult 34% 25% 40% 20% 
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5.3.2 Psychiatric epidemiology of catchment areas 
Bangalore site: The catchment area for screening of this population for common 
psychiatric disorders was done in Sakalawara and Jigani, with respective populations 
of 1146 and 5600 individuals. These localities were systematically mapped, with 
each household separately identified. The screening instrument (SRQ) was 
administered to the available adults (aged 16 to 65 years). About 317 available 
adults were screened in Sakalawara area (integrated model of care) and 22.3% (or 71) 
persons had an SRQ score of 5 or more. Evaluation of these probable cases on SCAN 
revealed that 11 (15.4%) were excluded because of alcoholism, epilepsy and 
anaernia. The proportion of cases confirmed using SCAN was 18.9% of the adult 
population screened. In the Jigani locality, 478 adults were screened. 82 (17.1%) of 
the individuals were taken up for second stage interview (SRQ 5 and more). 
Evaluation revealed that 26.8% (22 individuals) could be excluded because of 
anaernia, pregnancy or alcoholism. The proportion of confirmed cases in Jigani area 
was 12.5% of the screened population of 478 people. The prevalence of diagnosable 
common mental disorder using samples from these localities was therefore 18.9% in 
Sakalawara and 12.5% in Jigani. 
Rawalpindi site: 475 SRQs were administered in Lehtrar and 473 in Taxila, 
representing 4.5% and 2.2% of the total adult populations (aged 16 to 65 years) of the 
two respective catchment areas. In Lehtrar, a total of 168 subjects (35%) scored 6 or 
more on the SRQ (the cut-off score for the Pakistani population), whilst in Taxila the 
corresponding rate was 49% (232 individuals). Of these positive SRQ screens, 131 
cases (78%) were given a full psychiatric assessment using the Psychiatric 
Assessment Schedule (PAS) in Lehtrar, and 186 (82%) in Taxila. The proportion of 
confirmed cases as a percentage of the screened population (i. e the prevalence of 
diagnosable common mental disorder) was 28% in Lehtrar and 39% in Taxila. 
The various (primary) diagnoses reached for the sampled populations are given in 
Table 5.4. The large proportion of cases (72% in Bangalore, 92% in Rawalpindi) fall 
under the broad diagnostic category of mood (affective) disorders (ICD-10 code F32- 
F39), the remaining proportion being made up of neurotic and somatisation disorders. 
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The most common (primary) diagnoses in the Bangalore site were dysthymia (68% of 
the sample), and phobic and other anxiety disorders (19%). In contrast, only 8% of 
cases in Rawalpindi were diagnosed with phobic and other anxiety disorders, and 
there were no diagnosed cases of dysthymia. Rather, the majority of cases were 
diagnosed as having depressive episodes (22% mild, 32% moderate and 35% severe, 
of which over a third had psychotic symptoms). 
Table 5.4 Diagnosis and SRQ scores 







Diagnosis (ICD-10) (120) (133) 
" Mild depressive episode F32.0 3 2.5 29 21.8 
" Moderate depressive episode F32.1 1 0.8 42 31.6 
" Severe depressive episode F32.2 0 0 32 24.1 
(w/o psychotic symptoms) 
" Severe depressive episode F32.3 0 0 19 14.3 
(with psychotic symptoms) 
" Dysthymia F34.1 82 68.3 0 0 
" Phobic and other anxiety disorders F40, F41 23 19.2 11 8.3 
" Other diagnosis F43, F45 11 9.2 0 0 
(somatoform disorders, neurasthenia) & F48 
Scale Mean S. D. Mean S. D. 
Mean score at screen (SRQ) 0-20 9.84 3.96 11.17 3.48 
1 T-test statistic for comparison of means = -2.830, significant at p<0.01 
Comparison of the mean SRQ scores for the cases selected for full psychiatric 
assessment in the two sites revealed an important difference (Table 5.4), with 
subjects in Rawalpindi (mean = 11.17, S. D. 3.48) scoring on average 1.32 points 
higher than subjects in Bangalore (mean = 9.84, S. D. 3.96). This difference was 
found to be statistically significant, which suggests that the Rawalpindi population 
somatised distress more than their Indian counterparts. 
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5.3.3 Sociodemographic characteristics of the sampled population 
The sociodernographic characteristics of the sampled populations in each of the four 
catchment areas of the study are given in Table 5.5. There are a number of broad 
similarities across the catchment areas, including the preponderance of women (71- 
87% of the samples), the proportion of married people (62-80%), and the small 
minority who are currently employed (2-13%). There are also clear differences 
between and within sites, however, such as the age distribution (for example, 50% of 
subjects in Lehtrar were aged 45 years or more, compared to only 13% in Taxila), the 
range of monthly incomes and the extent of educational achievement. 








Standard care Integrated care 
(Lehtrar) (Taxila. ) 
N%N %- 
Gender Male 13 21.7 16 26.7 20 28.6 8 12.7 
Female 47 78.3 44 73.3 50 71.4 55 87.3 
Age (years) 16-30 28 46.7 17 28.3 15 21.4 26 41.3 
31-45 19 31.7 20 33.3 19 27.1 29 46.0 
45-60 13 21.7 23 38.3 36 51.4 8 12.7 
Marital status Single 7 11.7 3 5.0 9 12.9 17 27.0 
Married 42 70.0 48 80.0 49 70.0 39 61.9 
No longer 10 18.3 9 15.0 12 17.1 7 11.1 
Children None 13 21.7 9 15.0 14 20.0 21 33.3 
1-3 29 48.3 26 43.3 18 25.7 10 15.9 
4 or more 18 30.0 25 41.7 38 54.3 32 50.8 
Employment Employed 6 10.0 8 13.3 8 11.4 1 1.6 
Unemploy 21 36.0 26 43.3 13 18.6 20 31.7 
Housewife 33 54.0 26 43.3 49 70.0 42 66.7 
Income' < Rs 2000 41 68.3 51 85.0 50 71.4 19 30.2 
(monthly) Rs 2-5000 19 31.7 8 13.3 17 24.3 36 57.1 
> Rs 5000 0 0 1 1.7 3 4.3 8 12.7 
Education < Primary 34 56.7 50 83.3 21 30.0 13 20.6 
(completed) Primary 11 18.3 4 6.7 8 11.4 12 19.0 
Secondary 15 25.0 6 10.0 15 21.4 18 28.6 
Missing 0 0 0 0 26 37.1 20 31.7 
I Expressed as gross personal income in local currencies (not adjusted) 
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5.3.4 Rates of contact with services 
In the standard care locality in the Bangalore site (Jigani), 17% had contacted a 
government primary care provider in the one month preceding baseline assessment, 
33% had consulted a private provider in the community, 10% had had an hospital 
outpatient attendance and 5% had been admitted as a hospital inpatient (Table 5.6). 
In the integrated care locality (Sakawalara), 37% of the population had been in 
contact with a government primary care provider, 25% had contacted a private 
community-based provider, 7% had had an outpatient attendance and 3% had used 
inpatient facilities. The higher rate of contact with primary health care in the 
integrated care locality is maintained at the three month follow-up assessment point 
(43%, compared to 25% in Jigani). Users in the standard care locality of Jigani 
appear to have utilised hospital outpatient services more than primary care as a result 
of their diagnosed condition, reflected by an increase in attendance rates. Most 
significantly for this site, only 25% in Jigani and 43% in Sakalawara actually sought 
care from a government primary care provider (and only 55% and 65% for any 
contact in the two respective areas), even after being informed of their clinical 
condition and advised to seek care. 
Trends in service use were different in the Rawalpindi site. Two-thirds of subjects at 
baseline had had contact with a government primary care worker in the non- 
integrated site (Lehtrar), compared to a quarter of subjects in the integrated locality 
(Taxila). After three months, the contact rates with government primary care 
providers rose to 88% and 52% respectively, both considerable increases of more 
than 20% (McNemar test for significant differences: p<0.05). In other aspects of 
health care seeking, in both sites approximately two-thirds of subjects had consulted 
a private community provider at baseline, one-third had had an outpatient attendance, 
and 2-7% had been admitted to hospital. Whereas there were only modest changes to 
these contact rates in the standard care locality of Lehtrar (except an I I% increase in 
admission rates), there were marked and statistically significant increases in the 
extent to which subjects in the integratred care locality of Taxila utilised services 
(changes of over 20%). There were also significant increases in the proportion of 
cases in contact with any type of service (from 86% to 100% in Lehtrar, and 75% to 
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5.3.5 Access to services 
It is important to observe that use of services to mitigate distress is a complex 
phenomenon. In other words, differential patterns of use may not only be related to 
severity of distress, but also to distance from the agency; affordability of treatment, 
awareness about the change intervention can bring about, etc.. As well as obtaining 
data on clinical outcomes and service utilisation, therefore, information was also 
sought on the health-seeking behaviour and perceptions of care of the sampled 
population, in order to explore issues around access to services. A series of potential 
barriers or impediments to appropriate care and treatment were presented to the 
sampled populations (see Appendix 5A). 
Barriers to access 
Key factors affecting use of services at baseline assessment in both the Bangalore 
localities included cost of care (37% in Jigani, 22% in Sakawalara), feelings of 
embarrassment (20% and 30% respectively), and the perception that care if sought 
would not be effective (25% and 18% respectively) (Table 5.7). Significant 
reductions occurred after three months with regard to the perceived cost of care in 
both localities (27% and 17% less), and with regard to embarrassment in the 
integrated site (22% less). In the Rawalpindi sites a high proportion of cases agreed 
that the presented reasons were a constraint on their uptake of services - in Lehtrar, 
distance (81%), affordability (76%) and medical side effects (60%) were the main 
barriers to access at baseline and a large proportion also felt embarrassment was a 
constraint on their uptake of services (49%). For all factors, there were reductions in 
the proportion who viewed the presented reasons as barriers to access, with 
statistically significant differences in perceptions with regard to the inconvenience of 
services (-23%), the expense of services (-30%), stigma attached to seeking care (- 
30%) and perceptions regarding the ineffectiveness of services (-16%). In Taxila, the 
cost of services (46%) and a belief that services will be ineffective (37%) seemed to 
be initial constraints to use. There is very little change over time in this locality. A 
significant change is noted with regard to other reasons affecting seeking care, which 
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Individuals were asked to indicate whether they preferred a public or private provider 
and to give reasons for their choice (Table 5.7). In the Bangalore site, there is a 
preference for a public provider in Sakalawara (72%) whereas in Jigani preference is 
equally divided. At the follow-up assessment, there is little observed change in 
Sakawalara but in Jigani there is a clear and statistically significant shift towards 
preferring to consult a public provider. There is a similar pattern of change in the 
Rawalpindi site, with little observed change in the choice of provider in Taxila 
(where preference is equally provided), compared to a significant shift away from the 
private to the public sector in the Lehtrar catchment area (preference for a private 
provider drops from 27% to 13%). 
Impact ofperceived barriers to access on use ofgovernment health services 
For each site, the sampled populations of both catchment areas were pooled and split 
according to whether they had used government health services or not (defined as at 
least one contact with government primary or secondary care), in order to assess the 
potential influence of key sociodemographic, clinical and access variables on this 
service uptake (Table 5.8). In the Bangalore site, men were more likely to have used 
goverm-nent services (multivariate odds ratio = 3.53; 95% Cl 1.06,11.7), as were 
employed individuals (OR = 9.98; 95% CI 1.87,53.2). Of the access variables, 
embarrassment and/or family discouragement was associated with reduced use of 
government services (OR = 0.13; 95% CI 0.02,0.75). In the Rawalpindi site, the 
only statistically significant association in the multivariate model relating to the use 
of government services was the perception that treatment was of poor quality or 
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Costs of common mental disorders 
Health care costs 
Whilst there were considerable variations in cost between sampled individuals within 
particular localities, a number of general trends emerge from the cost analysis Qable 
5.9). The mean cost of contacts with government primary health care workers, which 
would be expected to rise if individuals seek appropriate treatment for their 
diagnosed mental health condition, does in fact increase in the localities where 
mental health care training and support has been introduced (Sakalwara and Taxila), 
whereas there is very little change in the standard care localities. By contrast, costs 
of contacts with community-based private health care providers (general 
practitioners, traditional healers) drops in all localities, significantly so except in the 
Sakalwara locality. Privately incurred expenditures on medication, on the other 
hand, remain relatively constant over the three month period. Aggregated health care 
costs increase, but not statistically significantly so, in both integrated care localities, 
resulting mainly from increased contact with secondary care services. 
Total societal costs 
The opportunity costs associated with lost work, time and travel to obtain treatment 
and informal caregiving by family members were also estimated (Table 5.9). Costs of 
lost work days decreased significantly in all localities, particularly in the Bangalore 
site where costs fell by 80-90%. Opportunity costs associated with informal care- 
giving (help from relatives in or outside the home such as child care, cooking and 
shopping) decrease in the Bangalore site also, but rise considerably in the Rawalpindi 
site, notably in Taxila. When all costs are combined (health care and patient/family 
costs), the magnitude of the economic impact of depression and anxiety becomes 
evident: in the Bangalore site, the cost at baseline is Indian Rupees 700 per month, 
and in the Rawalpindi site the baseline cost is in excess of Pakistani Rupees 3000 per 
month. To put this in context, this is equivalent to between 7-14 days of an 
agricultural worker's wages in India, and approximately 20 days in Pakistan. These 
total costs, however, fall appreciably by the follow-up assessment point in all 
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5.3.6 Outcome assessments 
Baseline depression scores were markedly higher in the Rawalpindi site, indicative of 
greater psychiatric morbidity. However, since the interviewers were not trained 
simultaneously or by the same trainer, it is conceivable that rating methods differed 
in the two sites. Results are therefore couched in terms of changes in scores over 
time in the two separate sites (Table 5. ID. Overall, there were improvements in 
quality of life, and significant reductions in symptornatology and disability. In three 
of the four localities, there was a substantial reduction in depression symptom levels 
(between 5.1 and 8.6 points lower, each statistically significant at p<0.01). The 
exception was Taxila, where there is only a very modest reduction (0.5 points). 
Results for the BDQ closely reflect those for depression scores, in the sense that in all 
localities bar Taxila there is a significant reduction in overall disability score (6.2 to 
7.9 points less). There is a slight, though not statistically significant, increase in 
BDQ score for Taxila (0.3 points higher). There were statistically significant 
improvements in quality of life scores in Sakalawara and Lehtrar, only modest 
improvements in Jigani and in Taxila there was no clear change either way. 
Summary of change scoresfor key cost and outcome domains 
A summary of observed changes over time in the principle cost and outcome 
domains is given in Table 5.11, including a comparison of change scores between 
those who had been in contact with government primary and secondary health care 
and those who had only consulted local practitioners or not accessed care at all. For 
both localities in the Bangalore site, there are higher service costs but greater 
improvements in depression score. Improvements in disability change scores are also 
better among government health care users. There are no statisitically significant 
differences in change scores in the Rawalpindi site, but again service costs are higher 
among government health care users. Depression and disability change scores are 
actually better among the (very small number of) non-users in the Lehtrar locality, 
and in Taxila users of government health care services had a marginally better 
depression mean change score but slightly worse disability score. In the two 
integrated care localities, therefore, there are no clear advantages in clinical or 
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Table 5.11 Summary of changes in cost and outcome 
Change 










(users vs non-users) 
Mean 95% CI 
Jigani (N= 60) (N= 24) (N= 36) 
(standard care) 
Service costs -R 131 501 +R78 347 -R 271 542 R 348 -598 -98 
Family costs -R 342 652 -R 407 710 -R 245 553 R 162 -505 182 
Depression (HDRS) -6.83 7.9 -9.79 8.05 -4.86 7.18 4.93 0.95 8.91 
Disability (BDQ) -4.13 5.2 -4.17 5.60 -4.11 4.93 0.06 -2.80 2.69 
---- ------------------------------- Sakalwara --------------- (N= ----------------- 60) --------------- (N= -------------- 3 1) -------------- (N= -------------- 29) ------------- --------------------------- 
(integrated care) 
Service costs +R 169 1230 +R 366 1324 -R 15 1126 R 381 -1015 253 
Family costs - R422 685 -R 392 705 -R450 678 R58 -415 299 
Depression (HDRS) -5.10 6.5 -5.66 7.47 -4.58 5.47 1.07 -2.29 4.44 
Disability (BDQ) -5.35 5.3 -6.10 4.90 -4.65 5.59 1.46 - 1.27 4.18 
-- ------------------------ - --- -- -- Lehtrar -------- -- ---- (N= ----- - --------- 67) ------ - ---- - -- (N= ------- - ------ 59) ---------------- (N -- - ----- -- --- =8) --------------- --------------------------- 
(standard care) 
Service costs +R48 996 +R 70 1060 -RI 11 132 R 181 -935 573 
Family costs -R 634 2294 -R 626 2394 -R 689 1524 R 62 - 1809 1684 
Depression (HDRS) -8.64 6.34 -8.42 6.35 -10.25 6.41 1.83 -6.61 2.96 
Disability (BDQ) -4.75 5.90 -4.73 5.99 -4.88 5.54 0.15 -4.62 4.32 
------------- ----------------------- Taxila --------------- (N= ----------- - 63) -------------- (N= ---------------- 20) ---------------- (N= --------------- 43) -------- -- ------------ - ------------- 
(integrated care) 
Service costs +R 370 1984 +R 666 2300 -R 299 567 R 965 -2040 108 
Family costs +R 1297 1981 +R 1293 2046 +R 1304 1889 R 11 -1074 1096 
Depression (HDRS) -0.51 5.21 -0.81 5.73 +0.15 3.90 0.96 -1.87; 3.79 
Disability (BDQ) +0.30 2.69 +0.56 2.72 -0.25 2.59 0.81 -2.26 ; 0.64 
Users defined as all subjects who had at least one contact with government primary or 
secondary care services; non-users had no contact with these services 
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5.4 Discussion 
Feasibility of economic analysis of mental health care in low-income countries 
Against the backdrop of a widening recognition of the public health burden of 
psychiatric disorders, this demonstration study set out to develop and test methods 
for conducting economic analysis of community mental health programmes in low- 
income countries. Such evaluative techniques, if appropriate and feasible to employ, 
enable the generation of data on the relative costs and benefits of a range of responses 
to psychiatric disorder in the community, which can subsequently inform policy 
discussion and service development. On the basis of this demonstration project, it is 
possible to conclude that economic analysis in low-income countries is both feasible 
and practicable. In reaching this conclusion, however, it is important to be cognisant 
of a number of factors that have contributed to the successful conduct of this 
particular study, including the research and training capacity of the collaborating 
institutions, the interest shown in incorporating economic perspectives into existing 
evaluative programmes, and the professionalism of key workers. We are 
nevertheless confident that other centres in low-income countries who possess a 
grounding in research methodology and an interest in addressing issues of cost- 
effectiveness will be able to carry out economic analysis alongside their other 
activities. Towards this end, a brief set of guidelines have been prepared (Appendix 
F), which are aimed at providing a set of principles and procedures that need to be 
pursued in order to carry out an economic evaluation of a mental health care 
intervention in this context. 
The economic burden of common mental disorders 
The health care and other patient/family opportunity costs incurred by sampled 
individuals with a diagnosed common mental disorder were considerable. It is 
important to note that the preponderance of these costs were privately incurred 
expenditures, and that a significant category of health care cost was consultations 
with local general or traditional practitioners (neither of whom are trained or 
qualified to detect or treat psychiatric morbidity). Thus, whilst individuals (and 
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households) are seeking help, and spending significant amounts of money in the 
process, they are not in the main receiving appropriate care for their mental health 
condition. The imputed costs associated with reported levels of informal care-giving, 
travelling time/expenses and lost days of work are also very considerable, and in fact 
exceed formal health care costs by a factor of as much as three (a finding echoed in 
other cost of illness studies for depression and other affective disorders carried out in 
industrialised countries; Kind and Sorensen, 1993; Greenberg et al, 1993). Although 
self-reported estimates of specific care-giving activities such as 'help around the 
home' are subject to reliability constraints (typically leading to overestimation of 
opportunity cost), use of clearly specified activities and minimal wage rates for a 
house maid/servant nevertheless help to demonstrate the economic impact of 
common mental disorder on the productive opportunities of individuals and families. 
Strengths and limitations of the study 
An important feature of the chosen study design was that it enabled estimation of the 
prevalence of common mental disorders in the sampled catchment areas. This study 
reinforces the findings of earlier epidemiological studies in each site that common 
mental disorders are indeed common, particularly among women (an estimated 12- 
18% of the adult populations of the Bangalore catchment areas, and 28-39% in the 
Rawalpindi site). Although there are notable differences in the diagnostic profiles of 
the two sites (high rates of moderate and severe depressive episodes in the 
Rawalpindi site, and a high prevalence of dysthymia in the Bangalore site), which are 
potentially a ftmction of our use of different schedules, the focus of this study was on 
analysis of health care seeking patterns within rather than between sites, and our 
results in fact closely reflect those reported locally in other recent studies (Mumford 
et al, 1997; Ustfln and Sartorius, 1995). The observational study design also enabled 
assessment of the health-seeking behaviours of whole catchment populations, which 
demonstrated the economic consequences associated with unmet need at the level of 
individuals, families and local health services. For example, it was found that only 
just over half of the sampled populations in the Bangalore site had contacted services 
at alL, and an even smaller proportion were in contact with government primary 
health care workers. 
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The high proportion of subjects who did not access government primary health care 
services in the two localities where mental health care had been integrated 
confounded assessment of the relative cost-effectiveness of the programme at the 
catchment area level (only about half of subjects were exposed to the PHC-based 
intervention). An experimental study design involving the comparison of attenders 
only at primary care centres with and without the integrated care model is required to 
satisfactorily address this question. Comparison between those who did and did not 
access government primary and secondary services in the integrated care localities, 
however, showed no statistically significant advantages in clinical or economic 
outcomes for the former sub-group. In particular, the recent introduction of mental 
health training and support in the main primary health care centre in Taxila does not 
yet appear to have benefited the sampled mentally ill population of that area (a 
plausible reason for this is that there was a strong preference for, and consequent 
reliance on, private care providers in this population). 
A striking finding of the study is the significant improvement in the outcome 
domains of depression, disability and quality of life for both standard care localities. 
These results may represent a regression to the mean or be partly explained by 
spontaneous remission or improvement, particularly in the Rawalpindi site where 
there was a significant proportion of acutely depressed cases, but also suggest that 
interviewing individuals about their mental health state, and advising them to seek 
care locally, may exert an intervention effect itself. 
Factors affecting access to and uptake of services 
The findings of this component of the research, which focused on the inter-linked 
processes of access to appropriate care, perceptions about local health providers and 
actual utilisation of services, demonstrate that the successful implementation of a 
community mental health care programme is contingent on the health-seeking 
behaviours of both the local population at large and the specific target groups for 
whom the intervention is intended. Most notably, it is clearly apparent that only a 
modest proportion of sampled subjects use government-provided primary health care 
services. This confirms the findings of other recent research into health-seeking 
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behaviours in these countries (Government of Pakistan, 1998; Noorali et al, 1999; 
Regimi et al, 1999; Kishore Kumar et al, 1998). In the two localities where mental 
health care had been integrated into primary care, for example, the proportions who 
had used such a service in the month preceding baseline were 27% in Taxila 
(Rawalpindi) and 37% in Sakawalara (Bangalore). Although rates of contact 
improved over the course of the study (to about 50%), an obvious implication of this 
finding is that approximately one half of subjects did not access government primary 
health care, thereby rendering themselves unable to benefit from mental health care 
and treatment available at the two integrated primary health care centres. 
A further striking finding of the study is the impact that the process of identification 
and referral of cases of common mental disorder had in the different care localities. It 
is apparent that there was a discernible shift in the health-seeking behaviour of the 
standard care localities in both sites, particularly so in Lehtrar, reflected by an 
increase in the perceived access to, preference for and use of government primary 
care services. The positive shift in Lehtrar can be explained in part by the 
appointment of a lady doctor preceding the study period (contact rates have since 
decreased dramatically following her departure). By contrast, attitudes towards local 
health services and providers in the integrated locality of that site (Taxila) were more 
ambivalent and changed very little over time, manifesting itself in increased rates of 
contact with private as well as public providers. In Sakawalara, where mental health 
care has long been integrated into primary care, contact rates and choice of provider 
remained more stable. 
What these findings suggest is that changes in perceived access to care, preferred 
provider and actual use of services are largely independent of the introduction of 
mental health training and support into government primary care facilities. A more 
plausible explanation is that interaction with mental health researchers (as a result of 
face-to-face research interviews) has had an influence on subjects' perceptions of 
service access and provision. Furthermore, improvements in depressive symptoms 
(through natural remission or successful treatment) and functioning are likely to have 
played their part in forming preferences about the quality and value of local health 
care services. Formal testing of these and other possible inter-relationships has been 
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limited to a logistic regression of factors that are associated with the uptake of 
government services, which indicated that it is socio-demographic characteristics and 
individual perceptions about health services, rather than improvements in depression 
or disability per se, that may have the more important bearing on treatment choice. 
Future policy priorities and research needs 
The most pressing policy priority in low-income countries is to enhance the 
recognition of common mental disorders as a public health concern, not only through 
epidemiological, clinical, economic and social research, but through the 
dissemination of that evidence to decision-makers at all levels of federal and local 
government. Increased provision of appropriate care and resources for common and 
more severe psychiatric disorders cannot be expected to occur without a 
corresponding improvement in the awareness and understanding of key decision- 
makers. An important aspect of this awareness-raising campaign, already under way 
as part of the Nations for Mental Health initiative (Jenkins, 1997b), is the reduction 
of stigma towards mental illness, both at a policy and public level. Indeed, it would 
appear that efforts to make basic mental health care more widely available through 
integration with primary health care need to be accompanied by mental health 
promotion activities in order to increase awareness and reduce stigma about mental 
illness, as well as to communicate the availability of good quality, low-cost and 
effective treatment. Such promotional activities, through schools programmes or 
other campaigns, have high preventive value and are virtually bound to be cost- 
effective (Rahman et al, 1998). 
Since governments of low-income countries are fundamentally constrained by lack of 
resources, constructive ways of harnessing existing local resources must be given 
consideration, not only in terms of integrating mental health care into the primary 
care system but also in terms of engaging other professionals and leaders. In many 
cases the first 'port of call' for an individual with mental disorder (or a member of 
their household) is the traditional or general practitioner. Simple mental health 
training for these local private providers might represent an effective means of 
improving the detection, referral and management of common psychiatric disorders. 
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Of particular relevance in this respect is the currently widespread prescription of 
inappropriate medications by local private practitioners for these disorders, the cost 
of which is invariably met by the patient or family. Training in the detection and 
treatability of common psychiatric disorders needs to be accompanied by the 
availability of suitable drugs (and simple psychosocial interventions). Whilst the 
high acquisition cost of newer anti-depressants is an obvious constraint, conventional 
tricyclics are very cheap and equally effective (if not quite as well tolerated). And yet 
in many of the pharmacies visited in the present study, such medication is not 
stocked or available. The establishment and implementation of an essential drug list 
for psychiatric disorders is likely to represent a further policy consideration in many 
low-income countries. 
Finally, whilst the current study has generated data on the service utilisation patterns 
and costs of individuals with a diagnosed common mental disorder among two 
catchment area populations in India and Pakistan, there remains a chronic shortage of 
economic data to support mental health policy or resource allocation discussions at a 
national or international level. There is consequently a need to undertake further 
studies that not only address the relative cost-effectiveness of alternative 
interventions or strategies (using a prospective, experimental design), but also 
broaden our understanding of the inter-relationship between psychiatric morbidity 
and disability on the one hand, and access to and uptake of services on the other. 
Indeed, interventions for common psychiatric disorders need to be carefully planned 
in accordance with the prevailing health-seeking behaviours of the local 
population(s) as well as other demographic, cultural and socio-economic factors, 
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6. Discussion, conclusions and policy implications 
On the basis of the three preceding research studies, each with a common interest in 
the cross-cultural assessment of mental health services and associated costs, this 
research thesis set out to illustrate the development, application and promotion of 
methods for economic analysis relevant to multinational mental health services 
research and policy. These intentions were framed in the context of, on the one hand, 
the prevalent and highly disabling nature of psychiatric disorders globally, and on the 
other hand, the low priority and meagre level of investment accorded to the provision 
of services for these disorders in many parts of the world. The end goal towards 
which the research has been directed was stated as the generation of cost and cost- 
effectiveness methodologies and data that will enable improved decision-making in 
the allocation of resources to mental health care at an international level. Specific 
objectives of the research were formulated as follows: 
1. Development of culturally appropriate methodologies for the international 
measurement of mental health service utilisation and costs; 
2. Generation of comparative service utilisation, cost and outcome data on the basis 
of international studies of major psychiatric disorders and key policy issues; 
3. Exploration of the inter-relationships between the costs of psychiatric disorders 
and a range of individual and site-level characteristics; 
4. Examination of the varied socio-political, financial and health system contexts 
within which mental health services are provided in different cultural settings; 
5. Identification of key methodological and policy issues for the future conduct of 
international mental health economic analysis. 
Discussion of the extent to which these objectives have been addressed, together with 
emerging findings and conclusions, will be structured around what was attempted 
(methodological developments), what was found (empirical findings) and what is 
required in the future (implications for research and policy). 
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6.1 Methodological developments in the multinational analysis of 
mental health services and costs 
A considerable proportion of this thesis has been focused on methodological aspects 
of economic study design, data collection and analysis. The underlying reason for 
this focus of attention is not that appropriate methods for the economic analysis of 
health care are absent; there is in fact a reasonably good level of consensus around 
basic principles, conceptual frameworks and analytical methods (Drummond et al, 
1997; Gold et al, 1996; Knapp, 1995; Hargreaves et al, 1998). Rather, it is a 
reflection of the additional factors and difficulties that need to be taken into 
consideration when conducting multi-national studies. Interest in such comparative 
studies is on the increase, but to date there have been limited guidelines or methods 
that have been developed to accompany such multi-national research questions. 
What follows, therefore, is a set of guidelines and considerations relevant to mental 
health economic studies in general, but with a particular focus on the multi-national 
methodological developments described earlier within the three source projects. 
Discussion will be structured around the following key methodological stages, 
drawing liberally on examples taken from the three source projects: 
1. Study design and perspective of economic studies in mental health; 
2. Measurement and valuation of identified costs and outcomes; 
3. Comparative analysis of costs and outcomes; 
6.1.1 Study design and perspective of economic studies in mental health 
As in clinical evaluation, an important consideration for the review, assessment and 
interpretation of economic evidence is research design. For example, is the study a 
prospective, controlled trial or a retrospective study with no control group? Two 
further features can be added to this for economic studies, namely the type of 
economic evaluation, and the scope or perspective of the study. The merit of an 
economic study in terms of coverage and generalisability is determined to a 
significant extent by these three parameters (Table 6.1). Viewed as an inter- 
connected hierarchy of evidence, the ideal type of study upon which to base decisions 
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on cost-effectiveness and resource allocation is one conducted prospectively with two 
(or more) appropriately-sized, randomly-allocated groups of patients, for whom all 
conceivable costs and outcomes are measured in a common currency. Such a study 
has yet to be completed in mental health care, largely because of the demanding 
requirement to convert all costs and consequences into monetary units. Most studies 
to date have been cost-effectiveness or cost-consequences analyses, based on a range 
of clinical data sets and employing the cost perspective of the formal service sector. 
Table 6.1 Study design parameters 
Parameter 1 
Type of clinical data 
(What ratings are based on) 
Parameter 2 
Costing scopelperspective 
(What costs are included) 
Parameter 3 
Type of economic evaluation 
(How costs & outcomes combined) 
Non-empirical Single care agency Cost-minimisation analysis (CAM) 
(e. g. claims database) (e. g. health service only) (outcomes are the same) 
Observational Allformal care agencies Cost-effectiveness analysis (CEA) 
(e. g. cross-sectional study) (e. g. voluntary sector included) and cost-consequences analysis 
(e. g. cost per change in depression) 
Quasi-experimental Formal & informal care agencies Cost-utility analysis (CUA) 
(e. g. retrospective study) (e. g. lost employment included) (e. g. quality adjusted life year) 
Experimental All societal costs Cost-benefit analysis (CBA) 
(e. g. RCT) (e. g. user/carer distress included) (all costs and outcomes monetised) 
Study design 
Since economic analyses often take place alongside clinical evaluations or trials, the 
design of the study will typically need to be agreed in conjunction with other 
evaluators. The most desirable design requirements for the economic evaluation of a 
mental health care intervention revolve around the presence of a control group 
(against which to draw comparisons with the intervention group), and the prospective 
follow-up of these two groups over time (one year would be sufficient in most 
studies). This 'experimental' study design is the 'gold standard' of clinical and 
economic evaluation, since it is able to demonstrate most clearly that changes in 
selected measures are attributable to the intervention, as opposed to other possible 
explanatory factors (confounding' variables). Where it is not possible or practicable 
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to carry out an experimental study, an observational study design can be used; this 
design may have better external validity - preserving the context in which care is 
provided - but shifts the focus of the analysis towards identifying associations 
between the intervention and changes in costs or outcomes (as opposed to attributing 
a causal relationship) (Black, 1996). 
In terms of the design of the three source projects, the EPSILON study was a cross- 
sectional survey of prevalent cases of schizophrenia, the LIDO study was a one-year 
prospective observational study of major depression, and the MENDIP study was a 
short-term (3 month) prospective quasi-experimental study, with intervention at the 
level of the primary health care centre as the unit of contrast. None of the studies 
employed a randomised controlled design. The main strengths and limitations of the 
chosen study designs for the three studies are summarised below in Table 6-2. 
Table 6.2 Summary of study designs employed in the three source projects 
Study design Strength(s) Weakness(es) 
EPSILON study Cross-sectional Less resource-intensive (no Unable to measure change 
follow up procedures) over time (outcomes); 
LIDO study Observational Naturalistic No intra-centre control group 
MENDIP study Quasi-experimental Health-seeking behaviour Low attendance at PHC 
of whole catchment centres reduces ability to 
population measured measure effect of intervention 
The main weaknesses revolve around the lack (in the case of the EPSILON study) or 
short-term nature (in the case of the MENDIP study) of follow-up assessments, and 
the absence of a genuine control group against which to demonstrate the impact of 
treatment or intervention on the targeted population. Set against this, the chosen 
design of both the LIDO and MENDIP studies did allow for the assessment of 
everyday clinical practice and/or health-seeking patterns in identified populations 
with a diagnosable condition (an important feature commonly overlooked or 
undermined in experimental studies that are usually carried out under atypical 
conditions). For example, the finding that only a modest proportion of subjects 
enrolled into the MENDIP study actually attended the primary health care centres 
where mental health training and care had been incorporated is highly relevant to the 
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planning and cost-effectiveness of mental health care in these settings, yet would not 
have been revealed by an experimental study of a selective (and unrepresentative) 
sample of PHC attenders. 
However, while there is certainly a need to include cross-sectional and observational 
study designs in mental health care evaluation, the default study design option for the 
4core business' of assessing the relative cost-effectiveness of competing mental 
health care interventions is a prospective, controlled study using an experimental 
design. Although such a design poses known problems relating to external validity 
(Black, 1996), the absence of a randomised control arm against which relative or 
incremental changes in costs and outcomes can be compared is likely to represent an 
overriding limitation of alternative, naturalistic study methods. Put another way, 
there is a need to demonstrate that changes in costs and outcomes are caused by, 
rather than merely associated with, the intervention under investigation. Furthermore, 
external validity constraints, particularly for multi-site studies, can be markedly 
reduced by the selection of representative study sites, matched study facilities, 
comparison of findings across sites with shared health system characteristics, and 
examination of contextual factors including access to, and the responsiveness of, the 
local health care system. 
Mode of economic evaluation 
For intervention studies that have an experimental design, consideration must be 
given to the mode of economic evaluation (that is, the manner in which costs and 
outcomes data are to be combined for analysis). The simplest of cost evaluations is 
commonly referred to as cost-minimisation analysis, although this is only appropriate 
if outcomes are known or found to be identical (which is unlikely due to the multi- 
dimensional nature of mental health outcome studies), in which case the task is 
merely to establish the least cost method of achieving these outcomes. A much more 
common mode of economic evaluation in the field of mental health care is cost- 
effectiveness analysis5 which assesses not only the costs but also the outcome of an 
intervention, expressed in terms of cost per reduction in symptom level, cost per life 
saved, etc.. Where there is more than a single measure of outcome being 
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investigated, as is often the case in psychiatry and related fields, it is more correct to 
label this type of study as a cost-consequences analysis. This mode of evaluation is 
likely to represent the default choice in most contexts, and has the advantage of 
presenting an array of outcome findings to decision-makers. The MENDIP study, for 
instance, captured data for three outcome domains: depression and anxiety 
symptoms, quality of life and disability. 
Two further modes of evaluation are cost-utility analysis and cost-benefit analysis 
(neither type of analysis was employed in the three source projects). Cost-utility 
analysis has considerable appeal for decision-makers since it generates equivalent 
and therefore comparable study data ('utilities', expressed by a combined index of 
the mortality and quality of life or disability effects of an intervention), upon which 
priorities can then be based. However, there are technical difficulties in using this 
approach, and where it has been used in psychiatry, it has not performed very well to 
date (Chisholm et al, 1997a; but see Section 6.3.2 for a discussion of how utility 
measurement is being used to generate generalised estimates of the relative cost- 
effectiveness of a wide range of mental health care interventions globally). 
A similar conclusion can be reached with respect to the final evaluative option - cost- 
benefit analysis - which refers to a form of evaluation in which all costs and 
outcomes are valued in monetary units, thereby allowing assessment of whether a 
particular course of action is worthwhile, based on a simple decision rule that 
benefits must exceed costs. This approach is difficult to undertake because of the 
requirement to quantify outcomes in monetary terms, and consequently is found very 
rarely in mental health care evaluation. However, methodologies are being developed 
which aim to obtain direct valuations of health outcomes by patients or the general 
public, such as 'willingness-to-pay' techniques, where an individual states the 
amount they would be prepared to pay (hypothetically) to achieve a given health state 
or health gain (Healey and Chisholm, 1998). 
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Costing scope andperspective 
The clinical and social burden imposed on individuals, families and communities by 
mental health problems contains an economic dimension. This economic dimension 
covers not only the costs associated with health and social care support of users (in 
the past referred to as 'direct' costs), but also the knock-on effects (or 'indirect' 
costs) of mental disorder, such as the impact on someone's ability to work. 
Inconsistent definition of what constitutes 'direct' as opposed to 'indirect' costs has 
led to a move away from the use of these terms, to be replaced by the more useful 
distinction between health care (and other formal sector) costs and patient/family 
costs. 
A final key decision to make at the design stage of an economic study therefore 
relates to the scope or perspective of the evaluation. This refers to the viewpoint 
from which the analysis is being taken, which, in ascending order of 
comprehensiveness, might be that of a particular agency or government department 
(e. g. ministry of health), the statutory/formal sector as a whole (e. g. including social 
services), or a societal perspective which assesses the impact of the intervention on 
all agencies, including patients themselves as well as their carers. The choice of 
viewpoint, which will influence what costs and outcomes are to be measured, should 
be determined according to whether the intervention under study is expected to exert 
a differential impact on these various agencies/sectors. However, since 
comprehensive mental health care requires multi-disciplinary inputs, the adoption of 
a single agency perspective is unlikely to be appropriate for most evaluations. 
Rather, an analysis that seeks to identify the costs falling to the multiplicity of care 
agencies involved, plus any costs incurred by users or carers (typically lost 
employment opportunities as well as any payments for medication or institutional 
care), is likely to represent the most suitable perspective. A final category of costs 
covering, for example, the anguish or distress of carers or users, may also enter the 
analysis. Increasingly these costs can be valued by means of techniques such as 
ýwillingness to pay' or measurement of an individual's utility (Healey and Chisholm, 
1998). 
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Table 6.3 provides a summary of the resource utilisation and costs measured in the 
three source projects for this thesis. The first issue to note is that all of the three 
studies provide comprehensive estimates of direct care and treatment costs, covering 
both specialist / secondary care and community / primary care services as well as 
social care support where applicable. In this respect alone, these studies are doing at 
least as well as the vast majority of completed economic studies in the mental health 
field. Only in the MENDIP study, however, were the consequences of illness on the 
patient and family, in terms of lost employment, informal care giving and travel / 
time costs, fully quantified in monetary terms. Informal care-giving was assessed in 
the EPSILON study, but qualitatively via the administration of the Involvement 
Evaluation Questionnaire to family members (IEQ; Schene and van Wijngaarden, 
1992), while it was decided to exclude this dimension of assessment in the LIDO 
study due to the limitations of self-report and the additional expense of interviewing 
family members. Travel and time costs were also not included in the EPSILON and 
LIDO studies since, unlike the MENDIP study carried out in rural areas of India and 
Pakistan, they were not expected to contribute significantly to total costs. The final 
issue to note is that in none of these three studies could the longer-term outcomes of 
illness be measured, since one study was cross-sectional and the other two were 
restricted to relatively short follow-up periods. 
Table 6.3 Summary of costs measured in the three source projects 
Cost categories EPSILON study LIDO study MENDIF study 
Care and treatment 
" Treatment (drugs, therapy) 
" Inpatient / residential care 
" Day care / group support N/A 
" Outpatient / primary care 
Patient and family 
" Informal care (via IEQ) x 
" Lost work opportunities V., V-1 
" Travel and time costs x x 
155 
6.1.2 Measurement and valuation of costs and outcomes 
Measurement of resource utilisation 
Resource utilisation data relating to identified service components can be collected in 
a number of ways, depending on the design of the study, the coverage/extent of 
service components and the access to/quality of service provider databases (see 
Section 3.2.3 for a more detailed description of these issues in relation to the 
EPSILON study of schizophrenia). 
Economic analysis carried out alongside clinical evaluations offers a number of 
assessment points for the collection of individual service utilisation data. Individual 
profiles of service use can be constructed over a defined retrospective period via the 
administration of a service receipt schedule. Prospective studies provide an 
additional alternative to resource utilisation data collection, namely data collection 
through the keeping of a diary of any contacts made, rather than the completion of a 
formal interview-based schedule. An alternative method for eliciting data on 
individual service contacts is through the examination of patient records kept by 
service providers - particularly if these records are computerised - including 
hospitals, primary care providers and social services. Sole reliance on these data 
sources is made difficult by the multiplicity of databases on which an individual's 
service contact(s) may appear and the widespread potential for non-completeness and 
under-reporting. However, data from these databases may be sufficient in certain 
locations (for example, Seattle, where a series of depression studies have used 
administrative databases; Von Korff et al, 1992; Simon et al, 1995), or can act as 
useful cross-reference / validation of data obtained through interview. 
The disparate needs of different client groups translate into different patterns of 
demand for services. For example, the service demands of people with common 
mental disorders may be quite modest, focusing on primary health care and social 
care contacts, plus other support in the form of (more specialist) counselling or 
psychological therapy. This is quite different to the respective needs of users with 
more severe or enduring mental disorder, such as people with schizophrenia, whose 
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needs are likely to encompass a wide range of services over and above those cited 
above, such as psychiatric inpatient and outpatient hospital services, housing or 
residential care, structured day care support and activities and sheltered employment 
(see, for example, the range of service components included in the service receipt 
schedule used for the EPSILON study at Appendix A). The extensive range of 
services that people with mental health problems may use means that most 
evaluations need to adopt a wide coverage, which points to the usefulness of an 
instrument that pulls these disparate service components together in a single form. 
In each of the source projects, a resource utilisation schedule was developed for 
collecting service receipt data over a retrospective period of 3 months (see 
Appendices A, C and E). The principal advantages of this approach to service 
utilisation data collection include: 
" clear definition of service categories 
" semantic equivalence and standardisation of use between participating sites 
" collation of all resource use (and other) data necessary for economic analysis 
" administration at the same time points as other clinical/functioning measures 
These perceived advantages were bome out by the application of these service receipt 
schedules in the three source projects: comprehensive resource utilisation data 
necessary for the economic analysis of support costs, as well as socio-economic and 
informal care-giving data, were collated in a standardised format and, because the 
schedule was administered in an interview-format concurrently with other research 
instruments, completion rates were very good in all three studies. 
Measurement ofservice costs 
For each item of resource utilisation, a unit cost estimate is required, such as a cost 
per inpatient day, or cost per contact with a primary care worker. It is necessary to 
compute these estimates using a range of data sources, including national/local 
government statistics, health authority figures and specific facility or organisation 
revenue accounts. The broad perspective to be employed in the costing of services is 
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an economic one, such that in principle service costs are derived by reference to their 
marginal long-term opportunity costs. In practice, derivation of costs in this way is 
difficult. It is therefore common to use short-term average costs as a proxy for long- 
run marginal costs (Beecham, 1995). 
Collection and estimation of service costs across different countries is complicated 
by the shortage of good quality cost data, the diverse accounting rules and budget 
categories that exist, and the alternative payment mechanisms to health care 
providers. In addition, many health systems operate on a 'fee for service' basis, but 
these fees or charges may not reflect the true opportunity cost of a service and 
therefore need to be treated with great caution. Unit cost data collection in a 
multinational study can be greatly facilitated by the use of a standardised protocol 
and accompanying templates for data entry. Appendix D, which describes the unit 
cost protocol used in the LIDO study, provides a full example of the principles and 
procedures that can and should be pursued in studies of this kind. 
For investigation of pooled cost data, it is necessary to work in a common currency 
(such as US $). As argued earlier, simple use of exchange rates is not advisable, 
owing to the volatility of certain currencies, plus the different 'purchasing power' of 
different countries represented in a study. It is therefore necessary to adjust the costs 
of services in individual countries by a conversion factor, such as a 'purchasing 
power parity', which reflects the relative cost of health services in particular sites. 
This mechanism has the intentional effect of equalising the worth of health care 
service inputs/costs across the various sites. To date, however, the calculation of 
PPPs has been restricted to the level of overall gross national product (Organisation 
for Economic Co-operation and Development, 1996). Arguably, such GDP PPPs 
may not adequately reflect differences in the health sector specifically, as was 
suggested in the discussion of the marked differences in the costs of care observed 
across the LIDO study sites (Chapter 4, section 4.4). The availability of health- 
specific PPPs will clearly provide more sensitive adjustment of the relative price 
levels of health care provision. 
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Measurement of outcomes 
There is an important distinction to be made between indicators of intermediate 
outcomes and final outcomes. The former category, which can also be referred to as 
process indicators, should not ideally be the focus of the analysis, since positive 
changes in, for example, attendance or detection rates may not in fact result in 
improved patient welfare or mental health. Thus, while process indicators are 
undoubtedly an important source of differentiation between study samples at the 
institutional level, their use as indicators of improved patient welfare needs to be 
treated with caution. Final outcomes, on the other hand, are concerned with detecting 
changes in the physical, psychological or social well-being of individuals, and 
commonly revolve around the measurement of symptoms, functioning and disability, 
quality of life and service satisfaction. In the three research studies,, a wide range of 
outcome measures were employed across these domains, as surnmarised in Table 6.4. 
All of these measures are well-validated and reliable instruments that have been used 
extensively in mental health services research. A primary objective of the EPSILON 
study was of course to further assess the reliability and usefulness of these promising 
instruments in different national settings. As previously noted, none of the source 
projects were designed to elicit data on utilities or monetised benefits, which 
accounts for the absence of summary indices of outcome such as the Quality 
Adjusted Life Year (QALY). It can be expected that with the further development 
and refinement of cost-utility methods, such measures of outcome will be more 
routinely included as a corollary to more condition- or domain-specific measures. 
Table 6.4 Summary of outcomes measured in the three source projects 
Outcome domains EP IN study LED study MENDIP study 
Symptoms BPRS, GAF CES-D, SCL-90 HDRS 
Quality of life LQOLP WHOQOL Bref WHOQOL Bref 
QLDS 
Disability / functioning MOS SF-12 BDQ 
" Service needs CAN 
" Service satisfaction VSSS 
" Family burden IEQ (via CSRI) 
Note: Full names of measures can be found in the relevant Chapter and also in the Glossary 
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Service system profiling 
Over the course of conducting the three multi-site source projects, it became 
increasingly apparent that the uptake of services stands to be significantly affected by 
their availability. In the extreme case, sites in which services are entirely absent (for 
example, residential care in the community for people with enduring mental 
illnesses) will clearly result in zero utilisation and therefore cost. Whenever the 
objectives of mental health services research include multi-site or multi-national 
comparisons, therefore, a description and understanding of the service context in 
which individual resource utilisation is being measured is required for the appropriate 
analysis and interpretation of study findings. Moreover, differential levels of service 
provision and utilisation within and between sites are predicted to be associated with 
socio-demographic variables such as age, gender, employment status and income. In 
addition to the collection of socio-demographic characteristics of study subjects, 
therefore, there is a need to derive a socio-demographic profile of the local 
population. A good example of a local socio-demographic and service profile, 
developed and adapted for the LIDO study, appears at Appendix B (results from 
which are presented in Table 4.4 and discussed further in Section 6.2). 
Two main products of this kind of profile can be identified: a description of the 
prevailing health care system in each participating site; and elicitation of site-level 
indicators relating to socio-demography, service provision and access. The overall 
usefulness or performance of such profiles can be gauged by a) the quality of the 
qualitative descriptions in capturing key features of the local population and health 
system and b) the incorporation of site-level indicators into, and their contribution to 
explaining variations in, quantitative cost analyses. With respect to the three source 
projects, it is possible to conclude that the profiles elicited for each study site have 
been a valuable source of reference at a descriptive level, providing essential 
contextual information relating to the access to and availability of a range of health 
services. However, data from these profiles have not been successfully introduced as 
higher-order hierarchical variables into individual-level cost analyses (due to an 
insufficient number of sites to generate the kind of variation that would usefully 
inform the analysis and interpretation of individual -level costs, needs and outcomes). 
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Future multinational studies need to be mindful of this constraint and need to adopt 
appropriate statistical approaches that can successfully introduce this second-order 
set of site-level variables (see Section 6.2.3 below). 
6.1.3 Comparative analysis of costs and outcomes 
As the number of economic studies relating to mental health care has risen, so in 
general has the standard of data analysis and presentation, in no small part due to the 
higher standards and expectations of peer-review journals and commissioning 
agencies (Drummond et al, 1996; Gold et al, 1996). In particular, increasingly 
sophisticated statistical and econometric methods are now being employed by 
researchers in a bid to overcome some of the difficulties associated with the analysis 
of cost and cost-effectiveness data. A fundamental feature of costs data in mental 
health care evaluation is that uptake of the range of specified service components, 
each with their differing cost implications, is highly variable. The result of this 
variability is that pooled individual service use and cost data tends to be highly 
positively skewed, reflecting the relatively heavy use of services by a small number 
of sampled individuals, and compounded if those services, such as inpatient care, 
carry high unit costs. The skewed distribution of costs has important consequences 
both for the design and subsequent analyses of data, the most notable problem 
concerning the statistical power of a study (the probability of avoiding a type 11 error, 
that is the decision to not reject the null hypothesis, when in fact it is false). 
Studypower 
Alongside calculation of the sample size needed to show a statistically significant 
clinical difference, there is an increasing requirement to demonstrate that sufficient 
numbers of subjects are being recruited to and retained in a study in order to show 
that a real cost or cost-effectiveness difference has been observed, rather than a 
difference that could be attributable to chance. One important decision concerns what 
constitutes a worthwhile difference in cost or cost-effectiveness (effect size). The 
answer to this will depend on the perspective of the study and to an extent the 
societal burden of the disorder under investigation (a small cost-effectiveness 
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advantage of 10% for one intervention over another in the treatment of a highly 
prevalent or costly mental disorder may be considered more politically attractive than 
an equivalent relative advantage for treating a rare or lower impact disorder). An 
indicative range to consider when determining the effect size (differences in cost- 
effectiveness) might be 10-30%. The sensitivity of power calculations to the variance 
of the parameter(s) under investigation (as well as the effect size) means that the 
numbers needed to show a statistically significant cost difference between groups or 
over time may be very large, and may exceed the number necessary to show a clinical 
difference (Gray et al, 1997; Sturm et al, 1999). 
The importance of study power can be illustrated by reference to the three source 
projects. The EPSILON study was powered on the minimum number of cases 
needed to undertake a central component of this particular research study, namely the 
reliability analysis; the study was not specifically powered to detect significant cost 
differences within or across the five sampled populations. Even for total aggregated 
costs, standard deviations are typically double that of the mean, so this inevitably 
casts doubt on the power of the study to detect statistically significant differences in 
more disaggregated components of resource utilisation and costs. (In fact, many of 
the inter-site differences tested for did reach statistical significance at the 5% level, 
which indicates that there were sufficient numbers of cases to disprove the null 
hypothesis. ) With respect to the LIDO study, a series of calculations were 
performed, which suggested that large service cost differences would need to be 
observed between treated versus non-treated cases at baseline (a factor of 2.5); in 
terms of change over time, service costs would have to decrease by two-thirds in 
order to show a statistically significant difference (per site), or by 23% if site-data 
was pooled, whereas quite small changes could be detected in CES-D or health 
status. (Such predictions have been borne out by the 3-month prospective analysis, 
which shows few significant changes over time with respect to cost parameters but a 
substantial number of significant changes in outcomes; Tables 4.8 and 4.9). Finally, 
a convenience sample of a minimum of 50 cases per catchment area was established 
for the MENDIP study, owing to the limited time and resources available for this 
pilot project. Nevertheless, a number of statistically significant changes in both costs 
and outcomes were observed with this sample size (Tables 5.9 and 5.10). 
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Reporting of cost data 
In terms of data analysis, the key implication of skewed cost data is that parametric 
statistical approaches, which require normality of distribution, may not be 
appropriate, suggesting therefore that either non-parametric approaches or a process 
of data transformation may be required. Two common methodologies that have been 
used by researchers when faced with the prevailing problem of skewed costs data 
have been the use of median rather than mean values as the key measure of central 
tendency (with consequent reliance on non-parametric tests such as a Mann-Whitney 
U test), and transformation of the data onto a log or other scale. While use of the 
median may be useful for showing the 'typical' cost of a study subject, it is based on 
ranked data (rather than actual values), ignores the influence of outliers and does not 
capture the total or (arithmetic) mean cost of treatment and care, which is the 
measure of direct policy interest (Barber and Thompson, 1998). Likewise, while log- 
transformation of costs data may resolve the problem of skewness, the resulting test 
of difference between groups is on the geometric rather than the arithmetic mean. 
The estimated difference in log-costs (or any other non-linear transformation) of two 
treatments is not the same as the log of the estimated cost difference. 
Since logarithmic (or other) transformation of costs data and the use of standard non- 
parametric tests are usually inappropriate methods for dealing with skewed data when 
the focus of the study is on the comparison of group means, what can be done? One 
increasingly used approach to statistical inference in this situation is the non- 
parametric 'bootstrap', which makes no distributional assumptions, yet is able to 
generate standard errors and confidence intervals for the parameter of interest (Efron 
and Tibshuani, 1993; Mooney and Duval, 1993). Confidence intervals (not just 
standard deviations) around observed differences in mean costs should ideally be 
presented, since these provide a more informative measure of the magnitude of 
variability and effect size (see, for example, Table 3.7). Statistical inference using 
this non-parametric bootstrapping method commonly reveals that parametric tests 
such as the t-test are in fact robust to non-normality (particularly if the study sample 
size is relatively large, the distribution of costs is not too severely skewed and if the 
extent of skewness is similar across groups; Barber and Thompson, 1998). 
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When undertaking comparative analysis of pooled multinational data, one further 
need, even after controlling for underlying price differences in the costs of provision 
(via the application of purchasing power parities), is to report mean cost values that 
take into account underlying differences between sites with respect to socio- 
demographic and clinical characteristics. In the EPSILON study, for example, 
adjusted means were derived via a simple OLS regression of costs on centre, gender, 
marital status, ethnicity, language, employment (factors), plus age, education, GAF 
and BPRS (covariates). 
Multivariate cost analyses 
Skewness of cost data also presents problems for the modelling of costs and other 
variables through multivariate analysis, since again the key assumptions behind 
ordinary least squares (OLS) regression - normality of distribution, 
homoskedasticity and independence in the residual errors - may be broken. Where 
this is shown to be the case, there are a number of alternative analytical strategies that 
can be considered. Firstly, and in the same vein as two-group comparisons of mean 
costs, OLS regression coefficients can be re-estimated using non-parametric 
bootstrapping, thereby avoiding the strong distributional assumptions of parametric 
estimation. Independent variables that are significantly associated with cost can be 
identified in this way, and findings can be compared with those reached via 
conventional OLS estimation (see Tables 3.8 and 3.10). 
An alternative method for addressing the related problems of skewness, outliers and 
heteroscedasticity is transformation of the cost dependent variable onto a logarithmic 
scale (Diehr et al., 1999). After log transformation, it is often found that residual 
errors are normally distributed. As mentioned above, however, transformation of 
costs onto a log-scale produces geometric mean values. Where the focus of interest is 
on reporting arithmetic mean cost results in the original units of currency, therefore, 
it is necessary to apply a factor that overcomes this 'retransformation problem', such 
as Duan's 'smearing factor' (Manning, 1998). A final method that can be considered 
in order to explore the possibility that alternative models with differing distributional 
assumptions might fit the study data better is generalised linear modelling (GLM), 
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using for example a gamma distribution with a log-link function (Diehr et al., 1999). 
Table 3.10 provides an example of how these separate strategies were applied to the 
pooled EPSILON study data set of people with schizophrenia living in five European 
countries, involving successive OLS estimation on the untransformed and log- 
transformed cost data, followed by the generalised linear model. 
A further analytical stage that has great relevance to multinational cost and cost- 
effectiveness studies in mental health relates to the potential for multi-level 
modelling. Where data on site-level indicators of service provision, financing and 
access have been collected, for example, adjustment for these effects can be made via 
the conduct of random effects, graphical or multi-level modelling, which enable these 
intermediate, site-level influences to be incorporated into analyses of individual 
costs, needs and outcomes. An alternative method for incorporating these factors into 
cost: outcome studies is via an instrumental variable approach, which employs 
observable factors that influence treatment but do not directly affect patient 
outcomes, thereby isolating the effect of treatment variation that is independent of 
unobserved characteristics (Lu, 1999). The use of these statistical methods, however, 
requires an appreciable number of observations or degrees of freedom at the 
intermediate or site level to be practicable (see section 6.2.3 below). 
6.2 Empirical findings from three international mental health 
economic studies 
6.2.1 The economic burden of psychiatric disorders 
As reviewed in Chapter 2 of the thesis, ample documentation and research has been 
generated over the last forty years which shows that psychiatric disorders are 
relatively common throughout the world, highly disabling, chronic and/or recurring, 
which translates into high levels of global mortality and disability (Murray and 
Lopez, 1996) and a considerable health care service burden (Harding et al, 1983; 
Jablensky et al, 1981; UsWn and Sartorius, 1995). This burden has also been 
measured from an economic perspective, which has pointed to the wide range of 
costs that are incurred by society, not only in terms of health and social service 
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provision, but also in terms of production at the level of households and employers 
(Box 2.1). In practice, lack of data and measurement difficulties have made such 
comprehensive estimates hard to calculate. The most comprehensive estimates of the 
economic burden of psychiatric disorders have been achieved by 'cost of illness' 
studies via the extrapolation of service use and cost findings from empirical studies 
to whole national populations with a particular condition, supplemented by the 
imposition of assumed values for productivity and mortality losses. Where such 
studies are performed rigorously, such as the recent estimate for schizophrenia in 
Canada (Goeree et al, 1999b), they provide a valuable depiction of the multifaceted 
economic consequences of psychiatric disorder, as well as a useful tool for informing 
service planning, policy debate and resource allocation (Rupp et al, 1998). All too 
often, however, such studies have employed sub-optimal data sources and methods 
that have provoked academic controversy more than they have stimulated policy 
development (Jonsson and Bebbington, 1995; Woods and Rizzo, 1997). 
The breadth or comprehensiveness of cost measurement in empirical studies, 
however, has typically been narrower than cost of illness studies. This may be a 
deliberate decision or choice (for instance, the evaluation may only be interested in 
the impact of psychiatric disorder on the health service), but is more commonly a 
function of the measurement problems associated with longer-term consequences of 
psychiatric disorder in what are time-limited investigations (it is rare to find clinical 
or economic evaluations that exceed a two-year period of follow-up). Focusing on 
direct care and treatment costs, the economic burden associated with the psychiatric 
disorders covered by the three source projects - schizophrenia, major depression and 
common mental disorders - is still all too apparent. Table 6.5 provides annual 
estimates of total baseline care and treatment costs, expressed in international U. S. 
dollars (i. e. using PPPs rather than exchange rates as the conversion factor), for the 
sampled populations in each participating study site. To provide some measure of the 
excess burden associated with these disorders, the condition- specific service costs for 
the sampled populations at baseline assessment are compared to the average per 
capita health care expenditure for the total population in each country, based on 
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Total estimated treatment and care costs for people with schizophrenia, as captured in 
the EPSILON study, ranged between US$ PPP 2,415 - 15,398 per year. Virtually all 
of these costs are public health care expenditures. In the Danish, English, and Italian 
sites, these costs are more than 800% of the average per capita public health care 
expenditure in these countries. Costs of care in the Dutch site were 433% and in the 
Spanish site 282%, most likely owing to the very low admission rate in the former 
sampled population and the relatively modest set of public health care services 
available to the latter sampled population (see Chapter 3, section 3.5). 
Baseline estimates from the LIDO study, converted into annual figures, represent the 
costs of unrecognised major depression, and range from US$ 108 in St Petersburg to 
$3,264 in Seattle, with a pooled mean for all sites of US$ 1,620. Since these 
estimates incorporate some private expenditure in a number of sites, comparison is 
made to the total health care expenditure figures for each country (minus medication 
costs), which reveals that in three sites - Barcelona, Melbourne and Seattle - the 
costs of untreated major depression are 72-108% of average per capita expenditure, 
whereas in Be'er Sheva (160%) and Porto Alegre (400%) the costs are far higher. In 
contrast, the service costs of untreated, depressed subjects in St Petersburg were less 
than half the average per capita expenditure, perhaps highlighting the significant 
stigma and low prioritisation attached to depression in the Russian Federation. 
The data collection method adopted in the MENDIP study provided the opportunity 
to compare public and private expenditures separately. Again, baseline expenditures 
were multiplied by four to derive annual cost estimates, in this case for the economic 
burden associated with untreated common mental disorders in the community (as 
opposed to a sample of PHC attendees). Although the costs of publicly provided 
services are very low ($9 in India, $58 in Pakistan), these actually represent 82% and 
105% respectively of the average per capita public health expenditures in these 
countries. In terms of private expenditures (including medication), the estimate of 
$108 in Bangalore is again close to the national average, whereas in Rawalpindi, the 
privately bome costs are two and a half times the national average ($140 compared to 
$55). The preponderance of these costs were therefore privately incurred 
expenditures, of which a significant proportion was on consultations with local 
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general or traditional practitioners (neither of whom are trained or qualified to detect 
or treat psychiatric morbidity). Thus, whilst individuals (and households) are seeking 
help, and spending significant amounts of money in the process, they are not in the 
main receiving appropriate care for their mental health condition. 
Surnmarising and comparing data in this way is certainly subject to a number of 
limitations and should accordingly be treated with caution - sampled populations or 
localities may not be representative of their respective clinical populations or 
countries, and there are other potential contributors to cost variation that may not be 
accounted for. What the findings do seem to show, however, is that the direct costs 
of treatment and care for psychiatric disorders are at least as great as average per 
capita health care expenditures, and that the excess cost of disease increases with the 
severity of the underlying disorder - thus for schizophrenia care in Europe, costs are 
three to nine times the average. These estimates do not take into account other 
significant contributors to the societal costs of psychiatric disorders, including 
informal care-giving and lost work opportunities, which substantially increase the 
level of excess economic burden. For example, the imputed costs associated with 
reported levels of infon-nal caregiving, travelling time/expenses and lost work days in 
the MENDIP study exceeded formal health care costs by a factor of as much as three. 
6.2.2 Associations between mental health care costs and outcomes 
The preceding section took baseline mean cost values for the sampled populations in 
each of the three projects in order to demonstrate the economic burden associated 
with schizophrenia, major depression and common mental disorder in a selection of 
countries. This section moves onto a broader consideration of the observed inter- 
relationships between health care (and other measured) costs, on the one hand, and a 
range of individual- and site-level characteristics, either at one point in time 
(EPSILON) or over time (LIDO and MENDIP). It should be stressed that 
prospective associations between costs and outcomes for the latter two studies were 
restricted to the short-term owing to the unavailability of longer-term follow-up 
assessments at the time of submission. 
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In an optimal health care system, service costs at the individual level should be 
strongly associated or correlated with the severity of the disorder and the clinical 
need for care (other things being equal, including user preferences for specific care 
modalities). Resources would be targeted and consumed in accordance with these 
criteria, irrespective of differences in access to services or other supply-side 
constraints. When such hypotheses are subjected to real-world analyses of these 
inputs and outputs, an unsurprising finding is that the proportion of individual-level 
cost variation explained by measures of symptom severity and need-related factors is 
in fact quite low. Site-specific equations generated for the EPSILON study of 
schizophrenia, for example, show that while symptom severity (BPRS and GAF 
scores) and need (CAN scores for met and unmet need) do enter into the reduced, 
parsimonious regression models for all sites (Table 3.9), the overall proportion of 
variation explained by the models was no more than one third (adjusted R2values 
ranged between 12-32% across the five sites, quite typical results for regression 
models in this Population; Chisholm et al, 1997d; McCrone et al, 1998b; Haro et al, 
1998; Bonizatto et al, 2000). Patterns of association with cost in fact varied quite 
markedly across the sites, and included significant inter-relationships with socio- 
demographic factors such as age and employment status. The inclusion of quality of 
life and service satisfaction measures did not increase the explanatory power of these 
models, nor were there any significant associations with cost in any of the five sites. 
Turning to the LIDO depression study, a key finding of the 3-month prospective 
analyses was evidence of a cost-offset effect, indicating a change in the distribution 
of costs as previously unrecognised cases of major depression came into contact with 
services; although the overall cost of care did not alter over the first three months of 
follow-up, the proportion of cost associated with speciality mental health care did 
change (Figure 4.3). Across all six sites, general medical care service costs 
decreased significantly, by an average of $57 (95% Cl -110, -3), while mental health 
care costs increased by an average of $47 (95% Cl -15,110). For individual sites, 
however, paired sample t-tests of cost differences over time were not significant, 
partly due to modest effect sizes, further compounded by the marked uncertainty 
around point estimates of cost. In terms of outcomes, the results provide a clear and 
consistent picture of positive change in symptom severity, quality of life and 
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functioning cross-culturally. CES-D scores decreased by an average of 6 points 
(from 29.3 to 23.3., 95% CI -6.7, -5.3), QLDS scores decreased by 1.3 points (95% 
Cl -1.5, -1.0; lower scores indicate better QoL) and SF-12 mental health summary 
score rose by an average of 4.9 (95% CI, 4.1,5.6). The main conclusion that can be 
reached over the short-term follow-up period, therefore, is that there is an association 
between increased rates of appropriate treatment (as measured by the rise in mental 
health speciality costs) and improved clinical outcomes. 
The significant improvement in the outcome domains of depression, disability and 
quality of life for both standard care localities was also a striking finding of the 
MENDIP study. Although these results may be partly explained by spontaneous 
remission or improvement, particularly in the Rawalpindi site where there was a 
significant proportion of acutely depressed cases, it does suggest that interviewing 
individuals about their mental health state, and advising them to seek care locally, 
may have exerted an intervention effect itself. With regard to the economic 
dimension, mean cost of contacts with government primary health care workers 
increased in the localities where mental health care training and support had been 
introduced (as hypothesised), whereas there was little change in the standard care 
localities. By contrast, costs of contacts with community-based private health care 
providers (general practitioners, traditional healers) dropped in all localities. 
Comparison of change scores between those who had or had not used government 
health care services revealed a positive association between health care costs and 
clinical and social outcome, but this was not restricted to the localities where mental 
health training and support had been introduced (indeed, the only statistically 
significant difference was in the standard care locality of the Bangalore site). 
6.2.3 Supply side influences on the access to and uptake of services 
As clearly illustrated by multivariate analyses of the EPSILON study data set, 
individual-level associations are only capable of explaining cost variations to a 
modest extent. This points to the presence of considerable 'noise' around such 
individual-level model specifications, and raises the question of whether utilisation 
rates may be influenced by prevailing levels of service access, availability and other 
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supply-side factors. In terms of service availability, the EPSILON study revealed a 
fourfold difference in residential places between Copenhagen and Santander, which 
closely mirrored the difference in service costs for these sites Figure 3.2). In a 
similar vein, the LIDO study revealed marked differences with respect to the health 
care financing mechanisms and levels of service availability across the six sites, 
which could also be linked to differential service uptake and cost (Table 4.4). 
In both the LIDO and MENDIP studies, an attempt was made to examine individual- 
level factors that may have influenced the decision to seek care or effected the quality 
or quantity of care received. These analyses revealed a number of recurring 'barriers' 
to appropriate care across sampled populations (inconvenience, medication side- 
effects, etc. ) but also some marked differences, for example the financial barrier 
relating to the cost of medication in St Petersburg (LIDO study) or the geographical 
barrier of distance in the Lehtrar locality of the MENDIP study. While the perceived 
barriers to access did not alter appreciably in the LIDO study, a further striking 
finding of the MENDIP study was the discernible shift in the health-seeking 
behaviour of the standard care localities in both sites, reflected by an increase in the 
perceived access to, preference for and use of government primary care services. 
Exploration of the inter-linked processes of access to appropriate care, perceptions 
about local health providers and actual utilisation of services in the MENDIP study 
indicated that the successful implementation of a community mental health care 
programme is likely to be contingent on the health-seeking behaviours of both the 
local population at large and the specific target groups for whom the intervention is 
intended. Most notably, it was apparent that only a modest proportion of sampled 
subjects used goverm-nent-provided primary health care services, thereby rendering 
the remaining proportion unable to benefit from mental health care and treatment 
available at the two integrated primary health care centres. What these findings 
suggest is that socio-demographic characteristics and individual perceptions about 
health services, rather than depression or disability status per se, may have had the 
more important bearing on service use and treatment choice, and that changes in 
perceived access to care, preferred provider and actual use of services were largely 
independent of the introduction of mental health training and support. 
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The marked differences in service access and availability seen in all three source 
projects are not in themselves surprising, but clearly they have a potentially important 
influence on the interpretation of resource utilisation and cost findings at the level of 
sampled populations. Indeed, it is a fundamental conclusion of this thesis that multi- 
national cost comparisons, or even multi-site comparisons within a single country, 
need to be understood in terms of, and take account of, differential levels of service 
access and availability. Where it is not possible to do so - because the relevant data 
have not been collected, or because there are not sufficient statistical techniques to 
adequately control for such influences - analytical findings from pooled, multi- 
national data can still reveal the extent of individual or inter-site differences but 
cannot provide a full, integrated explanation of the relative contribution that 
individual versus site level factors make to these observed differences. 
This conclusion can be applied to the EPSILON and LIDO studies, which despite the 
collection of relevant data on local socio-demographic, socio-economic and service 
characteristics at the site level, lacked the large number of observations or degrees of 
freedom at both the individual and site level needed for multi-level or random effects 
models (the EPSILON and LIDO studies had only four and five degrees of freedom 
respectively at the site-level). Instead, fixed-effect models that included dummy 
variables for site were adopted in the EPSILON study, the pooled regression 
equations for which demonstrated, for example, that the Santander site had a 
significant cost-reducing impact. The limitation of such fixed-effect models, 
however, is that they do not fully address the question of what exactly it was about 
Santander that had an impact on costs? On the basis of the descriptive data collected 
for this locality, it is possible to point to the relatively low availability of certain 
services such as residential care and the high proportion of subjects living with their 
own families as potential explanatory factors, but this is one step short of 
systematically incorporating these site-level characteristics into the comparative 
analyses of individual costs, needs and outcomes. 
It is also possible that observed cost differences may be due to other, perhaps socio- 
cultural, factors that influence both the provision and utilisation of costs. An 
example of a potentially key variable in mental health care evaluative studies at this 
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socio-cultural level is the public perception and stigma attached to mental illness in 
different settings or countries. Negative attitudes to mental illness at a societal and 
political level may lead to a low level of priority and investment being accorded to 
mental health services. Equally, there may be positive mechanisms at work in local 
communities that engender improved awareness of mental health issues and quicker 
access to services for individuals in need, such as the school mental health 
programme evaluated recently in Rawalpindi, Pakistan (Rahman et al, 1998). Such 
community-level mechanisms are at the heart of the increasing interest being shown 
in the potential links between social cohesion - or its subset, social capital - and 
health (Stuart, 1999; Cullen, 2000; Kawachi and Berkman, 2000; Veenstra, 2000). 
The key hypothesis underpinning this research interest is that increased levels of 
social capital - as measured by levels of trust, reciprocity and support networks in the 
community - can reduce, for individuals with psychiatric disorder, the vulnerability, 
exclusion and hostile envirom-nent to which they are typically exposed to. 
On the basis of the preceding studies, therefore, it is possible to conclude that there 
are three levels of actual or potential effects that need to be considered when 
undertaking cross-cultural studies of mental health care costs or cost-effectiveness: 
* Individual-level effects - health care seeking and consumption 
0 Site-level effects - service organisation and provision 
o Country-level effects - service system and culture 
The studies reported here have systematically attempted to measure and describe 
inter-country variations at each of these levels, and in so doing have generated 
policy-relevant data on costs and cost associations at an international level, but 
ultimately they fall just short of a fully integrated, multi-level assessment of the 
respective influences of these various effects on costs and cost-effectiveness (mainly 
due to study design and power limitations). Unravelling the relative contribution of 
individual demand or need effects, provider supply responses and broader socio- 
cultural influences to changes and variations in costs and outcomes represents an 
important component of the unfinished or future agenda of health services research 
generally, and comparative mental health care studies in particular. 
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6.3 Implications for policy and research 
6.3.1 Implications for mental health policy and service development 
Significant advances have been made over the last forty years in treatments for a 
wide range of psychiatric disorders, perhaps most notably with respect to the 
development of psychotropic drugs (both old and new) for schizophrenia, bipolar 
disorder and depression, but also in terms of psychotherapeutic approaches to these 
disorders. Alongside and partly because of the greater availability of these novel 
treatments, the reorganisation of mental health care in many countries from a 
predominantly hospital-based service to one situated more closely in the 
'community' has also brought welcome improvements to many patients (and carers). 
Despite the accumulated knowledge relating to the serious impact that psychiatric 
disorders have on individuals, families and communities, and despite the 
opportunities offered by the above developments in mental health care delivery and 
treatment to contain (if not cure) many of the negative manifestations of psychiatric 
disorders, there has been very little investment into psychiatric care viewed from an 
international perspective (Institute of Medicine, 2000). Key reasons for this under- 
investment include negative and false perceptions about mental illness (stigma), low 
awareness of the prevalence and disabling consequences of mental disorder, and low 
priority in the health care programmes of most countries in the world. An 
unsurprising consequence of this low level of investment is that in many regions of 
the world individuals with major neuro-psychiatric conditions - including psychosis, 
clinical depression and epilepsy - go largely untreated (for example, the Global 
Burden of Disease study estimated that treatment rates for major depression in low- 
income countries were only 10- 15%; Murray and Lopez, 1996). 
The parlous state of mental health care in an international context begs the question 
of what can be done to reduce the existing gap between the identified burden of 
psychiatric disorders and current levels of mental health care investment. One key 
activity relates to increased political awareness via high profile reports aimed at 
raising political awareness of the under-recognition of and need for mental health 
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services, such as World Mental Health: Problems and Priorities in low-income 
countries (Desjarlais et al, 1995), Nations for Mental Health (Jenkins, 1997b), the 
1999 Surgeon General's Report (DHHS, 1999) and the Institute of Medicine's 
forthcoming report on nervous system disorders in developing countries (Institute of 
Medicine, 2000). Promotion and advocacy alone, however, are not sufficient to bring 
about change at an operational level; there is therefore also a requirement to instigate 
initiatives that address pragmatic considerations such as integration of mental health 
into the overall health care policy dialogue and reform process that may be occurring 
in a country. Finally, there is a need to generate an evidence base that can clearly and 
succinctly point to the benefits of investment in human and social capital terms, 
including the reduction of disability, and the enhancement of capabilities or 
productivity through sector-wide reform of health and education. 
What is the contribution of the three source projects to these international mental 
health policy priorities? Firstly, the research has demonstrated the feasibility of 
undertaking analysis and comparison of mental health care costs, processes and 
outcomes, both in a multinational context, and more specifically in low-income 
country settings. Demonstration of the viability and applicability of mental health 
economic analysis in developing countries, which was the underlying purpose of the 
MENDIP study, merits particular mention given the paucity of studies carried out to 
date and the expressed interest of policy makers and multinational agencies in 
obtaining cost-effectiveness data relevant to these settings. Secondly, in applying a 
standardised set of methods and measures, the research has been able to generate 
robust indicators of the economic consequences of psychiatric disorders, whether 
these consequences be in terms of the high health care costs attributable to the care of 
schizophrenia in Europe, the resource implications associated with unrecognised 
depression across a diverse range of international settings, or the lost productivity 
and household burden of common mental disorders in low-income countries. Thirdly, 
analysis contained in each of the three studies has explored and elicited links between 
health care (and other) costs and a range of clinical and social outcomes, in so doing 
providing support for the hypothesised positive association between service inputs 
and improved symptoms patients' or social functioning, as well as pointing to the 
scope for better targeting of resources. Finally, the conduct of the three studies has 
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led to new insights which have direct applicability to policy and service development, 
including the 'value' of specialist mental health care in producing improved clinical 
outcomes, and the importance of local health-seeking behaviours and other local 
factors in determining the suitability and likely success of the integration of mental 
health into primary care. 
6.3.2 Implications for multinational mental health services research 
Research priorities 
Since the current evidence base for the effectiveness and cost-effectiveness of mental 
health care interventions is currently so meagre in many regions of the world, and 
the costs of its acquisition so correspondingly high, there is a need to identify and 
select priority research questions (Global Forum for Health Research, 2000). The 
precise information requirements for policy development obviously need to reflect 
local or regional realities and levels of economic development; for example, 
assessing the relative cost-effectiveness of older versus newer anti-depressants is 
unlikely to represent a high priority concern in countries where the availability of any 
anti-depressants is at issue. Nevertheless, the experiences of the three source projects 
covered by this thesis point to a number of broad areas where economic evidence 
would appear to be particularly warranted (Table 6.6; see also, Chisholm, 1999, 
2000d). Addressing this research agenda represents a substantial challenge, not least 
because there are currently so many gaps and because findings generated in one 
particular setting or country cannot be readily generalised to others, owing to the 
heterogeneity of health care systems. 
Envisaged research deliverables emanating from pursuit of these broad research 
objectives, again reflecting in part the conclusions of the research presented here, 
include: the development of a standardised methodology (consistent and comparable 
with other areas of health care intervention) for the collection, analysis and reporting 
of mental-health related resource utilisation and costs in diverse cultural settings; 
empirical measurement of the cost-effectiveness and cost-utility of specified 
interventions; identification of the effect of exogeneous socio-economic and health 
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system indicators (poverty, education, social capital; service availability, access and 
responsiveness) on mental health costs and outcomes; and contribution to f uture 
projections of comparative disease burden and health care priority-setting through 
modelling of prevalence, costs and DALYs for key mental health conditions (Ustun 
and Chisholm, 2000). 
Table 6.6 Mental health policy and economic research priorities 
Level of economic Prevailingfeatures of Cost-effectiveness 
development mental health system research priorities 
Relatively well-resourced; Relative cost-effectiveness of older 
High-income countries Market-based reforrns; vs newer drugs and psychological 
(e. g. N. America, W. Europe) 
Community-based services; therapies; managed care; hospital 
New psychotropic drugs diversion 
Resources poorly distributed; Hospital vs community based care; 
Middle-income countries Hospital-based services; Prevention of alcohol abuse; 
(e. g. E. Europe) 
Poor perception of psychiatry Mental health promotion 
(repression of the past) 
Very poorly resourced; Availability of key, low-cost drugs; 
Low-income countries Low policy priority; Integrating MH into primary care; 
(e. g. E. & W. Africa, S. Asia) 
Very limited availability of / Mobilisation of local resources; 
access to treatment / services Demonstrating need for MH care 
Data comparability 
At an international level, a key research requirement is for generated cost: outcome 
data for mental health care interventions to be comparable to data for other disease 
areas in order to demonstrate issues of relative efficiency and affordability. Economic 
evaluation in mental health care has been concerned predominantly with establishing 
the relative worth of new or existing interventions or strategies over usual care or 
best alternative treatment, thereby addressing pertinent issues of technical efficiency 
within the health sector (i. e. identifying the most productive methods of spending 
defined budgets). The limitation of such mental health studies is that they do not 
permit normative conclusions to be drawn regarding whether any identified 
improvements in user outcomes are actually worth pursuing, relative to other 
potential areas of investment (Chisholm et al, 1997a; Healey and Chisholm, 1999). 
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This is an important limitation, and one that has particular relevance for multi- 
national studies, since the existing allocation resources varies widely between 
countries depending on the financial and political constraints that they are subject to. 
Issues of allocative efficiency can be addressed by cost-benefit analysis, in which 
both costs and benefits are quantified in monetary terms, but the application of this 
mode of evaluation to mental health care is in its infancy and is fraught with 
difficulties, including the multi-attribute and often hypothetical nature of the health 
care benefits that individuals are asked to value via willingness to pay techniques 
(Healey and Chisholm, 1999). An alternative metric to money for assessing the 
consequences of intervention are summary measures or indices such as the DALY or 
QALY, which enable comparisons of effectiveness across health care programmes or 
interventions. The use of these summary measures in the context of mental health 
services research has been limited to date, reflecting a general unease with the use of 
utility measurement and a series of more specific conceptual and technical 
measurement concerns (for a review, see Chisholm et al, 1997a). In particular, 
concern has been expressed as to the sensitivity of such measures to pick up 
meaningful change in health status, the valuation base for attaching relative weights 
to different conditions (should it be that of patients, professional or the public? ) and 
the feasibility of methods used to elicit health state preferences (such as the 'standard 
gamble' or 'person trade-off techniques; Arnesen and Nord, 1999). In response, 
new empirical research on DALYs has focused on exploring the impact and 
significance of these divergent valuation methods and reference populations in 
different cultural settings, using a 'multi-method, multi-informant' approach (Ustun 
and Chisholm, 2000). 
Despite the limited connection between QALYs or DALYs and the generation of 
cost-effectiveness evidence in mental health, such a link is needed because QALYS 
and DALYs are not in themselves sufficient as a mechanism for resource allocation 
and priority-setting in health care (Anand and Hanson, 1997; Sayers and Fliedner, 
1997); for these tasks, there is a need for an additional component, cost, which can be 
related subsequently to derive costs per QALY or DALY for different interventions. 
A disease can place a considerable burden on a population but if strategies or 
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interventions to reduce this burden are costly in relation to the outputs achieved, 
large-scale investment would be misplaced since scarce resources could be more 
efficiently channelled to other burdensome conditions for which cost-effective 
responses were available. The applicability of such an approach in mental health 
services research is illustrated by a recent attempt to model efficiency in reducing the 
burden of depression in Australia, with results showing that significant efficiency 
gains in terms of cost per averted DALY can be achieved by moving towards more 
optimal care strategies (Andrews et al, 200 1). 
Informed in part by the methodological developments reported in this thesis, work is 
underway at WHO to produce a set of estimates for the relative cost-effectiveness of 
a wide range of mental health care interventions for all sub-regions of the world, 
adopting a generalised approach and incorporating DALYs as a measure of 
effectiveness. This sectoral or 'generalised' approach to cost-effectiveness analysis 
(Murray et al, 2000) explicitly addresses allocative efficiency questions by lifting the 
constraint on the current mix of interventions, thereby permitting evaluation of all 
options (including currently funded interventions and the consequences of no 
intervention at all). The costs and effectiveness of all interventions are being 
estimated in a comprehensive but highly standardised manner, thereby enhancing 
substantially the comparability of results. Given the known uncertainty surrounding 
point estimates of cost-effectiveness (as well as the limited ability of DALYs to pick 
up small changes in health-related outcomes), however, results will be presented in 
terms of broad categories (rather than ranked league-tables) of cost-effectiveness. 
Such a standardised and comparable approach to data generation and reporting holds 
out the very significant prospect of greater parity between mental and physical 
aspects of health and health care. 
Generalisability offindings 
The tension between universalist versus context- specific, relativist approaches to the 
study of social or behavioural phenomena is a recurring theme in the social sciences, 
as made apparent by the socio-cultural perspective on the cross-cultural studies of 
psychiatric disorders reviewed in Chapter 2 (section 2.2). Universalists strive to 
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discover similarities or shared characteristics that hold across different cultures with 
a view to deriving generalised statements or arguments about human behaviours or 
social structures; relativists, by contrast, argue that human behaviours should only be 
analysed and interpreted within their own cultural milieu. An analogous situation can 
be depicted with regard to the economic analysis of health care from an international 
perspective. At one end, highly contextualised analyses can be carried out for 
specific treatment modalities in particular localities, the findings from which are 
largely relevant to local decision-makers alone and have limited generalisability; at 
the other end, global comparative studies could be conducted with the aim of 
eliciting common patterns of service utilisation or cost associations for the widest 
range of countries, cultures and settings. As recently stated in the WHO's guidelines 
for cost-effectiveness analysis (Murray et al, 2000): 
'Broader use of cost-effectiveness studies to analyse the allocative efficiency of 
health systems and recommend resource allocation has led to a number of 
challenges. It appears that the field can develop in two distinct directions, towards 
increasingly contextualised analyses or towards more generalised assessments'. 
In their extreme form, neither position is satisfactory - context-specific studies will 
clearly have low generalisability, while economic studies seeking to be genuinely 
global are vulnerable to accusations of insensitivity and inaccuracy. For economic 
analysis to go beyond specific contexts, however, a more generalised approach is 
certainly required. Such an argument is predicated on the pragmatic, global need for 
cost-effectiveness information relating to health care interventions (for policy, 
planning and priority-setting purposes) at a time when only a handful of countries 
world-wide have the internal resources to generate such information for themselves. 
There is therefore a need to find middle-ground between context-specific and fully 
generalised approaches to the economic analysis of health care. Definition of a 
limited set of average health system and epidemiological contexts within which 
comparisons are likely to be informative - grouped according to income per capita, 
region, or the public/private mix in financing and provision - would appear to be one 
logical approach worth pursuing, as suggested in this thesis (see aýo Murray et al. 
2000). For example, it can be argued that there are sufficient overlapping health 
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system and socio-cultural characteristics within the five European countries of the 
EPSILON study to suggest that pooled, comparative analyses of the costs and needs 
of schizophrenia is both justifiable and of use for the future planning, financing and 
organisation of services in this region. By contrast, there are evidently greater 
problems in pooling data from all six LIDO sites, most notably for Seattle and St 
Petersburg, which are at extreme ends of a spectrum of service consumption and 
provision. Rather, there may be merit in undertaking pooled analyses of, for 
example, Barcelona and Melbourne, or Be'er Sheva and Porto Alegre. 
The obvious concern, as made apparent from analysis in each of the source projects 
of the sizeable inter-site variations in health care financing and provision, is that such 
an approach may still be insensitive to more local socio-cultural variations or 
differences in the way that health care is accessed and practised in particular settings. 
However, the extent to which this represents a serious problem will depend on 
whether the derived data is to be used by a specific decision-maker faced by a 
context-specific set of financial and political constraints or whether it is to inform 
broader debates surrounding resource allocation (Murray et al, 2000). A notable 
example of this latter approach was the World Bank's review of Disease Control 
Priorities in Developing Countries (Jamison et al, 1993), which generated 
comparable cost per DALY evidence for a wide range of clinical areas and 
interventions, including case management of schizophrenia and bipolar affective 
disorder, in a (successftil) bid to stimulate renewed debate on priority-setting in the 
health sector. Its usefulness was not so much in providing national decision-makers 
with accurate measures of marginal cost-effectiveness than in developing broad 
categories of relative efficiency at the regional level. A similar standpoint 
characterises the ongoing WHO programme on generalised cost-effectiveness 
analysis, such that interventions will be categorised into those that are highly cost- 
effective, those that are highly cost-ineffective and those that fall between. 
In summary, there is a prevailing need for cost: outcome data to support mental health 
policy and decision-making at national and international levels, which argues for the 
usefulness of a generalised approach to the economic analysis of mental health care 
that can complement more context-specific research outputs. 
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6.4 Concluding remarks 
As demonstrated throughout this thesis, economic analysis can provide new insights 
and valuable contributions to pressing mental health policy concerns at national and 
international levels. At both levels of policy, there is a need to generate economic 
evidence that can both inform and support resource allocation decisions regarding 
new or existing initiatives and interventions. There are presently many gaps in this 
evidence base, so a primary objective for future research activities must be to begin 
the task of filling in these existing gaps in knowledge. It is perhaps not surprising, 
but nevertheless paradoxical, that there is least evidence where arguably it is most 
needed, namely in assessing the impact of low-cost drugs and mental health training 
among primary health care workers on the currently underserved mentally ill 
populations of low-income countries. 
The set of research methodologies and empirical findings presented in this thesis can 
be seen as providing a set of analytical tools and baseline estimates with which to set 
about filling these gaps in knowledge. While the further application of these tested 
methods to identified mental health research priorities is of course open to further 
development, it is important to emphasise the need for a comprehensive, standardised 
and comparable approach to data collection and reporting. Failure to do so can only 
weaken the validity of such information to policy-makers and consequently tarnish 
future demands for such data. However, the large number of completed studies with 
illuminating or useful findings, together with the broad methodological consensus 
that has been reached in the application of economic evaluation to health care, holds 
out the prospect of a new generation of studies that are capable of demonstrating that 
interventions for psychiatric disorders in diverse cultural settings are affordable, 
effective and can be expected to lead not only to improvements in health but also to 
the greater productivity of individuals, households and communities alike. Finally, it 
is clear that international comparative studies of mental health care pose additional 
challenges to the conduct of economic analysis; this points to the need for continuing 
refinement of techniques that allow for the cultural ly-sensitive assessment of 
economic costs, organisational structures and health-related outcomes. 
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Glossary and list of abbreviations 
Term Acronym Main page 
references 
Definition 
Bootstrap 56 A non-parametric approach to statistical 
inference involving repetitive computations 
to estimate a statistic's sampling distribution 
Brief Disability Questionnaire BDQ 117,138 Outcome measure for disability status 
Brief Psychiatric Rating Scale BPRS 45,62,75 Outcome measure for psychotic symptoms 
Camberwell Assessment of Need CAN 45,75 Outcome measure for assessing met and 
unmet service needs 
Centre for Epiderniologic Studies - CES-D 87 Screening and outcome measure for 
Depression depression symptoms 
Client Sociodemographic CSSRI 49-51,77 Schedule for collecting individual- leve I 
and Service Receipt Inventory service utilisation and socio-economic data 
Composite International Diagnosis CIDI 87 WHO diagnostic interview schedule 
Interview 
Cost of illness studies COI 26-29 Form of economic analysis which estimates 
the aggregated (national) economic burden 
of a disease 
Disability Adjusted Life Year DALY 23-25 Summary measure of population health (life 
years adjusted for disability level) used to 
estimate disease burden and health outcome 
European Service Mapping ESMS 45,61 Schedule for identifying and measuring 
Schedule levels of mental health related service 
categories for a defined catchment area 
Global Assessment of Functioning GAF 45,62,75 Outcome measure for functioning status 
Generalised Linear Modelling GLM 58,74 Multivariate statistical analytical approach; 
GLM with a gamma distribution and a log- 
link function incorporates the logarithmic 
scale through a link function but fits 
expected values to data on the raw scale 
Global Burden of Disease study GBD 23,25,29 WHO/World Bank study of global causes of 
mortality and non-fatal health consequences 
of disease (DALYs) 
Gross Domestic Product GDP 95-98 Summary measure of national wealth 
Hamilton Depression Rating Scale HDRS 117,138 Outcome measure for depression symptoms 
Involvement Evaluation IEQ 45 Outcome measure for family caregiving and 
Questionnaire family burden 
International Classification of ICD-10 44,116-7 WHO standardised classification system for 
Diseases (version 10) coding diseases :D 
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references 
Definition 
Lancashire Quality of Life Profile LQoLP 45,75 Outcome measure for assessing health- 
related quality of life 
Medical Outcomes Study short- SF-12 88 Outcome measure for assessing functioning 
form 12 
Ordinary Least Squares regression OLS 57-58,70 Standard approach to regression analysis 
Purchasing Power Parity PPP 55,93 Rates of currency conversion which 
eliminate differences in price level between 
countries, i. e. reflect relative prices 
Quality Adjusted Life Year QALY 24 Summary measure of population health 
(years lived adjusted for their quality) used 
to estimate outcomes of health interventions 
Quality of Life Depression Scale QLDS 88 Outcome measure for assessing health- 
related quality of life in depression 
Schedule for Clinical Assessment in SCAN 44,117 WHO diagnostic interview schedule for 
Neuropsychiatry mental and neurological disorders 
Self Report Questionnaire SRQ 117 Screening measure for psychiatric morbidity 
Verona Service Satisfaction Scale VSSS 45 Outcome measure for assessing satisfaction 
with services and carer support 
WHO Quality of Life scale - WHOQOL 88,117, Outcome measure for assessing health- 





CLIENT SOCIODEMOGRAPHIC AND SERVICE 
RECEIPT INVENTORY (CSSRI - EU) 
EU BIOMED study: Schizophrenia needs and costs 
Centre F] Patient study numberF-][: 
][: ] Date F-I F-I/Fl 1-1/1-1 El 
ddmmYY 
1. SOCIODEMOGRAPHIC INFORAL4 TION 
1.1 Date of birth Date EIF-1/1-11-1/F11: 1 
dd rn M YY 
1.2 Sex I Female 
2 Male F-I 
1.3 Marital status I Single/unmarried 




9 Not known 
1.4 What is your ethnic group? 
(Refer to manualfor assistance) Ethnic group 
1.5 Country of birth Country FIFIFI 
(Refer to coding sheet) 
1.6 Mother tongue I National language 
2 Other language (but having good 
knowledge of national language) 
3 Other language (and having pgor or 
no knowledge of national language) D 
1.7 Number of years of schooling 
in general education Number of years schooling FIF-I 
1.8 Highest completed level of I Primary education or less 
education 2 Secondary education 
3 Tertiary / further education 
4 Other general education 
9 Not known 
1.9 What further education or Specific vocational training (< I year) 
vocational training have you Specific vocational training (> I year) 
completed or are doing now? Tertiary level qualification /diploma 
(Tick all boxes that apply) University degree (undergraduate) 
University higher degree (postgraduate) 
Other vocational training 
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2. USUAL LIVING SITUATION 
2.1 What is your usual/normal 
living situation now? 
I Living alone (+/- children) 
2 Living with husband/wife (+/- children) 
3 Living together as a couple 
4 Living with parents 
5 Living with other relatives 
6 Living with others 
9 Not known 
2.2 What kind of accommodation is it? 
(Refer to manualfor definitions) 
Domestic / family I Owner occupied flat or house 
2 Privately rented flat or house 
3 Rented from local authority/municipality 
or housing association/co-operative 
Communijy (non-hosp. Ltatil 4 Overnight facility, 24-hour staffed 
5 Overnight facility, staffed (not 24-hour) 
6 Overnight facility, unstaffed at all times 
Hospital 7 Acute psychiatric ward 
8 Rehabilitation psychiatric ward 
9 Long-stay psychiatric ward 
10 General medical ward 
II Homeless / roofless 
12 Other 
2.3 If domestic accommodation: 
How many adults live there? Number of adults 
(over the age of 18) 
And how many children? Number of children 
(under the age of 18) 
Note: If hospital or community accommodation: 
Complete the final sheet of the schedule after finishing this interview. 
2.4 Have you lived anywhere else 
in the last 3 months? 
Ifyes: please complete table: 
Yes= 1; No= 2 F-I 
Accommodation type Number of days in 
(see 0.2.2 fior code) 
I 
last 3 rnonthN 
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EMPLOYMENT AND INCOME 
What is your employment status? 
3.2 If employed: state occupation: 
(Refer to manualfor definitions) 
How many days have you been 
absent from work owing to illness 
within the last 3 months? 
3.3 If unemployed: 
Number of weeks unemployed 
within the last 3 months 
I Paid or self employment 
2 Voluntary employment 





8 Other F1 
8 Other 
I Manager/administrator 
2 Professional (eg health, teaching, legal) 
3 Associate professional (eg technical, nursing) 
4 Clerical worker /secretary 
5 Skilled labourer (eg building, electrical etc. ) 
6 Services/sales (eg retail) 
7 Factory worker 
Days absent from work 
Number of weeks 
Yes= 1; No= 2 3.4 Do you receive any state benefits? 
Ifyes: What benefits are received? 
(Please tick all boxes that apply) 
International categories 







Disability living allowance 




3.5 What is your main income source? I Salary/Wage 
2 State benefits 
3 Pension 
4 Family support (e. g. fi-om spouse) 
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3.6 What is your total personal gross income from all sources? 
Qte: if gross income not known, please give net income, i. e. af (N r ter tax and other deductions) 
Weekly or Monthly or Yearlv 
I Under f 149 1 Less than E649 1 Less than E7,785 
2 E150 - f204 2 f650 - f885 2f7,786 -f 10,63 5 
3 E205 - f279 3f 886 -f1,208 3f 10,636 - E14,504 gross income F-I 
4 f280 - f392 4f1,209 - fl, 699 4f 14,505 - f20,394 or net income 5 More than f3 93 5 More than f 1,700 5 More than f20,395 
4. SER "CE RECEIPT 
4.1 Please list any use of inpatient hospital services over the last 3 months 
ote 1: please enter 'O'ifservice has not been used; Note 2: see manualfor definitions) 
Service Admissions Total number of inpatient 
days (over the last 3 months) 
Acute psychiatric ward 
Psychiatric rehabilitation ward 
Long-stay ward 
Emergency / crisis centre 
General medical ward 
Other 
4.2 Please list any use of outpatient hospital services over the last 3 months 
(ýýte 1: please enter '0' ifservice has not been used; Note : see manualfor definitions) 
Service Unit of 
measurement 
Number of units received 
(over the last 3 months) 
Psychiatric outpatient visit Appointment 
Other hospital outpatient visit (incl. A&E) Appointment 
Day hospital Day attendance 
Other 
4.3 Please list any use of community-based day services over the last 3 months 
(ýLote 1: please enter 'O'ifservice has not been used; Note 2: see manualfor definitions) 
Service Number of 
attendances 
Average duration of 
attendance 
Community mental health centre 
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4.4 Please list any other primary and community care contacts over the last 3 
months (Mote 1: enter 'O'ifservice has not been used; Note 2: see manualfor definitions) 
Service 
Sector 
(I = govt; 2= vol 
3= private) 
Total number 
of contacts over 






Primary care physician 
District nurse 
Community psychiatric nurse case manager 
Social worker 
Occupational therapist 
Home help / care worker 
Other 
Other 
4.5 Over the last 3 months, has the patient been 
in contact with the criminal justice services? Yes = 1, No =2 
Ifyes: How many contacts with the police Contacts F-I 
(nte: contact = interview or stay of some hours, but not overnight) 
How many nights spent in a police cell or prison? Nights FIF] 
How many psychiatric assessments whilst in custody? Assessments 
How many (criminal or civil) court appearances? Criminal courts 
Civil courts 
5. MEDICATION PROFILE 
5.1 Please list below use of qny drugs taken over the last one month: 
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CLIENT SOCIODEMO GRAPHIC AND SERVICE 
RECEIPT INVENTORY (CSSRI - EU) 
EU BIOMED study: Schizophrenia needs and costs 
HOSPITAL OR COMMUNITY ACCOMMODATION DETAILS 
Centre Fý Patient study number Date 
dd mm yy 
Note: This sheet should be completed as soon as possible after the patientface-to-face interview. 
The best source of information is likely to be a key worker orfacility manager. 
I How many beds/places in the hospital Available beds/places FIFT] 
ward or residential facility are currently 
a) available and b) occupied? Occupied beds/places FIFIFI 
2. Please complete the following staffing table (see manualfor assistance): 
Care staff category 
(Note: only one category per staff member) 
Number of 'full-time 
equivalent' posts 
Total annual cost of 
care staff category 
Staff with a medical qualification 
Staff with a psychology qualification 
Staff with a nursing qualification 
Staff with a social care qualification 
Staff with no care qualification 
Vacant care staff positions 
All care staff categories (total) 
3. What is the annual recurrent cost of 
the facility, excluding care staff?, Total cost per year 
(Include catering, cleaning, etc., but 
exclude rent and capital costs; See manual) 
4. What is the average weekly charge 
or fee per resident place/bed? 
(See manualfor definition) 
Charge per week EIFIFT71 
5. Who contributes towards the full 
cost of this accommodation? 
(Tick all boxes that apply) 
National government (health 
service/insurance fund) F1 
Local government 
II 
Voluntary organ isation/charity 
Private organ isati on/c ornpany 
Private individual 
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Client Sociodemographic and Service Receipt Inventory 
(CSSRI - EU) 
MANUAL 
Introduction 
This manual has been developed for use by participants in the EU BIOMED study of 
schizophrenia in 5 European countries. The Client Sociodemographic and Service 
Receipt Inventory (CSSRI - EU) is one of five instruments that are being used to 
measure the needs, quality of life and cost of schizophrenia in each participating 
centre. The manual provides explanatory notes for particular questions or items in the 
schedule that require some additional information, definition or guidance. 
Instrument overview 
The CSSRI - EU brings together questions which allow the comprehensive costing of 
care packages for individual patients or clients with schizophrenia. It does this by 
collecting information on the current living arrangements and expenses of the client 
(including income, employment and accommodation), followed by questions about 
any use the client may have made of a range of health care, social care and other 
services over a defined retrospective period. A profile of each client's medication is 
collated in a similar way. Unit costs for each of these services and drugs are 
calculated (as a separate exercise) and subsequently applied to the resource use data 
from the CSSRI - EU, to give the total costs associated with each client's use of 
services and medication. The instrument is also used to collect key sociodemographic 
data. There are also costs associated with the informal care inputs by family members 
and friends, which we are obtaining from one of the other instruments in the study. 
Contact point 
If you have any queries regarding the meaning of any items, or are unclear about how 
to complete any aspect of the instrument, please contact Daniel Chisholm or Martin 
Knapp at the Centre for the Economics of Mental Health, Institute of Psychiatry, 7 
Windsor Walk, London SE5 81313, UK. Tel: + 44 171 919 3503; Fax: + 44 171 701 
7600; e-mail: cemh@iop. bpmf. ac. uk 
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Section by section explanatory notes 
Frontpage : Patient's con dential details If, 
This frontpage is to be completed at the beginning of the patient face-to-face 
interview. It should be stored securely in a separate location to the completed 
interviews. This is in order to preserve the confidentiality of the subjects 
surveyed in this study. 
Centre number: Each participating centre has a numbered code: 
I= Amsterdam; 2= Copenhagen; 3= London; 4= Santander; 5= Verona 
Patient number: Please ensure that this is recorded before the interview 
starts. 
4 Date of birth: Complete both here on front page and on the main instrument 
(Q 1.1) so that subjects can be traced if the study number is illegible. 
Section I: Sociodemographic information 
1.4 Ethnic group: It has not been possible to generate a coded shortlist of 
possible ethnic groups into which subjects will fall, since the study covers five 
countries, each with its own historical, political and cultural heritage. 
Definition of ethnicity = 'shared origins, social background, traditions or 
culture that lead to a sense of identity and group' The ethnic group of most 
patients will be best described as 'White European'. Other possibilities 
include 'African-Caribbean', 'Sikh', 'Chinese% etc. Ethnicity is NOT to be 
confused with race (race = division of humankind by physical characteristics). 
1.5 Country of birth: is an objective (but potentially crude) index of ethnicity. A 
coding sheet for countries is attached to the back of this manual. Please 
include the number code for the country. 
1.7 Years of schooling: start point = beginning of compulsory (free) schooling. 
Section 2: Living situation 
2.1 Usual living situation: Please identify with the patient his/her usual or 
normal place of residence. Definition of children = under the age of 18. 
2.2 Type of accommodation: This item attempts to provide a simple 
classification of possible types of accommodation in which patients are 
residing. Some of the categories are (necessarily) broad in order to allow 
comparisons between centres to be made. 
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The following definitions should be employed for specialist community and 
hospital accommodation: 
Community (non-hospital residentialfacilties): 
Overnight facility, 24 hour staffed: Facility where a member of staff is present on site 24 
hours a day, with responsibilities related to the monitoring and clinical and social care of 
patients (i. e. domestic or security staff are not included). 
Overnight facilfty, staffed (not 24 hour): Facility where a member of staff is regularly on site 
at least three days a week for some part of the day, with responsibilities related to the 
monitoring and clinical and social care of patients. 
Overnight facilily, unstaffed: Facility where there is no regular staff presence (less than three 
days per week), i. e. staff are present only occasionally in the week, either as visits or in 
reponse to particular care needs. 
rT- 
huspital. - 
Acute psychiatric ward: Acute facility to which patients are routinely admitted because of a 
deterioration in mental state, behaviour or social functioning which is related to psychiatric 
disorder. 
Rehabilitation ward: Non-acute facility to which patients are referred, usually for a fixed 
maximum period of residence. 
Long-stay ward: Non-acute facility to which patients are referred, usually for an indefinite 
period. 
General medical ward: Facility whose core function is the care of inpatients outside the 
speciality of psychiatry. 
Note: If hospital or (specialist) community accommodation: It is necessary to 
complete the supplementary page of the schedule (after the interview with 
patient), which asks for facility staffing and financial details. See p. 5 below. 
Section 3: Employment and income 
This section is aimed at getting information on patients' employment and 
income circumstances. It is an important source of information for 
establishing the knock-on effects (or indirect costs) of schizophrenia, such as 
lost ability to work, and also for estimating the living expenses of the patient. 
3.2 Occupational categories: The categories are based on the International 
Standard Classification of Occupations (ISCO), a copy of which is attached. 
(Please note that ISCO categories 6.9 and 0 have been dropped from the list at 
Q. 3.2 and should be identified at 'Other.... ' on the schedule if applicable. ) 
3.4 State benefits: The approach taken here has been to identify a number of 
international categories of benefits/entitlements, and to have a list of national 
variants that fall under these broad international categories. This meets the 
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dual requirement of making consistent comparisons between centres whilst 
building up a set of data that has most meaning and use in each individual site. 
3.6 Personal income: We have attempted to reduce the sensitivity of questions 
about personal income by offering a number of possible income bands. The 
income bands can be shown to patients on a separate card, who can than be 
asked to point to the number of the band which corresponds to their total 
personal income (per week, per month or per year - it does not matter which, 
each amounts to the same income leveo. If at all possible, this should be given 
as a gross income level, i. e. before tax and other deductions, but if this is not 
possible, the net income level can be inserted (i. e. after tax and other 
deductions). Please note that this question is asking for the income of the 
patient, NO household income. 
Section 4: Service receipt 
Note: All service receipt is being collected over a retrospective period of 3 months. 
4.1 Inpatient hospital services: Please see above for definitions of hospital 
services. Please record all days in these facilities, including if the patient was 
identified at Q. 2.2 as currently living in one of these settings. 
4.3 Community-based day services: These are services which are normally 
available to several patients at a time and which usually provide some 
combination of treatment for problems related to mental illness, structured 
activity, social contact and/or support. Facilities have regular opening hours. 
4.4 Primary and community care contacts: These are services which involve 
contact between health and social care professionals and patients for some 
purpose related to management of mental illness and its associated clinical and 
social difficulties. They are provided separately, i. e. do not form part of the 
delivery of residential or day services. 
Please identify the sector from which the service contact is delivered (I = 
Statutory/government; 2= voluntary; 3= private). If there is a mixture of 
sectors for any given contact type, indicate the main sector of provision. 
4.5 Criminal justice services: Please code 9 if number of police contacts, nights 
in custody, psychiatric assessments or court appearances not known. 
Section 5: Medication profile 
5.1 Medication: Please record all drugs taken, not just those related to mental 
illness. Please code 9 if dosage not known, otherwise giNTe volume per unit of 
measurement (e. g. 5 mg). 
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Supplement: Hospitallcomm unity accommodation details 
The final page of the schedule only needs to be completed for patients who are 
resident in hospital or specialist community settings (rather than domestic 
accommodation). Data should be collected after the face-to-face interview, in 
consultation with a facility manager or senior key worker. We recommend that 
time is made available as soon after the patient interview as possible. 
Note: For study patients who reside in the same facility, the accommodation details 
will only need to be obtained once. However, please ensure that 
accommodation details are recorded on each patient's schedule. 
Number of places/beds: Please give the number of places in the residential 
facility or hospital ward that are both currently available and occupied. 
2 Staffing: Please include all staff involved in the direct care and management 
of patients. The number of ftill-time equivalent (FTE) staff is calculated by 
aggregating all full-time and part-time positions and expressing them in terms 
of full-time posts. For example, a facility with 4 full-time posts and 4 posts 
working half-time would have a FTE count of 6. The total annual cost of the 
various categories of staff should include actual salaries only (salary on-costs, 
such as national insurance, will be calculated separately by CEMH). 
3 Recurrent cost (excluding care staff): Apart from the salaries of care 
workers, there are other revenue or recurrent costs involved with operating the 
facility. Using annual accounts (it available), please identify the annual costs 
associated with catering and cleaning staff and consumables, heating and 
lighting, transport etc. For hospital wards, an apportionment of the overall 
hospital recurrent costs (excluding care staff) may be the best estimate 
possible. 
Note: There are also likely to be other costs, such as rent, capital or overheads. 
These are a relatively small proportion of the overall cost and will be 
calculated separately by CEMH. Please do NOT include these costs in this 
question. 
(If you do have useful information about these costs that you can share with 
us, please contact Daniel Chisholm at CEMH. ) 
4 Charge per week: Charge refers to the fee or price that is payable in the 
market for residential care. It is often different to the actual cost of resources 
involved in residential/hospital care (staffing, running costs etc. ). For 
example, a private, for-profit company may charge a fee above what it actually 
costs to provide care. Fees or charges for a place at a facility are often 
available, and are useful where it is difficult to estimate the true cost. 
THANK YOU FOR YOUR VALUABLE HELP LV THIS STUD Y 
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Longitudinal Investigation of Depression Outcomes (LIDO): 
Local socio-demographic and service profile 
Background [Sourc : Socio-demographic Schedule] 
Name of participating site (country) 
2. For which local health service catchment 
area are you answering this questionnaire? 
(Note: a profile must be completedfor each area 
from which study subjects are being recruited) 
3. What year do your responses relate to? 19 
f data takenftom more than one year, (PLote. - ir 
state most commonly usedyear) 
4. How many inhabitants does the local 
health service catchment area have? 
What is its size? km 
2 
6. How would you best describe its 





" mixed (specify) 
7. How is the catchment area defined? 
(e. g. local government area boundaries, 
health service sector etc. ) 
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Socio-demographic prorile [Source. - Socio-demographic Schedule] 
Locally 
Male Female 
8. Please give the percentage of total 
population in each age category 
Nationally 
Male Female 
(PLote: give the exact years that are 
reported in your country) 
" Children (0- 18): 0 years % % % 
" Young adults (19-39): years % % % 
" Older adults (40-65): years % % % 
" Retired (65 +): years or more % % % % 
100% 100% 
9. Please give the percentage of 
people over school leaving age in 
each employment category 
e Employed (including part-time) % % % 
Unemployed ! ý] %] % 
Other economically inactive % %] 0 
(including housewives, students, 
retired and permanently sick) 
Locally Nationally 
10. What % of people over school leaving age are %% 
not married (i. e. single, widowed, divorced etc. )? 
What % of people over school leaving age are %% 
living alone, with no adults and no dependents? 
12. What % of people over school leaving age are %% 
living alone as a single parent, with children? 
I 
13. What is the death rate per 100,000 people for 
all causes and all ages? 
14. What is the death rate per 100,000 people for 
all causes for people aged under 65 years? 
LIDO SlIldy socio-demographic and service pro le 
Final version: I AlUl-Ch 1998 
Appendix B 
Overview of health care system 
15. Please give a brief description (typed in English) of the health care system in 
your country, including: a) the basic organisation and structure of services; b) 
the delivery / provision of services; and c) financing of / payment for services: 
(An example of a completed profile is attachedfor your assistance) 
16. Please circle the cell number which describes your country best and estimate 




Public %% (2) 
Provision of 
health care Private % (3) % (4) 
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Secondary care services [Source: Service Mapping Schedule] 
services refer (except Q. 17) to the catchment area's or country's population of adults who have 
mental and behavioural disorders. For Q. 17, it is the whole adult population, not just those with 
mental disorders. In both cases, please exclude services for children and adolescents (aged less than 
18 years, or the close equivalent in your country), and include services for the elderly. 
when estimating mental health service levels, please exclude services for people with learning 
difficulties (mental handicap), but include people with organic mental disorders and substance 
misuse disorders. 
services outside the local catchment area which routinel deliver services to the catchment area 
population should be included 
services provided by health service, social services, voluntary sector and private sector providers 
should all be included (e. g. private as well as public hospital beds) 
service use per 100,000 adult population (over 18 years, or the close equivalent in your country) 
should be calculated by dividing total identified beds/places by the total local / national population 
over 18 years old and then multiplying by 100,000 
17. How many medical (non-psychiatric) hospital 
beds per 100,000 people aged over 18 years? 
Note: include all medical specialities except psychiatry, 
including medical care beds for the elderly) 
18. How many psychiatric hospital beds per 100,000 
people aged over 18 years? 
Notes: include all secure, acute and non-acute beds; 
include secure beds in prisons; 
include psychiatric beds in general hospitals 
19. How many non-hospital residential places for the 
mentally ill per 100,000 people? 
Note: include all accommodation outside hospital 
grounds/prison specifically designated for people 
with mental illnesses (hostels, group homes etc. ) 
Locally Nationally 
20. How many places per 100,000 people for day 
services/activities for the mentally ill? 
Note: include day hospital places and community 
facilities available for users to attend for at least 
the equivalent of four half days per week; 
exclude employment / work-related schernes 
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Primary care services [Source. - WHO PPGHC Study Form 43] 
Note: Please complete a profile for each participating primary care centre in your site. 
2 1. Name of primary care centre 
22. Setting: Urban; Rural; Other (specify) 
23. Total number of ftill-time equivalent physicians 
(hLote: express part-time posts asjull-time equivalents) 
24. Total number of full-time equivalent nurses 
(N 
. Qte: express part-time posts asjull-time equivalents) 
25. Total number of full-time equivalent other staff 
(ýLote: express part-time posts asjull-time equivalents) 
26. Average length of a typical visit minutes 
efinition: jace-to-jace contact with a physician) 
27. Total number of patients per month (on average)? 
(bLote. - please adjustfor seasonal variations) 
Male Female 
28. Percentage of patients in each age category 
(ýýte: give exact age bands that are available) 
Children (0- 18): 0 years %% 
Younger adults (19-39): years %I % 
Older adults (40-65): years % 
9 Retired (65 +): years or more %I% 
100 % 
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29. Please estimate the distribution of attenders' 
reasons for visits: 
9 acute illness and injuries 
9 definite chronic diseases 
9 indefinite/ill-defined chronic symptoms 
9 psychological problems 
30. What percentage of attenders live within 30 
minutes journey of the primary care centre? 
3 1. Transportation to the primary care centre: 
easy 
* with some difficulty 
9 difficult 
32. Who pays for the patient's visit? 
(a) patient/family; b) health service; c) combination 
33. Who pays for the patient's medications? 
(a) patient/family; b) health service; c) combination 
34. Do patients easily access care in an organised 
way (appointment system)? 
35. Do doctors or clinics have well-kept, detailed 
records of patients? 
36. Are physicians 'personal doctors'? 
Does the patient usually see the same doctor? 
37. Do physicians assume responsibility for 
coordination of patients' follow-up, referral 
and other services? 
THANK YOU 
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A FEW MORE QUESTIONS 
-DEMOGRAPHICS 
A Few More Questions 
About You 
1. What is your current marital status ? Please circle the number ofyour answer. 




5 NEVER MARRIED 
Appendix C 
2. What is your cuiTent living situation? Please circle the number ofyour answer. 
I LivfNG ALONE 
2 LIVING WITH SPOUSE/PARTNER ONLY 
3 LiviNG WITH SPOUSE/PARTNER AND CHILDREN 
4 LivING WITH OTHER RELATIVE(S) 
5 LivING WITH OTHER(S) (NOT RELATED) 
6 OTHER, SPECIFY 
3. What is the highest grade or year of school that you have completed? Please circle your answer. 
012345678 9101112 13141516 17 18 1920+ 
ELEMENTARY SCHOOL HIGH SCHOOL COLLEGE GRADUATEOR 
Circle 14for PROFESSIONAL 
vocational school SCHOOL 
4. Please indicate the type of living accommodation that describes you best. 
Please circle the number ofyour answer. 
I OWNER OCCUPIED APARTMENT, FLAT, CONDOMINIUM OR HOUSE? 
2 PRIVATELY RENTED APARTMENT, FLAT, CONDOMINIUM OR HOUSE? 
3 APARTMENT, FLAT, CONDOMINIUM OR HOUSE RENTED FROM A PUBLIC AGENCY 
4 OTHER TYPE OF LIVING ACCOMMODATION (DESCRIBE: 
5. Please indicate the employment status that describes you best. Please circle the number ofyour answer. 
1 PAID OR SELF-EMPLOYED 
2 VOLUNTARY EMPLOYMENT (NO FINANCIAL COMPENSATION) 
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6. If unemployed, for how many weeks within the last 3 months? Number of weeks 
7. If employed, please indicate the occupational status that describes you best. 
Please circle the number ofyour answer 
I MANAGER/ADMINISTRATOR 
2 PROFESSIONAL (HEALTH, TEACHING, LEGAL, ETC.... ) 
3 ASSOCIATE PROFESSIONAL (TECHNICAUVOCATIONAL) 
4 CLERICAL WORKER/SECRETARY 
5 SERVICES/SALES 
6 SKILLED LABORER (BUILDING, ELECTRICAL, ETC.... 
7 UNSKILLED LABORER (FACTORY WORKER) 
8 ARMED FORCES (FULL TIME) 
8. In the last 3 months, how many days have you been absent from work? Number of days 
9. Please indicate the main source of income that describes you best. Please circle the number. 
I SALARY 
2 STATE BENEFITS 
3 PENSION 
4 FAMILY SUPPORT (I. E. SPOUSE) 
5 OTHER: 
10. What is your total personal income from all sources? If possible give gross income before 
taxes and deductions. Total personal income 
Please circle your answer. 
Is this income: WEEKLY MONTHLY ANNuAL 
Is this income: GROSS NET 
1. In the last 3 months, have you been counseled or given medications for the 
treatment of depression? Please circle your answer. Yes 
No 
12. Do you expect to be moving away from this area in the next twelve months? 
Please circle your answer. Yes 
No 
4600 cqýoo f 
ry'l I 
-I hank you very much 
for completing this survey. Pleaselook 
through it once to see that it is complete, and then hand it to your 
interviewer. 
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Use of Health Care Services 
Now I am going to ask you about the primary care and outpatient visits you have had during the last 3 
months (these include any home services, emergency room visits, or diagnostic tests you have had). 
Where did these visits On average, 
During the past three months, have you 
I 
How many visits usually take place? about how 
had visits to any of the following health 
did you have I= hospital outpatient 
2 =primary care center long were 
care providers? 
during the past 3= emergency room these visits? 
(Circle) 
three months ? 4 =private clinir-lpractice Number 
No Yes 
5 =your own home minutes 
1. Primary care doctor (MD/DO) 01 # visits # minutes 
2. Other health care worker 
(nurse practitioner, PA, M SW, PT) 
01 
# visits # minutes 
3. Psychiatrist 01 # visits # minutes 
4. Psychologist or other therapist 
(independent practitioners) 
01 # visits # minutes 
5. Other mental health worker (such 
as a care manager, community 
01 
services worker or social worker) # visits # minutes 
6. Other non-mental health specialist 
physician or dentist 
01 
# visits # minutes 
7. Alternative therapies (regardless of 
delivery by a physician) 
01 
# visits # minutes 
8. Other specify (include diagnostic 
services by technician and ambulance 01 
service) # visits # minutes 
Next I will be asking you about any day services or day care activities that you might have used during 
the nast three months. includiniz LyroUD theraDV. day treatment, or dav surperies? 
During the past three months, have you used any of How many times did On average, how 
the following services? (Circle) you use those services long did you use 
No Yes during the past three each service? 
months? 
9. Day hospital for physical health (including day 
surgery, oral surgery, dialysis, ) 
01 # times # hours 
10. Day hospital for mental health (like group therapy, 01 
day treatment, partial hospitalization) # times # hours 
11. Day care in comi-nuniiy-based program for 
mental health (like occupational therapy, group therapy, 01 
adult day care, senior center programs) # times # hours 
12. Other cornmunity-based non mental health 
day programs or services, including AA, and 01 
other support groups (specify) 





SITE ID PATIENT ID 
For the next part, I am going to ask you about any stays you had in a hospital as an inpatient. 
How many separate 
During the past three months, have you admissions did you have In total, how many 
used any of the following types of (Circle) over the past three days did you spend in 
inpatient services? No Yes months ? this type of facility? 
13. Psychiatric hospital ward 01 # admissions # days 
14. Psychiatric ward of general hospital 01 
_ 
# admissions # days 
15. Medical ward of general hospital 01 # admissions # days 
16. Emergency ward psychiatric facility 01 # admissions # days 
17. Emergency ward general facility 01 
_ 
# admissions # days 
18. Other specify 01 # admissions # days 
19. Now, please can you tell me what prescribed medications you have been taking during the past three 
months? [Interviewer: Ask to see patient's medication bottles. ] [ALL medications] 
Strength Number How many weeks out D me ' 
of dose pills per Freq uency of 
the past three 
Name of medication (Mg. ) dose months have you 




# weeks C. 
d. # weeks 
# weeks e. 
# weeks 
# weeks 9. 
h. # weeks 
Do you feel that your treatment or use of services is affected by any of the following: 
Circle one response per question 
20. The place you need to go to for treatment is far away or inconvenient to get to ................... Yes No 
21. Seeking treatment might compromise my job opportunities ................................................. Yes No 
22. The costs or charges that you pay towards treatment/medicines are not affordable . ............ Yes No 
23. Asking for treatment or attending a treatment center can feel embarrassing . ...................... Yes No 
24. Family and/or friends discourage you in some way from seeking or getting treatment . ...... Yes No 
25. Taking medication sometimes makes you feel unwell or causes side-effects ....................... Yes No 




Longitudinal Investigation of Depression Outcomes (LIDO) 
UNIT COST PROTOCOL 
1. Introduction 
This protocol has been developed for use by local site investigators and collaborating 
economists in the Eli-Lilly sponsored Longitudinal Investigation of Depression 
Outcomes (LIDO), the aim of which is to study the QoL and economic correlates of 
recognized major depression in primary care. The protocol sets out the scope, 
principles and procedures of the unit cost data collection exercise to be conducted in 
each participating site. The information contained in this document will be presented 
to local site investigators and collaborating economists by a member of the co- 
ordinating agency (HRA) or an Advisor to the study with special expertise in health 
economics and service costing. 
Adherence to this protocol is particularly important in an international study of this 
kind in order to ensure that a standardised approach has been adopted across sites. 
The templates that can be found in the Appendices have been prepared in order to 
ensure this standardised approach, as well as to assist you in what can be an onerous 
task! Please complete all templates and return to the contact point below. 
2. Scope of exercise and principles of costing 
The broad perspective to be employed in the costing of services is an economic one, 
such that in principle service costs are derived by reference to their marginal long- 
term opportunity costs (see Knapp, 1995 for an overview of this theoretical 
framework in relation to mental health care) For example, the opportunity cost of an 
inpatient hospital bed is in principle to be based on established calculations of how 
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those resources could be used in their best alternative use, such as a day care place or 
an entirely different service within or outside mental health care. 
In practice, derivation of costs in this way is difficult. It is therefore conventional to 
use short-term average costs as a proxy for long-run marginal costs (Beecham, 1995; 
Beecham and Knapp, 1992). There is widespread consensus in health economics as 
to the validity of these proxies, provided that necessary adjustments such as the 
inclusion of capital in a unit of service provision are made (see Chisholm et al, 1997 
for a practical application to mental health residential care; see Netten and Dennett, 
1997 for a wide range of UK unit costs of health and social care derived in this way). 
Economic or opportunity costs are not the same as market prices, charges, fees or per 
diems. Profit motives, varying accounting and reimbursement practices mean that the 
use of per diems and hospital charges are unlikely to represent a good proxy of 
opportunity cost. For example, a private, for-profit company may charge a fee above 
what it actually costs to provide care. Where used (because no other data possible to 
collect), they should be explicitly justified and, if necessary, adjusted to reflect the 
real economic cost. 
Estimation of costs should either be based on local catchment area data, or if this is 
not possible, on national data so long as the local catchment area is typical or 
representative of the national picture. As a general rule, the unit cost of contacts with 
primary care workers or outpatient consultants are not likely to vary significantly 
(making national estimates an acceptable choice), whereas the unit cost of day care 
provision and particularly inpatient services may vary considerably between different 
areas of the country. Facility-specific estimates should be obtained if possible. A 
further general principle is that routinely collected data are preferable to data collected 
on a one-time basis. 
A further principle of cost evaluation is that the resource implications of all elements 
of a service should be considered, even though individual service planners may only 
be interested in the cost to their own agencies. Again, there are difficulties in realising 
this principle on pragmatic grounds; for instance, the full cost of a day care place may 
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include inputs from unpaid volunteer staff or financial contributions from clients over 
and above those of the managing agency. 
In this study, the following direct and indirect costs are to be included: 
* direct costs: refer to the costs of health and social care services provided for the 
care and support of people with depression. These services are iternised in the 
interview schedules at Baseline and subsequent follow-up assessment points under 
the section 'Use of Health Care Services', to which it will be necessary to attach 
unit costs. 
9 indirect costs: refer to the wider-reaching economic effects of depression, and in 
particular to foregone opportunities for employment. Data is being collected on 
weeks off work (for people normally employed) and weeks of unemployment as 
part of the self-completed schedule under the section 'A Few More Questions: 
About You'. Estimates of the indirect costs of lost employment will be calculated 
by multiplying days off work by the local wage rate for the occupational category 
of the patient. 
There are other indirect costs, such as reduced productivity whilst at work or informal 
care support, but these are outside the scope of this particular study (largely due to 
measurement difficulties). 
3. Unit cost data collection and calculation 
Constructing a profile of the service costs requires the combination of two sets of 
data, the first of which is information on service utilisation - to be collected as part of 
the interview schedule at Baseline and subsequent assessment points. For each of the 
service components described - and this is the second set of data - an estimate of the 
cost associated with the provision of a unit of service provision is needed. 
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The appropriate unit of analysis differs across the service components (for example, 
hospital inpatient beds are usually described in daily units, whereas contacts with 
primary care workers are expressed in terms of number (and average duration) of 
visits. or the purposes of subsequent data analysis, costs will be converted into the 
same time frame (cost per year). 
There are four main categories of cost that need to be quantified for each service: 
1. Salaries and wages of staff employed in the direct care and management of patients 
2. Facility operating costs where the service is provided (cleaning, catering etc. ) 
3. Any overhead costs relating to the service (personnel, finance etc. ) 
4. The capital costs of the facility where the service is provided (land, buildings etc. ) 
This last category of cost needs particular explanation. The (opportunity) cost of 
capital is conventionally calculated as the annuity (the constant stream of payments 
arising from interest, taken to be the best alternative use for the capital) which will 
deplete the lump sum value or expenditure over the lifetime of the capital. The 
lifetime of land and buildings is normally set at 60 years, and the lifetime of 
equipment (including furniture and vehicles) is normally set at 10 years. The other 
determining feature of the annuity factor is the prevailing discount rate for public 
and/or private capital assets. The general fonnula for deriving the annual capital cost 
I -n of an asset (annuitising rate, denoted a- n) is r/l-(l + r) , where r is the discount rate 
and n is the lifespan of the asset. A number of annuity factors relating to different 
discount rates are given below for easy reference: 
Asset Lifespan Discount rate 
3% 5% 7% 10% 15% 
Land and buildings 60 years 0.0361 0.0528 0.0712 0.1003 0.1500 
Equipment and vehicles 10 years 0.1172 0.1295 0.1424 0.1627 0.1992 
Example: Using the 5% discount rate, a day care centre worth $500,000 would have 
an annual capital cost of $26,400 (500,000 x 0.0528) 
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3.1 Primary care and outpatient visits 
Estimates of the unit cost of health care and social care professionals are needed for 
the section on 'Use of Health Services', questions 1-7. We need to arrive at a unit 
cost per minute of consultation time with these professionals. The main categories of 
information required to calculate this unit cost are: 
* wages/salary: salary costs can normally be obtained from local or national pay 
scales. The ideal salary value to use is a weighted average of all grades on a pay 
scale. 
* salary on-costs: this covers employer contributions to local/national taxes, pension 
or health insurance schemes etc., and can be given as a percentage add-on to the 
salary/wage. An indication of the basis of the percentage add-on should be given. 
*revenue overheads: this covers the costs associated with running the 
establishment where the professional is employed, for example a primary care 
clinic. This can be worked out by dividing pro rata the total running costs of the 
establishment (excluding capital costs or rent) by the total number of 'full-time 
equivalent' staff (see below for definition), and can be expressed as a percentage 
add-on to the salary. 
9 capital overheads: refers to the costs associated with the buildings, land and 
equipment of an establishment. This can be worked out by dividing pro rata the 
annuitised capital costs of the establishment by the total number of full-time 
equivalent staff, and can also be expressed as a percentage add-on to the salary. 
* travel costs: refers to the typical cost of travel, which is particularly relevant for 
professionals who make home visits. 
In order to reach a unit cost per minute of contact time, the aggregate of these cost 
components needs to be divided by the typical working time of the professional (for 
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example, 35 hours per week, with 4 weeks holiday per year and I week sickness leave 
allowance). Because these professionals do not spend all their time with patients, it is 
also desirable to estimate the ratio of direct : indirect contact time with patients (for 
example, for every I hour spent face-to-face with a patient, a social worker may spend 
1.5 hours doing other things such as administration, staff supervision, etc. ). 
A blank template has been prepared for calculating the unit cost of each professional 
identified in items 1-8 of the 'Use of Health Services' section of the interview. 
Notes/comments should be given in English. 
3.2 Day services / day care activities 
The calculation of cost for a unit of day service provision (items 9-12 of Use of 
Health Services schedule) requires quantification of the following components: 
e revenue costs (salaries): an estimate is required for the cost of all care staff 
involved in the direct care and management of patients. Staffing should be 
calculated as the number of full-time equivalent (FTE) staff, which is calculated by 
aggregating all full-time, part-time and sessional positions and expressing them in 
terms of full-time posts. For example, a facility with 4 full-time posts and 4 half- 
time posts would have a FTE count of 6. The total annual cost of the various 
categories of staff should include actual salaries paid to staff and a percentage for 
on-costs (which covers employer contributions to occupational schemes etc. ). 
9 other revenue costs: this covers the costs associated with running the 
establishment where the day service is provided, including heating, lighting, 
catering/cleaning personnel and consumables etc. These costs can be taken from 
the establishment's expenditure accounts (if available) or if accounts are not 
available, it may be possible to use the typical fee or charge as a basis for 
calculation. It is important that all rental costs are removedftom this calculation. 
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9 agency overheads: refer to any costs associated with service management and 
administration, such as finance and personnel functions. For example, the 
management of a single day care facility's human and financial resources may be 
carried out by a headquarters office with many other facilities under its 
management. These costs are often difficult to identify with accuracy, and it may 
only be possible to establish a percentage add-on to known revenue costs. An 
indication of the basis for the percentage add-on should be given. 
* capital: refers to the economic costs associated with the buildings, land and 
equipment of an establishment. 
Derivation of the cost per hour of day care support/activity is complicated by the fact 
that multiple activities/functions may be offered at the same facility. In order to arrive 
at a basic estimate,, it is proposed that total identified costs associated with the facility 
(usually annual costs) should be divided by i) the number of days per year that the 
facility operates, ii) the average number of opening hours per day and iii) the average 
number of clients who attend each day the facility is open to users. Specific unit costs 
by different types of activity and/or client group would require more detailed costing. 
A blank template has been prepared for calculating the unit cost of each day care 
setting (items 9-12 of the 'Use of Health Services' section of the interview). 
3.3 Hospital inpatient services 
The calculation of hospital inpatient service costs (items 13-18) has the same 
components as that for day care activities. However, a hospital is made up of many 
departments / wards. It is therefore likely that apportionment of hospital-wide costs to 
specific wards will be necessary. The unit cost for each of the hospital inpatient 
services identified in the interview should best reflect local circumstances. In other 
words, a calculation may be required for each hospital commonly used by the local 
population / patient sample (i. e. more than one template may need to be completed). 
The main cost components are: 
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9 revenue costs (salaries): an estimate is required for the cost of all care staff 
involved in the direct care and management of patients on the ward. Staffing 
should be calculated as the number of full-time equivalent (FTE) staff. The total 
annual cost of the various categories of staff should include actual salaries paid to 
staff and a percentage for on-costs (which covers employer contributions to 
occupational schemes etc. ). A template is given in the relevant appendices to assist 
in this calculation. 
* other revenue costs: this covers the costs associated with running the ward, 
including heating, lighting, catering/cleaning personnel and consumables etc. It 
may be necessary to apportion a percentage of the total running costs of the 
hospital to the particular ward. If the typical fee or charge is used as a basis for 
calculating this element, its components should be identified clearly. 
e agency overheads: refer to costs associated with service management and 
administration, such as finance and personnel functions. These costs are often 
difficult to identify with accuracy, and it may only be possible to establish a 
percentage add-on to known revenue costs. 
9 capital: refers to the economic costs associated with the hospital buildings, land 
and equipment. The annual capital cost of a specific ward can be established by 
apportioning a percentage of the total capital value of the hospital and then 
transforming this figure into an annual amount using an appropriate annuity factor. 
Unit costs for inpatient services need to be expressed in daily units, requiring the 
division of the aggregated annual costs by i) the number of days in the year (365), and 
ii) the number of beds on the ward. A blank template has been prepared for 
calculating the unit cost of each inpatient service (items 13-18 of 'Use of Health 
Services'). 
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3.4 Medications 
A profile of each patient's medication is being recorded (item 18 of the 'Use of 
Health Services' section of the interview schedule). Unit costs will be required for all 
drugs listed by patients (not just psychotropic agents). The full list of drugs used will 
only be available at the end of data collection, but before this time point it is 
recommended that unit costs of all anti-depressant drugs available locally should be 
calculated. Unit costs should be taken from the national or local formulary of 
medications. Alternatively, it may be necessary to consult with local hospital 
pharmacies regarding the cost of certain drugs. The unit of measurement for all drugs 
should be expressed as cost per 100mg. Example: the medication cost of an 
individual who has taken a prescribed dose of 20mg of Fluoxetine per day for 10 
weeks @ US$5 per 100mg = $70. 
4. Other required socioeconomic data 
In addition to the collection of unit costs for particular service components, there is 
also a need for other specified socioeconomic data, either to inform the interpretation 
of study findings or to enable other economic costs of depression to be calculated. 
4.1 Wage rates by occupational category 
Under the demographics section of the self-complete schedule at baseline and 
subsequent assessment points ('A Few More Questions - About You'), study 
participants are asked to indicate their occupational category (item 7). These 
categories have been taken from the International Standard Classification of 
Occupations. In order to derive the opportunity cost of lost employment due to 
illness, an estimate of the average wage for each of these occupational categories is 
required. Wage statistics are expected to be available from national or local statistical 
offices. However, it is anticipated that there not be precise data for the categories 
specified in the schedule. Please provide the best/closest estimate possible for each of 
these categories. The rate should be expressed as a gross wage/salary per year (before 
tax and deductions). 
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4.2 Distribution of national income / wealth 
Under the demographics section of the self-complete schedule at baseline and 
subsequent assessment points ('A Few More Questions - About You'), study 
participants are also asked to indicate their income level (item 10). In order to place 
given values within the context of the national distribution of income, it is proposed 
that this distribution is sought from each participating site. The distribution of 
income should be available from national statistical offices, and should be expressed 
as equal percentages (or quantiles). The particular quantile required in this study is the 
quartile (equal bands of 25%), or the nearest equivalent in your country. 
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Does the patient feel that access to / use of services is affected by these factors? (tick one box only) 






B. The understanding / responsiveness of care providers to your health needs 
1-1 F-I 1-1 
C. The quality or continuity of the treatment or care that you receive (quality) 
1-1 F-I F-I 
D. The fees/charges that you pay towards treatment/medicines (cost) 
1-1 1-1 F-I 
E. Seeking treatment can make you or your family feel embarrassed (stigma) F 1-1 F 
F. You dislike taking medication or taking it can make you feel unwell (side-effects) 
1-1 F-I F-I 
G. Other reason(s) for using / not using treatment services (specify) F-I F-I F-I 
Please list medication prescribed to the patient for emotional problems in the last 8 weeks: 
Generic (and brand) name of drug 
e. g. Fluoxetine (Prozac) 
For how many days? 
(max = 56 dqyý 
Dose per day (Mg) 
In the last 8 weeks, has the patient, a family member or friend had to 0 =No; I =Yes F-I 
stop or reduce usual work / activities due to the patient's ill-health9 
If yes: Patient Family Ifriend I Family Ifriend 2 
A. Relationship to patient 
B. a) No. of dqys in the last 8 weeks 
or: 
b) No. of hours per week less 
C. Type of work forgone (1-3; see key below) 
D. If applicable, income lost per da 
_ 
(before tax & other deductions) 
Kgy. - Type of work forgone: I= unpaid housework (e. g. housewife) 
2= manual work (e. g. agricultural or factory worker) 
3= office / non-manual work (e. g. skilled worker, business, professional) 
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GUIDELINES FOR THE ECONOMIC ANALYSIS 
OF COMMUNITY MENTAL HEALTH CARE 
PRO GRAMMES IN L0 W-INCOME COUNTRIES 
Contents A. The rationale for an economic perspective 
B. Principles of economic analysis 
C. Planning and designing an economic analysis 
D. Data collection: i) resource utilisation 
ii) costs 
iii) outcomes 
iv) local service structures 
E. Data analysis andpresentation 
The guidelines: i) have been drawn up in order to provide an overview of issues, principles and 
procedures related to the economic analysis of mental health care 
programmes in low-income countries. 
are aimed at mental health workers who have an interest in incorporating an 
economic perspective into their evaluative research activities. 
are largely based on the principles and methods used in the US and UK, but 
also reflect an additional set offeatures associated with the implementation of 
these methods in the context of low-income countries 
iv) do not attempt to be comprehensive, and it is recommended that a local health 
economist or closest equivalent is consulted in their application. 
The rationale for an economic perspective 
The increasing recognition of mental health as a significant public health issue globally has led to 
additional demands for resources that are already stretched. There is therefore a requirement to 
demonstrate that investment of resources into mental health care and prevention is needed and 
worthwhile. This translates into generating evidence on affordable and cost-effective mental health 
care and prevention strategies. Economic evaluation provides a methodology that allows policy 
makers, managers and clinicians to make choices between differing treatments, settings and 
illnesses in 
order to facilitate the judicious use of scarce resources. The current lack of mental health economic 
evaluative studies in low-income countries is a significant stumbling block to the investment of I- 
resources in mental health by governments and international agencies. 
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B. Principles of economic analysis 
Key to the understanding of an economic approach towards mental disorder is the notion of resource 
scarcity, since this necessarily prompts the requirement to make choices between different courses of 
possible action or investment. Making a choice implies in turn the sacrifice or foregoing of the 
alternative action or investment. The economic approach therefore attempts to value the worth of a 
particular resource, decision or strategy with reference to its 'opportunity cost', namely the value 
attached to the next best alternative. To give an example, the opportunity cost of an acute psychiatric 
bed is derived with reference to the alternative use with which those resources could be put to, such as 
within another medical speciality, outside medicine completely, or investment into an interest-bearing 
savings account. A further important principle of economic analysis is that it takes a broad, societal 
perspective, such that account is taken of costs falling to all relevant parties; for example, allowance 
should be made for inputs of unpaid volunteers/family carers as well as formal care inputs. 
C. Planning and designing an economic study 
For an appropriate economic evaluation of a mental health care intervention, programme or strategy, a 
number of study design features need to be considered. Since economic evaluations often take place 
alongside clinical evaluations or trials, the design of the stud will typically need to be agreed in 
conjunction with other evaluators. The most desirable design requirements for the economic evaluation 
of a mental health care intervention revolve around the presence of a control group (against which to 
draw comparisons with the intervention group), and the prospective follow-up of these two groups over 
time (one year would be sufficient for most studies) . 
This 'experimental' study design is the 'gold 
standard' of clinical and economic evaluation, since it is able to demonstrate most clearly that changes 
in selected measures are attributable to the intervention, as opposed to other possible explanatory 
factors ('confounding' variables). Where it is not possible or practicable to carry out an experimental 
study, an observational study design can be used; this design may have better external validity - 
preserving the context in which care is provided - but shifts the focus of the analysis towards 
identifying associations between the intervention and changes in costs or outcomes (as opposed to 
attributing a causal relationship). A further desirable is recruitment of a sufficient sample of patients 
and/or centres to show statistically significant changes between groups (at least 100-200 subjects per 
group is probably required); the sample size necessary to show a significant economic difference may 
be greater than that necessary to show a clinical difference between study groups. 
Alongside decisions regarding the most appropriate study design, consideration must also be given to 
the mode of economic evaluation (that is, the manner in which costs and outcomes data are to be 
combined). The simplest of cost evaluations is commonly referred to as cost-mininfisation analysis, but 
this is only appropriate if it is known that outcomes are identical (very unlikely), in which case the task 
is merely to establish the least cost method of achieving these outcomes. A much more common mode 
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of economic evaluation in the field of mental health care is cost-effectiveness analysis, which assesses 
not only the costs but also the outcome of an intervention, expressed in terms of cost per reduction in 
symptom level, cost per life saved, etc.. Where there is more than a single measure of outcome being 
investigated, as is often the case in psychiatry and related fields (see E iii below), it is more correct to 
label this type of study as a cost-consequences analysis. This mode of evaluation is likely to represent 
the default choice in most contexts, and has the advantage of presenting an array of outcome fmdings to 
decision-makers. A further mode of evaluation is cost-utility analysis, which has considerable appeal 
for decision-makers since it generates equivalent and therefore comparable study data ('utilities', 
expressed by a combined index of the mortality and quality of life or disability effects of an 
intervention), upon which priorities can then be based. However, there are technical difficulties in 
using this approach, and where it has been used in psychiatry, it has not performed very well to date. 
The final option is cost-benefit analysis, which refers to a form of evaluation in which all costs and 
outcomes are valued in monetary units, thereby allowing assessment of whether a particular course of 
action is worthwhile, based on a simple decision rule that benefits must exceed costs. This approach is 
difficult to undertake because of the requirement to quantify outcomes in monetary terms, and 
consequently is found very rarely in mental health care evaluation. 
One other key decision to make at the design stage of the study is the scope or perspective of the 
evaluation. This refers to the viewpoint from which the analysis is being taken, which, in ascending 
order of comprehensiveness, might be that of a particular agency or government department (e. g. 
ministry of health), the statutory/formal sector as a whole (e. g. including social services), or a societal 
perspective which assesses the impact of the intervention on all agencies, including patients themselves 
as well as their carers or households. The choice of viewpoint, which will influence what costs and 
outcomes are to be measured, should be determined according to whether the intervention under study 
is expected to exert a differential impact on these various agencies/sectors. 
In summary, it is possible to list a number of stages which typically comprise the conduct of an 
economic evaluation, all of which need to be considered and carried out in order to obtain a valid and 
reliable set of findings: 
i) definition of the alternative interventions to be evaluated (design); 
ii) identification of the costs and outcomes to be included in the study (scope); 
iii) quantification of these identified costs and outcomes (valuation); 
iv) comparison of costs and outcomes (analysis); 
v) revision of findings in the light of risk, uncertainty and sensitivity (qualification); and 
vi) examination of distributional effects (equity implications). 
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D. Data collection 
0 Resource utilisation: The collection of service utilisation data at the level of the individual 
patient enables the generation of detailed information on the consumption of a wide range of resources. 
Opportunity cost estimates can be applied subsequently to these data in order to calculate the overall 
economic costs associated with an individual's care, or at a more aggregated level, a particular 
intervention or strategy. An initial stage in the recording of resource utilisation data is the 
identification of relevant components of potential service receipt by users, such as contacts with 
primary care physicians and other health workers, community-based private or voluntary sector 
providers and hospital inpatient and outpatient care (both psychiatric and general). Services to include 
will differ with respect to a number of evaluative concerns, including the scope, objectives and setting 
of the study, as well as the particular service needs of the client group(s). For example, users with more 
severe or enduring mental disorder, such as persons with a diagnosis of schizophrenia, often need a 
wider range of service supports than people with common mental disorders such as depression and 
anxiety (e. g. day care services and residential care). For economic analyses carried out alongside 
clinical evaluations (the expected norm in this context), the most convenient means of data collection is 
often via an interviewer-administered service receipt schedule, which can record service use over 
defined retrospective periods at the various assessment points of the study (see Appendix I for a 
generic example of such a schedule). It is also important to ensure that data is available or collected on 
the socio-demographic and socio-economic characteristics of the individuals, including lost 
opportunities to work (this latter category may be an important economic outcome). 
ii) Resource costs: For each item of resource utilisation, a unit cost estimate is required, such as 
a cost per inpatient day, or cost per contact with a primary care worker. It will be necessary to compute 
these estimates using a range of data sources, including national/local government statistics, health 
authority figures and specific facility or organisation revenue accounts. The broad perspective to be 
employed in the costing of services is an economic one, such that in principle service costs are derived 
by reference to their marginal long-term opportunity costs. In practice, derivation of costs in this way is 
difficult. It is therefore common to use short-term average costs as a proxy for long-run marginal costs. 
The main categories of cost that need to be quantified for each service are: 
0 Salaries / wages of staff employed in the direct care and management of patients. Salary costs can 
be obtained from local or national pay scales. The ideal salary value to use is a weighted average 
of all grades on a pay scale. Supplementary (fringe) benefits, bonuses and allowances should be 
included. Also include employer contributions to local/national taxes, pension or health insurance 
schemes etc., which can be given as a percentage add-on to the salary/wage. 
0 Facility operating costs where the service is provided (cleaning, catering, consurnables, water, 
electricity etc. ). This covers the costs associated with running the establishment where the 
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professional is employed, for example a rural health centre. This can be worked out by dividing pro 
rata the total running costs of the establishment (excluding capital costs or rent) by the total 
number of 'full-time equivalent' staff. For government facilities, these costs can usually be 
obtained from the finance or planning departments of local or federal government. 
0 Any overhead costs relating to the service (personnel, finance etc. ). Costs associated with service 
management and administration, such as finance and personnel functions, are often difficult to 
identify with accuracy, and it may only be possible to establish a percentage add-on to known 
revenue (operating) costs. 
0 The capital costs of the facility where the service is provided (land, buildings etc. ). The 
(opportunity) cost of capital is calculated as the annuity (the constant stream of payments arising 
from interest, taken to be the best alternative use for the capital) which will deplete the lump sum 
value over the lifetime of the capital. The lump sum value can be obtained from government 
contracts for similar buildings. The lifetime of land and buildings is best set at 20 years, and the 
lifetime of equipment (including furniture and vehicles) can be set at 5 years. The other 
determining feature of the annuityjactor is the prevailing discount rate for public and/or private 
capital assets (this should be available through local government offices). For example, using the 
5% discount rate, a hospital worth $500,000 would have an annual capital cost of $40,122. 
In order to reach a unit cost of contact time, the aggregate of these cost components needs to be divided 
by the typical availability of the service or the working time of the professional (for example, 35 hours 
per week, with 4 weeks holiday per year and I week sickness leave allowance). See Appendix 2 for an 
example of a unit cost template for a primary health care centre. 
It should be emphasised that economic or opportunity costs are not the same as market prices, charges, 
fees or per diems. Profit motives, varying accounting and reimbursement practices mean that the use of 
per diems and hospital charges may not represent a good proxy of opportunity cost. For example, a 
private, for-profit company may charge a fee above what it actually costs to provide care. Where used, 
this should be clearly stated and, if possible, adjusted to reflect the real economic cost. 
iii) outcomes: There is an important distinction to be made between indicators of intermediate 
outcomes and final outcomes. The former category, which can also be referred to as process indicators, 
should not ideally be the focus of the analysis, since positive changes in, for example, attendance or 
detection rates may not in fact result in improved patient welfare or mental health. Thus, while process 
indicators are undoubtedly an important source of differentiation between study samples at the 
institutional level, their use as indicators of improved patient welfare needs to be treated with caution. 
Final outcomes, on the other hand, are concerned with detecting changes in the physical, psychological ZI) 
or social well-being of individuals, and commonly revolve around the measurement of symptoms, 
functioning and disability, quality of life and service satisfaction. 1. 
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iv) local service structures: The take up and subsequent effectiveness of services is determined to 
a significant extent by the access, availability and quality of mental health services. Without comparable 
and standardised descriptions of the structure and content of service systems, analysis of the role of 
organisational characteristics in evaluating costs and outcomes is severely compromised. It is therefore 
vital to have an understanding of the features that characterise each site's local service system. Data is 
needed at a local area level in two domains: sociodemography, to include the age, sex, education and 
employment profiles of the population; and primary and secondary health services, to include the 
structure, organisation and fmancing of both general medical and mental health services, plus the 
availability of / access to these services to / by the population(s) under study. 
E. Data analysis and presentation 
Economic evaluation provides a means of comparing the costs and outcomes of a mental health care 
intervention or programme together in an explicit framework. This in turn enables decision-makers to 
assess the extent to which the intervention or strategy offers a good use of (scarce) resources. An 
analysis of costs alone, or indeed of outcomes alone, does not provide such information. In analytical 
terms, there are a number of scenarios that can be considered when assessing whether an intervention 
represents a worthwhile use of resources: 
If statistical analyses of cost and outcome data show that the new intervention is both significantly 
less costly and more beneficial than the control group (usual care), then one can immediately 
conclude that the intervention is preferable. Likewise, usual care is the preferred choice when it is 
cheaper and more effective. 
If the costs and outcomes are found to be equivalent, then either is acceptable. If only cost is 
equivalent, then the more effective intervention is preferable, and if only outcome is equivalent, then 
the cheaper intervention is preferable. 
When the evidence shows that one of the two (or more) interventions is both more costly and more 
effective, it is necessary to assess whether the additional costs is worth the greater effectiveness. 
This can be established by calculating a cost-effectiveness ratio (the difference in cost over the 
difference in outcome between the experimental intervention and the control or comparison group). 
The ratio is positive when one of the groups both costs more and produces a superior outcome. For 
example, an intervention that i) costs an extra Rupees 1000 over a year and ii) produces an 
additional improvement of 5 points on a social functioning measure compared to usual care, would 
result in a positive ratio of Rupees 200, interpreted as the increased average cost necessary to gain 
an average of I point of improvement per year. The cost-effectiveness ratio is negative when the 
innovative intervention costs less but has superior outcomes (i. e. cost saving), or when the 
innovation costs more but produces worse outcomes (i. e. a bad investment). 
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In any of these circumstances, the usefulness of these estimates depends on the validity and credibility 
of the evidence about the sampled populations of the study, and this is never perfect. A key activity of 
the analysis stage of an economic evaluation is therefore to carry out a sensitivity analysis, which 
involves the introduction of alternative values to key study parameters (such as the cost per inpatient 
day, or the rate at which capital costs have been discounted) with a view to assessing whether overall 
conclusions are robust to these plausible changes to values or whether in fact results are very sensitive 
to such changes. 
While the addition of economic analysis to mental health care evaluations introduces an extra 
dimension that offers a wider assessment of the implications of new or existing courses of action, it is 
important to mention some of the limitations of the approach. Many economic evaluations fall short of 
the ideal, whether that be in terms of sample size, or comprehensiveness of cost and outcome 
measurement. Conclusions based on a small trial with less than 50 subjects per arm can often only be 
tentative, while the failure to measure the indirect consequences associated with two alternative 
treatments (such as lost opportunities for work) may give rise to misleading results. There are also a 
number of ongoing methodological debates with respect to certain aspects of economic evaluation, such 
as the alternative techniques available for measuring health state preferences (essential for both cost- 
utility and cost-benefit analysis). In this context, it is worth noting that economic evaluation is no 
panacea for making difficult allocative and policy decisions; rather, it is one additional tool that 
together with clinical and social dimensions can facilitate explicit, evidence-based decision-making. 
Contact point 
If you have any queries regarding these guidelines, please contact: 
Daniel Chisholm, Economist 
Classification, Assessment and Surveys (CAS) 
World Health Organisation 
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